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Abstract 
Bone Tissue Engineering (TE) has been evolved as a promising mean to repair and regenerate 
defect and/or diseased bone tissues through the development of artificial extracellular matrix 
made from biopolymers. Silk fibroin based biomaterials are considered ideal for developing 
scaffolds for TE applications. The present research aims to develop novel biomimetic silk 
fibroin (SF) and carboxymethyl cellulose (CMC) based nanofibrous scaffold by free liquid 
surface electrospinning method. Randomly oriented electrospun nanofibrous scaffolds were 
developed from SF/CMC blends. Among the different blend ratios, 98:2 w/w of SF/CMC2 is 
the optimal achieving a set of superior scaffold properties in comparison to pure SF scaffold.  
The scaffolds were characterized for morphology (SEM, AFM), structural (XRD, FT-IR), 
surface property (% water uptake and contact angle measurement) and mechanical strength. 
The average fiber diameter was obtained as 227.8 ± 87 nm. The scaffold exhibited higher 
water uptake capacity, hydrophilicity and bioactivity showing uniform nucleation of Ca/P over 
the surface with controlled particle size of  ≤ 100 nm than the pure bombyx mori SF scaffolds.  
Though the tensile strength of pure SF (12.7 ± 1.5 MPa) was slightly reduced by the addition 
of CMC (10.54 ± 1.3 MPa), the scaffold still possess sufficient strength to support many types 
of bone tissue regeneration.  In vitro cell culture study has confirmed the cell supportive 
property of the scaffold as evident from cell attachment, cell proliferation, cell penetration and 
cellular metabolic activity of hMSCs which was derived from umbilical cord blood over the 
scaffold. The developed calcified SF/CMC2 blend scaffold possess good osteogenic property 
as confirmed by ALP activity, biomineralization ability, GAG secretion, osteocalcin, RUN X2 
and collagen type1 expression. The osteogenic potential of SF/CMC scaffold was further 
enhanced by incorporating nano-bioglass thereby SF/CMC/nBG composite scaffold was 
developed. The surface roughness of SF/CMC/nBG (5 - 20 wt%) scaffolds was linearly 
increased with nano-bioglass content. Among the various concentration of nBG, SF/CMC 
loaded with 10%nBG shows optimal tensile strength of 7.591 ± 1.23 MPa and tensile strain at 
break of 9.62 ± 0.85 %. The ALP activity of hMSCs on SF/CMC/10nBG was significantly 
(p˂0.05) higher than SF/CMC2 throughout the culture period. The OCN expression on 
SF/CMC/10%nBG was observed to be 4.1 fold higher than SF/CMC2 and 2.3 fold higher than 
calcified SF/CMC2 nanofibrous scaffold. Hence, SF/CMC/10%nBG composite scaffold is 
proven to provide better osteogenic platform for hMSCs. An effort has further been given to 
     
       
improve the angiogenic property of SF/CMC/nBG composite scaffolds by incorporating Cu2+ 
ion.  Among the scaffolds with varied compositions, SF/CMC/Cu1-5%nBG exhibited superior 
osteogenic and angiogenic property. Though a slightly higher OCN expression was observed 
over SF/CMC/Cu0.5-5%nBG composite scaffold than SF/CMC/Cu1-5%nBG, the difference in 
the expression was not statistically significant. However, SF/CMC/Cu1-5%nBG shows higher 
VEGF expression representing its superior angiogenic property than SF/CMC/Cu0.5-5%nBG 
scaffold. Thus, copper doped nano bioglass incorporated SF/CMC/Cu1-5%nBG composite 
nanofibrous matrix was proven to be a potential artificial extracellular matrix with enhanced 
bioactivity, osteogenic and angiogenic properties which might be a promising scaffold for 
future bone tissue regeneration. 
 
 Keywords: Silk fibroin; Electrospinning; Carboxymethyl cellulose; Tissue engineered 
scaffold; Bioactive glass; Osteogenesis; Angiogenesis; Biomineralization. 
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CHAPTER 1: General Introduction 
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1.1 Background and significance of study 
Bone tissue related defects, wounds and diseases predominantly due to the consequences of 
trauma, infection and degenerative bone defects and diseases are of major apprehension in the 
field of human health [1-2]. In USA, around 1 million bone injury cases is reported to occur 
every year and an alarming increase in bone related defects and diseases is expected to arise 
worldwide in future [3]. Presently, orthopaedic reconstruction procedure has been 
dramatically increased, that triggers the high demand for advanced bone reconstruction 
technology. The current modern clinical alternatives for orthopaedic reconstructive surgery 
are includes autografts, allograft, and xenografts [4-5]. These bone substitutes have several 
limitations such as limited supply, immunogenic, zoonotic disease transfer and donor site 
morbidity which are of major concern [6-7]. Such intrinsic problems associated with the 
currently available clinical strategy lead to the evolution of bone tissue engineering as a 
promising clinical alternative in the last decade. The aim of this interdisciplinary tissue 
engineering field is to replace, maintain and restore damage tissues through the development 
of bioactive, biodegradable and biocompatible functionalized three dimensional (3D) 
scaffolds made of natural or synthetic biopolymers [8-9].  
 
The key challenges for bone tissue engineering is to develop scaffold with desired physico-
chemical properties such as biomimetic, non-immunogenicity, desired mechanical strength, 
desirable biodegradation, porosity, swelling behaviour and to guide tissue regeneration [10]. 
The surface modification of the scaffold to produce biologically active matrix is another 
important aspect which improves the cell adhesion, proliferation and differentiation of host 
cells [11]. Bone tissue extracellular matrix is composed of collageneous fibers and inorganic 
substances like carbonated hydroxyapatite as biological mineral, which provides properties 
like hardness, rigidity and strength [12]. To achieve biomimetic properties of bone 
extracellular matrix, use of potential biopolymers, inorganic ceramics like hydroxyapatite, 
beta-tricalciumphosphate and bioglass and their composites are of prime interest.  In this 
context, silk fibroin, a natural polymer widely used in textile industry has drawned attention 
of the researchers worldwide in last two decades for use in medical and tissue engineering 
field because of its excellent property like mechanical strength, biodegradability, 
biocompatibility and desired oxygen and water permeability [13-15]. However, SF alone 
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cannot meet all the desired property of the tissue engineered scaffold, as it lacks 
hydrophilicity, bioactivity, osteoconductivity, swelling, flexibility and lack of bioactive cell 
signalling molecule [16]. Therefore, many researchers have been given effort to prepared SF 
blends like SF/chitosan, SF/chitin, and SF/PLA to improve the property of SF [17-20]. 
Besides SF biomaterial, Cellulose derivatives like carboxymethyl cellulose, cellulose acetate, 
hydroxyethyl cellulose and bacterial cellulose have been reported to be good candidates to 
fabricate scaffolds for tissue engineering application in bone regeneration, postinjury brain, 
blood vessels, artificial liver and cardiac cell construct development [21-25]. Furthermore, 
development of biopolymer/ceramic composite scaffold has gained significant interest over 
the last decade for bone tissue engineering applications. Besides exploring potential 
scaffolding material, fabrication of scaffold with nanostructure is important aspect as it 
mimics the extracellular matrix the structure and provide suitable template for cell 
attachment, proliferation and differentiation. In this context electrospinning is considered as 
the suitable fabrication technique that can produce nanofiber from polymeric blend and their 
composite solution. Thus the present research focused on the development of silk 
fibroin/carboxymethyl cellulose based composite nanofibrous scaffolds as potential artificial 
extracellular matrix for bone tissue engineering application. 
 
1.2 Strategies for Tissue regeneration  
Langer and Vacanti defined tissue engineering as an interdisciplinary field that applies the 
principles of engineering and the life sciences towards the development of biological 
substitutes that can restore, maintain or improve tissue or organ function [26-27]. Tissue 
engineering emerges as a clinical alternative in response to the problem related with the tissue 
damage or loss due to trauma or diseases. Tissue engineering deals with the creation of 
scaffold, which allows cell growth and proliferation in vitro and in vivo as well as degraded 
in time with tissue regeneration [28]. The biocompatible and biodegradable scaffold will 
degrade completely and prevent any chronic inflammation at the site of implantation. The 
scaffold should promote angiogenesis or vasculogenesis for the development of vascular 
network throughout the scaffold matrix for supplying oxygen, nutrient, growth factor and 
removal of degraded waste of scaffold while tissue regeneration. The design of surrogate 
 3 
 
extracellular matrix with appropriate structural framework embedded with suitable bioactive 
agent is essential to guide cells behaviour and organize tissue regeneration in vivo.  
 
1.3 Applications of tissue engineering  
Tissue engineering (TE) is emerging as a low cost and long term alternative clinical treatment 
method for tissue damage and organ failure. The technique involves the implantation of 
natural, synthetic, or semi-synthetic polymeric biological substitute that mimic tissue or 
organ and led to regeneration of functional tissue or organ. Tissue engineering is used to 
develop extracellular matrix to coax differentiated or undifferentiated cells into desired cell 
type and its important application of includes bone [29-30], cartilage [31-32], skin [33], 
ligament [34], tendon [34], neural [35], liver [36], cardiovascular [37] and muscle tissue [38-
40] related diseases [41]. The global medical and market potential attracted significant 
research & development academic and corporate interest in the field of tissue engineering. 
 
1.4 Tissue engineered scaffold 
In TE scaffold is a three dimensional temporary structure which supports cell attachment, 
proliferation and differentiation. Scaffold should be biocompatible, bioactive and 
biodegradable in nature [42]. Scaffold material, its structure or design and surface property 
are some of the crucial factors which guide cell attachment, proliferation and cell fate 
determination for desired tissue regeneration. Furthermore, the by-product of scaffold 
degradation should not be toxic, inflammatory and should be quickly removed from the site 
of implantation.  
 
1.4.1 Properties of scaffold  
Microscopic topography 
The microscopic and ultrafine structural properties of scaffold play vital role in regulating 
cell behaviour, cell migration into scaffold and influencing cell phenotype while tissue 
regeneration [43-44]. The irregular fibrous structures can facilitate cell adhesion and 
penetration into the scaffold [43]. The biomimetic architecture of human body consists of 
collagen fibers as natural extracellular matrices (ECM) with 50-500 nm diameter range [45]. 
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Thus the nanofibrous architecture of scaffold is one of the essential considerations in scaffold 
development for tissue engineering applications. 
  
Pore size 
Structure and size of pore is an important consideration in the fabrication of scaffolds in TE. 
Scaffolds must possess interconnected pores to facilitate cell growth, migration, diffusion of 
nutrients and removal of waste [46-47]. If the pore size is too small it limit the cell migration, 
diffusion of nutrient, removable of waste while if too large it will limit the cell attachment, 
cell seeding, mechanical strength and thus scaffolds with too small or too large pore size are 
not suitable for tissue regeneration. The pore sizes for scaffold varies depending on the type 
of applications such as for bone tissue engineering pore size lie in the range of 50-300 µm, 
whereas for cartilage tissue engineering the range is 150–300 µm [48-49]. The minimum pore 
size for significant bone tissue regeneration is 75-100 µm [49-50]. 
 
Porosity 
Scaffold must be porous and having optimum porosity, as porosity play important role in 
regulating cell migration, diffusion of nutrients and removal of degraded waste [51-52]. 
Furthermore, porosity influences directly or indirectly mechanical properties of scaffold, thus 
the scaffold should have optimum porosity within the construct [53]. 
 
Mechanical property 
The scaffold supports the tissue regeneration from the time of cell seeding to the remodelling 
of scaffold at the site of implantation by the host tissue [54]. While application in the case of 
bone and cartilage tissue, the scaffold matrix must provide enough mechanical support to 
endure in vivo stress and loading [54]. Also the mechanical property should be optimized so 
that it can stimulate lineage specific cell differentiation [55]. The material selection for 
scaffold fabrication is also important consideration for tissue regeneration, as the scaffold 
should have adequate strength to support complete tissue regeneration without failure [54]. 
 
Hydrophilicity 
The affinity of scaffold for water and getting wet is defined as hydrophilicity. The wetting 
affinity of scaffold material influences cell adhesion, spreading, proliferation, differentiation 
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and diffusion of nutrients within the cell-seeded construct [48]. The hydrophilicity of scaffold 
is determined by measuring contact angle. The cell response to scaffold material surface is 
governed by the adsorption of protein and cell secreted extracellular matrix [48].  Proteins 
tend to adsorb quickly on hydrophobic surface in comparison to hydrophilic surface. Thus 
scaffold material should have optimum contact angle [48].  
 
Surface roughness 
Surface roughness is one of the crucial factors that regulates cell adhesion, proliferation and 
phenotype expression [48]. The roughness of material surface can be classified as macro-
roughness (100 µm - millimetres), micro-roughness (100 nm - 100 µm) and nanoroughness 
(less than 100 nm) [48]. Different types of cells have different response depending on surface 
roughness of the scaffold. However, osteoblast cells show favourable behaviour over scaffold 
with macro-roughness [48].  
 
Biocompatibility 
Biocompatibility of scaffold refers to its ability to interact with the host tissue without 
causing any inflammatory or harmful reaction. The degraded product of the scaffold should 
be non-toxic for the successful tissue regeneration at the site of implantation. 
 
Biodegradation 
The scaffold material should be selected by taking into consideration of its rate of 
degradation and resorption while tissue regeneration [54]. Moreover, the rate of degradation 
and resorption should be optimized, so that the scaffold maintains its physical properties for 
at least 6 months [54]. The scaffold should allow cells to proliferate, migrate and differentiate 
in a controlled way while the scaffold matrix degrades and it should leaves enough space for 
new tissue growth and vascularisation [54]. 
 
Bioactivity 
The development of biocompatible, biodegradable and bioactive scaffold with suitable 
porosity and mechanical property is of prime goal in tissue engineering application. The 
bioactivity of scaffold determine its ability to integrate or bonding with host tissue at the site 
of implantation [56]. Therefore, In case of bone tissue engineering it is desirable to determine 
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apatite forming ability of scaffold material for predicting bioactivity of the material [56]. The 
osteoconductive and osteoinductive property of scaffold are essential for bone tissue 
engineering. Thus the development of scaffold with innate osteoconductive and 
osteoinductive property is of prime goal in bone tissue engineering application. 
 
1.4.2 Biomaterials for scaffold development 
Material selection for tissue engineered scaffold development is one of the most important 
strategies in tissue engineering as it determines the rate of degradation and remodelling while 
host tissue regeneration [57]. An appropriate scaffolding material should possess some of the 
crucial properties like biocompatibility, biodegradability, bioresorbable, desired physico-
chemical properties and desired mechanical strength for successful tissue regeneration [57-
59]. Although a number of implantable metal and ceramic based structures has been 
developed earlier but since these materials fail to meet the criteria of biodegradability thus 
not suitable for tissue regeneration application [57-58]. Although there are various ceramic 
materials such as tri calcium phosphate and bioglass with biodegradability, bioactivity and 
biocompatibility properties but these materials are difficult to process into complex structure 
and also highly brittle. Thus ceramic material alone cannot fulfil the prerequisite for tissue 
engineering application [57-58]. However, polymeric material either natural or synthetic can 
be used alone or in combination to develop complex structure as polymers are ductile and can 
be processed into various shapes. Thus to fulfil various strategies for developing smart 
scaffolding material polymers and ceramics are combined to form composite to achieve 
prerequisite for successful tissue engineering application. 
 
Natural polymer 
Natural polymers derived from animal or plant sources are considered as the most suitable 
scaffolding material for TE including bone tissue engineering application. Natural polymers 
like collagen [60], chitosan [61-62], silk fibroin [63-64], cellulose and its derivatives [65] and 
gelatin [66-67] are considered as suitable material for the development of scaffold, as these 
materials offer superior cell adhesion, spreading and proliferation properties. Natural 
biopolymers are of great interest for the researchers because of their low toxicity, 
biocompatibility, low cost, large availability and renewability.   Also well known chemical 
structure of biopolymer provides opportunity to develop advanced functionalized scaffolds 
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and well known biosynthetic pathway offers to genetically modify the biopolymer structure 
and function to make them more potential for tissue engineering application [65].  
 
Synthetic polymers 
Biodegradable and biocompatible synthetic polymers offer various advantageous properties 
such as tuneable mechanical property, defined degradation kinetics, can be modified with 
desired chemical functional moieties and also can be fabricated in to various shapes thereby 
making them suitable for various biomedical applications [68-69]. Synthetic biopolymer offer 
extensive applications in making resorbable sutures, drug delivery and orthopaedic fixations 
such as screws, pins, rods and plates [68]. Selection of synthetic polymers for tissue 
engineering application is one of the important parameters as the biopolymers like 
poly(glycolic acid), poly(lactic acid) and their copolymers resulted in to release of acidic 
products while biodegradation, which resulted in inflammatory reaction and thus failure of 
tissue regeneration occurs [68]. Thus synthetic biopolymer, which offers nontoxic degraded 
product during biodegradation are of preferred choice for tissue engineering application. To 
fulfil desired characteristic of scaffold for application in tissue engineering various synthetic 
polymers, natural polymers and ceramics were used alone or in combination for successful 
tissue regeneration.  
 
Bioceramics 
Various bio-ceramics like hydroxyapatite (HAp) [70], tri-calcium phosphate (TCP) [71-72], 
biphasic calcium phosphate (BCP) [73], bioglass [74] and wollastonite [75] have been the 
choice of many researcher for the development of 3D structure by adding with biopolymers 
for bone tissue engineering applications [76]. However matching mechanical properties of 
ceramic based scaffold with native bone remains a challenge as these ceramics based 
matrices are highly brittle and thus limit their clinical application. Presently various ceramic 
based products are available for various clinical applications such as dental, maxillofacial and 
orthopaedic.  But there is of great need to identify smart biomaterials to overcome the 
limitations such as brittleness of ceramics based product, lack of bioactivity in case of 
polymeric scaffold, toxic product produced through degradation of synthetic polymers and 
lack of osteoconductivity of polymeric scaffolds. Thus the development of ceramic-
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biodegradable polymer composites is of great interest in bone tissue engineering to achive 
desirable mechanical property. 
 
Hydroxyapatite Ca10(PO4)6(OH)2 is an important biomaterial constituent of bone and teeth. It 
is used in the replacement of hip joints, heart valves etc. Due to its similarity with bone 
material at chemical and crystallographic structure hydroxyapatite, is used as bio-active 
material in bone tissue engineering [77]. Hydroxyapatite can be synthesized by using 
chemical source of calcium like calcium nitrate or by using natural source of calcium like egg 
shell. Using natural source will minimize the impurities like silica in the material. 
Concentrations of reactant were determined by the fact that Ca/P ratio for hydroxyapatite 
equal to 1.67 [78]. Bioactive glass and other class of ceramic material are able to stimulate 
bone regeneration better than other bioactive ceramic materials. Although in vivo study 
reveals that bioactive glass possess ability to bond with bone much faster in comparison of 
other bioactive ceramics. Also in vitro studies shows that its osteogenic property are due to 
the product formed after its dissolution which stimulate stem cell at genetic level to form 
bone [79-80]. Professor Hench made a biodegradable glass with Na2O-CaO-SiO2-P2O5 
system having high calcium content. Hench developed a glass having composition 46.1 mol% 
SiO2, 24.4 mol% Na2O, 26.9 mol% CaO and 2.6 mol% P2O5, later called as 45S5 Bioglass 
[81-82]. Dissolution of glass leads to the formation of carbonated hydroxyapatite on the 
surface of glass. carbonated hydroxyapatite is similar to bone mineral, and interact with 
collagen fibrils that leads to formation of mineralized bone extra cellular matrix [82]. Soluble 
silica and calcium ions stimulate osteoprogenetor cells to produce bone matrix [83]. 
Dissolution rate of glass were regulated by varying its composition and thus can be used for 
long term regeneration therapy as well as short term regeneration therapy. Various types of 
bioactive glasses developed are conventional silicates (45S5 Bioglass), phosphate based 
glasses, and borate based glasses, which were made by either melt-down method or by sol-gel 
method. 
 
Biocomposites 
The ideal scaffolds for bone tissue engineering must possess appropriate pore size, porosity, 
mechanical strength, biodegradability, biocompatibility and ability to integrate with host bone 
tissue. However polymeric scaffold alone fails to provide proper mechanical strength, 
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bioactive environment for cell differentiation and structural feature for bone tissue 
regeneration. Thus in recent years, composite materials gained tremendous attention to fulfil 
the properties like bioactivity, biocompatibility, biodegradability and mechanical strength for 
successful bone tissue regeneration. Composites are fabricated by using two or more different 
materials like polymers (silk fibroin, chitosan, and gelatin etc) and ceramics (hydroxyapatite, 
bioglass and tricalcium phosphate etc). Bioceramics in polymers-ceramics composite 
improves its osteogenic differentiation potential, upregulated various osteogenic genes such 
as collagen type 1, osteocalcin, runt-related transcription factor, bone sialoprotein and 
alkaline phosphatase activity. Thus bioceramic based polymeric composite may provide 
suitable platform for bone tissues regeneration. 
 
1.4.3 Scaffold fabrication techniques 
Artificial extracellular matrices (scaffold) with three dimensional architecture have gained 
widespread application in tissue engineering due to their nano-scale topography, biomimetic 
property and ability to direct specific tissue regeneration. As of now there are various 
techniques available to fabricate scaffold such as electrospinning, freeze drying, phase 
separation, rapid prototyping and particulate leaching [84]. But the numbers of challenges are 
still need to overcome for developing a functional smart matrix for successful bone tissue 
regeneration. Apart from the fabrication of scaffold by using various techniques, surface 
modification of scaffold is also desirable to improve cell attachment, migration, proliferation 
and differentiation. Various methods and its merits and demerits are listed out in Table 1.1 
[85]. The most important methods are described below. 
 
Particulate leaching 
Artificial extracellular matrix (scaffold) provide appropriate surface for cell attachment, 
proliferation and help in tissue regeneration. Pore size and porosity of scaffold are one of the 
crucial factors which determine specific surface area for cell adherence and tissue in-growth 
[86]. Particulate leaching technique involves preparation of polymer solution with well 
distributed salt particles with uniform diameter followed by evaporation of solvent leaving 
behind polymer matrix [87]. The polymer –salt composite is then soaked in water to remove 
salt through leaching. The porogens particle size, amount and shape determine pore size and 
porosity of developed scaffold by particulate leaching method [84].  
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Melt molding 
Melt molding method involves the filling of mould with polymer powder and porogens of 
specific diameter followed by heating above the glass transition temperature of polymer 
under applied pressure. This leads to binding of polymeric materials together and then 
porogens are leached out using non-solvent. Finally porous scaffold with appropriate 
morphology and shape are fabricated. However the major disadvantage of melt molding 
method includes high processing temperature and residual porogens.  
 
Freeze drying 
Freeze drying a drying process based on the principle of sublimation is used to fabricate 
porous structure and to convert solution with useful labile material into solid form with good 
stability [84]. It has wide application in food science, pharmaceutical, enzyme stabilization 
and biomedical applications [88]. Freeze drying process mainly consists of three steps 
freezing of solution at low temperature (-20°C to -80°C), followed by primary drying at -
110°C under low pressure (high vacuum) [88].  The porous structure with proper 
interconnectivity is obtained from polymeric solution through freeze drying.   The pore size, 
distribution and interconnectivity of pores can be controlled through the controlling rate of 
freezing and direction of solidification [84]. However, it’s a time consuming process but 
avoids high temperature and separate leaching step as involved in other process such as melt 
molding, particulate leaching etc [84]. 
 
Freeze gelation 
The freeze gelation technique based on freezing of polymeric solution followed by use of 
non-solvent to generate phase separation in polymeric solution, which finally leads to 
development of porous scaffold [84]. While freeze gelation two distinct phase develop one 
having high polymer concentration and other is polymer deficient [84]. As the temperature 
lowered liquid-liquid phase separations occur and quenched to form solid phase and the 
solvent phase, where the solvent phase is finally removed by extraction, evaporation and 
sublimation to fabricate three dimensional porous structures [84]. Polymeric nanofiber can 
also be fabricated using phase separation method however selection of solvent and phase 
separation temperature is crucial factor for nanofiber formation [84].  
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Table 1.1 Advantage and disadvantage of various scaffold fabrication techniques 
Techniques Advantages Disadvantages References 
Solvent casting/ 
Particulate leaching 
Control over Porosity, pore 
size and crystallinity 
Limited mechanical 
property, residual solvents 
and porogen material 
[89] 
Porogen leaching Controlled over  porosity 
and pore geometry  
Inadequate pore sizeand 
pore interconnectivity  
[90] 
Gas forming Free of harsh organic 
solvents, control over 
porosity and pore size 
Limited mechanical 
property, inadequate pore 
interconnectivity 
[84] 
Self-assembly Control over organization 
of biomolecule, fiber 
diameter, porosity 
Complicated and elaborated 
process, high cost of 
synthesis of biomaterial 
[91] 
Electrospinning Control over porosity, pore 
size and fiber diameter 
Limited mechanical 
property, pore size decrease 
with fiber thickness 
[92] 
Phase separation  No decrease in the activity 
of the molecule 
Difficult to control 
precisely scaffold 
morphology  
[93] 
Rapid prototyping Excellent control over 
geometry, porosity, no 
supporting material require 
Limited polymer type 
highly expensive equipment  
[54, 94] 
Fiber mesh Large surface area for cell 
attachment, rapid nutrient 
diffusion  
Lack the structure stability 
 
[95] 
Fiber bonding  High surface to volume 
ratio, high porosity 
Poor mechanical property, 
limited applications to other 
polymers  
[96] 
Melting molding Independent control over 
porosity and pore size 
Required high temperature 
for non-amorphous polymer 
[97-98] 
Membrane lamination Provide 3D matrix Lack required mechanical 
strength, inadequate pore 
interconnectivity  
[99] 
Freeze drying High temperature & 
leaching  not required 
Small pore size and long 
processing time 
[85, 100] 
 
Self assembly 
Self assembly technique is based on organization of the natural or synthetic molecule in to 
nanofibrous structure.  The method is based on interaction between hydrophilic and 
hydrophobic domain of amphiphilic peptides, which further assemble into nanofibrous 
structure through weak non covalent bonding such as hydrogen bond, van der waals 
interaction, ionic interaction etc. Apart from peptides synthetic polymer molecule can also be 
used to fabricate nanofiber by self assembly method. The major advantage of self assembly 
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method is fabrication of nanofiber from aqueous solution and avoids organic solvent, thus 
reduce the cytotoxicity. However, this technique is very complicated. 
 
Electrospinning 
Electrospinning is a versatile technique used to fabricate polymeric fibers with diameters 
either in nanoscale or microscale range. Electrospinning technique is classified as needle 
based electrospinning and free liquid surface electrospinning both are operated at high 
electric voltage. The needle based electrospinning machine consists of a syringe pump, high 
voltage electric source and collector, where free liquid surface electrospinning consists of 
spinning electrode tray, high voltage source and collector electrode. In needle based 
electrospinning high voltage is applied to a syringe filled with polymer solution and under 
high electric field polymer solution electrospun and deposited on collector positioned at 
appropriate distance. In free liquid surface electrospinning spinning electrode carries thin 
layer of solution over its surface and under high electric field polymer solution electrospun 
over collector positioned at appropriate distance.  In both the cases when charge repulsion 
under high electrical field overcomes the surface tension a charged jet of polymer solution 
formed. Finally, the solvent get evaporated under dehumidified condition leading to the 
formation of electrospun fibers over the collector. Although electrospinning is the simplest 
method to fabricate nanofibrous scaffold, it needs further improvement in order to fabricate 
scaffolds for complex tissues 3D in particular. 
 
Rapid prototyping 
Rapid prototyping (RP) is computer controlled technique used to produce three dimensional 
scaffolds by using layer by layer deposition method [84]. Rapid prototyping is also called as 
solid free form technique. The RP method is based on computer assisted design (CAD) and 
computer assisted manufacturing technique [87]. It allows fabrication of scaffold with better 
control of internal and external macroshape in comparison to other fabrication techniques 
[87]. Rapid prototyping uses images of site of wound and create CAD model, which is further 
reduced to a thin slices to utilize it to deign appropriate three dimensional architecture [84]. 
Finally three dimensional structures are developed by layer by layer deposition of polymeric 
or polymer composite solution using rapid prototyping [84]. This is the most suitable 
technique to fabricate scaffold with appropriate deign or architecture for complex tissue 
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regeneration. The comparison of various scaffold fabrication technique are shown in table 
[1.1]. 
 
1.4.4 Stem cells for tissue engineering 
In recent years great interest has been shown by the researchers in stem cell research and 
derivation of its potential applications in tissue regeneration and other biomedical 
applications [101]. The development of tissue engineered construct in vitro requires three 
dimensional scaffolds seeded with cells derived from patient native tissue. However, the 
invasive method of cell collection and disease carrying possibilities limit their application 
[102].  Therefore stem cells such as embryonic stem cells and mesenchymal stem cells from 
various sources has gained much attention in recent years for tissue engineering applications 
[102-103]. 
 
Embryonic stem cells 
Embryonic stem cells are isolated from blastocyst before uterine implantation and are 
maintained for longer culture duration [101]. The embryonic stem cells can be characterized 
by analysing various markers such as CD324, CD90, CD117 and CD326 [104]. The 
important characteristics of embryonic stem cells are their ability to maintain undifferentiated 
stage for longer period, capable of self renewal, lead to formation of teratoma and ability to 
differentiate into all three germ layer [101-102]. Though embryonic stem cells are one of the 
prominent cell types for the development of tissue engineered constructs, the formation of 
teratoma and teratocarcinoma limits their applications in tissue engineering [102].  
 
Mesenchymal stem cells (hMSCs) 
Mesenchymal stem cells are post-natal stem cells and having capability to differentiate into 
various cell types such as chondrocytes, osteoblasts, adipocytes, muscle cells and neural cells 
[105]. hMSCs shows expression of a unique cell surface markers such as STRO-1, CD29, 
CD73, CD90, CD105, CD146 and Octamer-4, whereas negative for hematopoietic stem cell 
marker such as CD14, CD45 and CD34 [106]. Bone marrow mesenchymal stem cells having 
colony forming ability, fibroblast like morphology and capable to differentiate both in vitro 
and in vivo without any specific treatment into osteoblast cells. Also hMSCs leads to form 
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mineralized nodule when cultured with a specific medium.  Various animal models were used 
and bone tissue regeneration capability of hMSCs was observed [105]. Also ceramic carriers 
loaded with hMSCs shows significant improvement in bone tissue regeneration and thus 
confirm its therapeutic application [105].  
 
Umbilical cord blood derived mesenchymal stem cells shows ability to differentiate into cells 
of multi-lineage fate such as adipocytes, osteoblasts, hepatocytes and neuronal cells [105]. 
Also the gene expression profile and cell surface marker was observed to be similar of 
hMSCs gene expression [105]. In animal models, umbilical cord blood derived mesenchymal 
stem cells shows in vivo differentiation capability and immunocompatibility with host tissue 
even in xenotransplantation as they are immunologically younger [107-108].  Thus cord 
blood derived mesenchymal stem cells would also be used as prominent therapeutics stem 
cell source for bone tissue engineering application. 
 
1.4.6 Bone 
Bone tissue is a mineralized, dynamic, highly vascularised and have the capacity to heal and 
remodel [109]. Besides providing structural support to the body, it also acts as mineral 
reservoir, withstands body load, protect internal body structure and supports muscular 
activity [53, 109]. Thus any diseases or injury to bone may alter the body function and 
lifestyle. The present available treatment for bone tissue related injury or diseases are mostly 
consisting of titanium or stainless steel based bone graft or autografts, allografts and 
xenografts. However metal based bone grafts have several limitations such as poor 
integration with host tissue and failure due to fatigue loading, which are of major concern. 
Whereas natural bone tissue based graft from various sources suffer from non-availability, 
possibilities of immune rejection and pathogen transmission from donor to host [53]. Even 
though ceramic based bone substitutes offer more favourable environment for bone tissue 
regeneration but their application are limited due to low tensile strength and brittleness [53]. 
Hence for satisfactory and successful bone tissue injury recovery, a much more advanced 
alternative therapeutics is of great demand and tissue engineering could be a possible 
solution.  
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Structure and composition of bone 
Bone tissue extracellular matrix consists of two major components, a biomineral component 
constituted of hydroxyapatite, which covers 65% to 70% of the extracellular matrix and an 
organic component consisting of proteoglycans, glycoproteins, bone sialoproteins and bone 
gla proteins which cover 25% to 30% of the extracellular matrix. Various components of 
extracellular matrix of bone and its role highlighted in Table 1.2. 
 
Table 1.2: Various component of extracellular matrix of bone and its role 
Bone Extracellular matrix constituent Functions and properties Reference 
Collagen I Responsible for matrix 
calcification and skeletal 
framework construction 
[110] 
Byglican, Decorin Control collagen fiber growth and 
diameter, participate in 
mineralization of bone matrix 
[111] 
Osteonectin Hydroxyapatite nucleation and 
bind with calcium and collagen 
and help in resorption of bone 
tissue and remodelling 
[112] 
Thrombospondin Glycoprotein binds calcium and 
hydroxyapatite, facilitate 
adhesion of cells through  RGD-
independent fashion 
[113-114] 
Fibronectin Help in osteoblast adhesion, 
attachment 
[115] 
Osteopontin Helps in remodelling of bone 
tissue  
[112] 
Bone sialoprotein Bone sialoprotein; major 
constituent of cement line of bone 
tissue 
[112] 
Osteocalcin late marker of osteogenic 
phenotype, regulate 
mineralization of matrix and 
remodelling of bone tissue 
[116-117] 
 
Types of bone and bone cells 
Bone tissue is classified depending upon its architectural forms as cancelous or spongy bone, 
which covers 20% of the total skeleton and cortical or compact bone which covers 80% of the 
total skeleton. Cortical bone posses 10% porosity, whereas cancelous bone posses around 50-
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90% porosity. Thus, cortical bone posses 20 times higher ultimate compressive strength than 
cancelous bone. Bone tissue is a mineralized connective tissue which is made up of mineral 
phase mainly hydroxyapatite, organic phase and various bone cells such as osteoblast, 
osteocytes and osteoclasts [118]. However the role of bone cells is not well understood 
through they play vital role in coupling bone resorption to bone formation [118].  Each type 
of bone cells have particular functions and thus play important role in maintenance of a 
healthy bone [53]. The characteristics and functions of bone cells are detailed in Table 1.3. 
 
Table 1.3: Bone cells and their function 
 
Cell type Morphological 
characteristics 
Function Reference 
Osteoblasts Cuboidal in shape and 
polarized cell 
Regulate bone extracellular matrix 
deposition and mineralization,  
[119-121] 
Osteocytes Stellate shaped  Calcification of the bone  matrix, 
blood calcium homeostasis,  
[122] 
Osteoclasts Multinucleated and 
polarized cells 
Mediate bone resorption [123] 
 
1.4.7 Silk fibroin as ideal biopolymer for tissue regeneration 
Silk is a natural biopolymer used in the textile industry from centuries because of its luster 
and mechanical property. Various organisms such as members of class Arachnida and of 
order Lepidoptera produces silk [14, 124]. These organisms produces silk fibroin (SF) to 
provide structural framework in cocoon formation, nest building and protection of eggs [14]. 
Silk fibroin protein consists of beta-sheet structure and rich in  hydrophobic domains with 
short side chain amino acid, which allows tight packing of stacked anti-parallel chains of the 
protein [14]. The hierarchical molecular structure of silk fibroin consists of large hydrophobic 
domains interspaced with smaller hydrophilic domains, which provide excellent assembly of 
silk fibroin and higher tensile property [14]. Silk fibers from B.Mori used as suture material 
in medical feild for centuries, thus silk fibroin have been widely investigated as promising 
biomaterial for tissue engineering applications [14]. The flexibility of silk fibers makes it 
suitable for the development of scaffold for load bearing bone tissue regeneration [125]. The 
superior mechanical characteristic of silk fibroin scaffold as compared of other natural 
polymers scaffolds makes silk fibroin as suitable candidate for bone tissue engineering 
applications [126]. Silk fibroin possess various important characteristics such as 
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biocompatibility, biodegradability, solubility in aqueous/organic solvent, ease to process into 
various forms of structure (film, nanofiber, porous) and tuneable mechanical strength, which 
make it suitable biopolymer for wide application in biomedical and tissue engineering [14]. 
However due to lack of bioactivity, hydrophilicity and osteoconductivity property, silk 
fibroin alone is not able to offer suitable template for bone tissue regeneration.  Therefore, it 
is of great need to fabricate calcified SF or composite SF scaffolds combined with biocermics 
is of paramount importance.  
 
1.4.8 Future prospects of tissue engineering 
Tissue engineering is emerging as one of the potential science and technology applications to 
restore, maintain or replace the damaged and/or diseased tissues of different type. However in 
current scenario, it needs to be far broader in coming future, which not only deals with the 
development of engineered tissue to reduce organ transplantation but also accelerate the 
novel drug development. Although some of the tissue engineered products have been 
approved by the Food and Drug Administration and more than 70 corporate companies and 
government research agencies are spending 600 million dollar per year for the development 
of novel tissue engineered products [8, 127]. The production of tissue engineered product at 
large scale requires efficient technique to isolate, culture and maintenance of cells for longer 
duration, optimization and development of smart scaffolds, and development of suitable 
bioreactor to mimic body tissue environment and  capable to scale-up [8]. Thus in future, 
tissue engineering will emerge as a potential clinical treatment method as compared to 
traditional clinical approaches to cure not only bone but other tissue defects and diseases as 
well.  
 
1.4.9 Thesis outline 
The entire thesis wsork has been organised in six chapters as follows: Chapter 1- deals with 
the general introduction on the topic including the principle of tissue engineering and its 
application to bone TE by overcoming the limitations associated with the current clinical 
approaches, extracellular matrix and its role, strategies employed to fabricate and develop 
smart polymeric matrices for bone tissue engineering. Chapter 2- presents the literature 
review covering fundamental concept and recent advancement in silk fibroin, cellulose and 
its derivatives based scaffold fabrication for bone tissue engineering application. It also 
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covers the possible ways to improve or modify bio-relevant properties as well as material 
characteristic of silk fibroin scaffold for its successful application in bone tissue regeneration. 
Chapter 3- describes the scope and objective of the research work. Chapter 4- presents 
materials and methods adopted to fabricate silk fibroin and carboxymethyl cellulose based 
composite nanofibrous scaffold incorporated with nano-bioglass and copper doped nano-
bioglass. It covers various methods adopted to evaluate physical, chemical and biological 
characterization of developed scaffolds. Chapter 5- presents the result and discussion of 
experimental work, which is sub-divided into the following parts: Chapter 5A deals with the 
development of SF and SF/CMC blend scaffolds and their characterization for physical, 
chemical and biological property. Chapter 5B describes the synthesis and characterization of 
nano-bioglass. Chapter 5C reports on the further improvement of osteogenic potential of 
SF/CMC nanofibrous scaffold by incorporation of nano-bioglass. Chapter 5D deals with 
improvement of osteogenic and angiogenic potential of SF/CMC composite scaffold loaded 
with copper doped nano-bioglass. Chapter 6- presents a brief summary and conclusion of the 
experimental work along with suggested future study.  
  
 
 
 
 
 
 
 
 
 
CHAPTER 2: Literature Review 
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2.1 Current status, prospects and challenges of bone tissue 
engineering 
Bone tissue defects and diseases because of the consequences of trauma, degeneration 
infection, deformity etc affecting human life style as well as death are of major concern in 
health sector.  Every year, more than 700,000 total joint replacement are performed only in 
the US [128], whereas, 50% of total osteoporotic hip fracture has been projected to occur in 
Asia alone by 2050 [129].  In India, approximately 26 million osteoporosis patients was 
reported in 2010 and was expected to reach 36 million by 2013 [130]. It has been reported 
that more than 51 million peoples had been diagnosed with some form of arthritis, according 
to the National Health Interview Survey [131]. This prevalence is higher than many well 
known diseases. Current clinical treatment strategies for cartilage tissue and subchondral 
bone damage like mosaicplasty, autologous chondrocytes implantation (ACI) and marrow 
stimulation technique have varying success rates, but average long-term results are 
unsatisfactory thereby eventually pain continues [132-133].  
 
The various clinical approaches such as artificial prosthesis, surgical reconstruction and other 
bone grafts (allografts, autografts and xenografts) are currently used to treat various bone 
tissue defects. However due to some of the major limitations of such approaches like 
corrosion of prosthesis, immunogenic reaction, disease transmission, donor morbidity and 
lack of donor limits their applications. In this context the reparative ability of bone tissue 
leads to adopt various tissue engineering strategies to develop alternative clinical treatment 
options [134]. For this appropriate molecular and macroscopic architectural framework of 
regenerated tissue are essential factors of consideration in tissue engineering approaches. 
Bone tissue engineering particularly deals with the development of living tissues in vitro 
through growing cells over bioactive degradable scaffolds. Thus it is important to understand 
cell behaviour over the scaffold surface, role of scaffolding material to guide tissue specific 
differentiation of cells and their assembly into 3D functional tissue [8]. In addition fabrication 
and design of scaffold are also crucial factors which determine the successful development of 
functional tissue construct. Selection of ideal biomaterial is crucial mainstay of tissue 
engineering as it plays key role in guiding bone tissue regeneration, angiogenesis and growth 
of nerves  under the  orchestrate activity of specific cell signalling molecule [8].  
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2.2 Ideal biomaterials for bone tissue engineering 
The ideal scaffold material should mimic the body extracellular matrix to support cell 
adhesion, cell proliferation and differentiation leading to tissue regeneration [54, 135]. 
Scaffolding material and fabrication technology play critical role in designing and 
development of appropriate functional three dimensional artificial extracellular matrices. 
Developed scaffold should have high porosity, appropriate pore size, biodegradability, 
biocompatibility, bioactivity, needed to degrade with regeneration of damaged tissue 
parallelly, should provide high surface area for cell adhesion, proliferation and migration, 
adequate mechanical strength, ability to deliver active molecules to guide cell proliferation 
and tissue specific differentiation [136-138]. Natural and synthetic biopolymer alone or in 
combination are the primary scaffolding material, as these can be easily molded into 
appropriate architecture, facilitate surface modification to improve cell interaction and 
biomineralization for bone tissue engineering application [139]. For successful bone tissue 
regeneration polymeric materials are reported to be reinforced with bioceramic to achieve 
scaffold with enhanced osteogenic potential or other desirable properties [140].  
 
For tissue engineering application it is of great need to fabricate scaffold from bioactive 
biodegradable material that provide physical and chemical cues to guide cell adhesion, 
proliferation, differentiation and assembly into appropriate three-dimensional structure 
similar to native tissue [141]. The basic requirements of the biomaterials used for fabrication 
of scaffold are biocompatible, suitable mechanical strength and bioactivity. However to meet 
such requirement single polymeric materials cannot fulfil the desirable prerequisite for tissue 
regeneration [141]. Therefore, multi-polymeric material system might be a suitable strategy 
to design and fabricate functional biomaterial [141]. The potential biopolymers have been 
explored for TE application in recent decades includes silk fibroin [142], chitosan [143], 
collagen [144], and so on. Whereas bioceramics such as hydroxyapatite, beta-tricalcium 
phosphate and bioglass at both micro and nano scale are reported as suitable bioceramics for 
making composite with biopolymer [145]. Further, interaction between bioceramics and 
polymer matrix at nano scale provides enhanced mechanical and functional properties to 
polymeric nanocomposites [141]. In fact, natural bone tissue extracellular matrix are made up 
of organic/inorganic composite material of collagen and apatite, thus composite materials are 
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appropriate choices to design and fabricate scaffold for bone tissue engineering [146]. To 
optimize or adjust the properties of scaffolding biopolymers to apply in tissue engineering 
application, a wide variety of approaches are considered for their modification. The 
biopolymer surfaces have been physically and chemically  modified with bioactive agents 
after the processing condition, which consequently  provides bio-modulating or biomimetic 
microenvironment for tissue regeneration [141, 147]. Thus, various approaches has been 
adopted to modify the surface of scaffolding materials in order to achieve desired surface 
characteristic for improvement of tissue regeneration.  
 
Various surface treatment techniques such as plasma treatment [148], ion sputtering [149], 
oxidation and corona discharge [150] has been considered as potential methods of  modifying 
surface characteristic of polymeric material without much affecting their bulk properties 
[141]. Furthermore, to improve apatite nucleation or deposition polymeric surface was 
functionalized with calcium ion using calcium chloride solution [151]. The surface of 
scaffolding materials were conjugated with extracellular matrix component or peptide 
sequence like Arg-Gly-Asp (RGD sequence) to achieve superior cell adhesion [152]. The 
incorporation of RGD sequence improved the scaffold bio-responsive surface site for integrin 
receptors of cells that eventually facilitated integrin mediated cell adhesion process. 
Biopolymers such as silk fibroin and chitosan used as scaffolding materials were also 
reported to be cross-linked using carbodimide chemistry to graft cell adhesive peptides and to 
improve physico-chemical, biological and degradation properties [153-154]. Various natural 
and synthetic biopolymers and its application listed out in table 2.1. 
 
Table 2.1: Various biopolymers and its application in tissue engineering. 
Sl. No. Biopolymer Application References 
1 Silk Fibroin Bone, cartilage and hepatic tissue 
engineering, Drug delivery 
[15, 155-157] 
2 Chitosan Bone and cartilage tissue engineering, 
Drug delivery, wound healing  
[143, 158-159] 
3 Chitin Bone, cartilage and dental tissue 
engineering, wound healing, drug delivery 
[158, 160] 
4 Starch Bone tissue engineering, biomolecules and [161-162] 
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cell delivery 
5 Pectin Bone tissue engineering, drug delivery [163] 
6 Cellulose Bone and vascular tissue engineering, [164] 
7 Carboxymethyl 
cellulose 
Bone tissue engineering, drug delivery [165-166] 
8 Gelatin Bone, cartilage and nerve tissue 
engineering 
[167-169] 
9 Polyvinyl alcohol 
(PVA) 
Cartilage and orthopaedic application [170] 
10 Poly(caprolactone) 
(PCL) 
Bone tissue engineering, drug delivery [171] 
11 Poly(3-
hydroxybutyrate) 
Bone and cartilage tissue engineering, 
peripheral nerve regeneration 
[172-173] 
12 Poly(dioxanone) Cardiovascular and Vascular tissue 
engineering 
[174-175] 
13 Poly(glycolic-co-lactic 
acid) 
Bone tissue engineering [176] 
14 Poly(lactic acid) Bone, cartilage and neural tissue 
engineering 
[35, 177-178] 
15 Poly(glycolic acid) Bone, cartilage and musculoskeletal tissue 
engineering 
[42, 179-180] 
 
2.3 Silk fibroin based polymer-polymer blend scaffold  
Silk fibroin is a unique biomaterial with various superior characteristics such as 
biocompatibility [181], biodegradability [182] and tuneable mechanical properties [183], 
which offer suitable platform for cells adhesion, proliferation and migration. Silk fibroin can 
be dissolved in both aqueous as well as in organic solvent and can be molded in to various 
structures such as film, fiber and porous architecture for various tissue engineering 
applications [184-186]. Non-woven silk fibroin mats having higher surface area and 
roughness, which provide superior surface topography thereby improving cell attachment 
phenomenon while tissue regeneration. Electrospinning technique is the most commonly used 
to fabricate non-woven mats. Park et al (2004) reported successful electrospinning of silk 
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fibroin (SF) and chitosan (CS) blend prepared in formic acid and demonstrated about 
significant conformational changes of the as-spun SF/CS blend nanofiber with improved β-
sheet content [187]. Chen et al (2012) also reported on fabrication of biomimetic SF/CS 
nanofiber and observed osteogenic potential of SF/CS blend nanofibrous scaffold [188]. 
Fabrication of porous SF/CS based scaffold with interconnected porous structure, suitable 
antimicrobial, degradation and mechanical property for tissue engineering especially cartilage 
was also reported [19]. Fan et al (2008) fabricated silk cable-reinforced silk fibroin based 
hybrid scaffold and observed to be suitable candidate for ligament tissue engineering, as it 
support proliferation and differentiation of co-culture mesenchymal stem cell/anterior 
cruciate ligament fibroblast cell [189]. Twisted structure developed using degummed silk 
fiber provides appropriate mechanical integrity (maximum load of 2337 ± 72 N, elastic 
modulus of 354 ± 26 N/mm and strain at failure of 38.6 ± 2.4 %) closer to native ligament 
tissue,  thus play vital role in ligament tissue regeneration [190]. Navakovik et al. developed 
six-cord silk fiber with appropriate configuration for enhanced tissue infiltration and ligament 
tissue regeneration [191]. 
 
Various components derived from natural extracellular matrix such as gelatin, collagen, 
chondroitin sulphate etc are of prime interest of researchers for development of suitable 
scaffold for tissue engineering applications. Fabrication of silk fibroin and gelatin blend 
nanofiber with improved mechanical and biological property was reported to be suitable 
template for vascular tissue engineering application as it support  proliferation of umbilical 
vein endothelial cells proliferation [192]. Sung et al (2008) reported fabrication of silk fibroin 
and collagen based biomimetic nanofibrous scaffold, which support cell attachment and 
spreading of fibroblast cell and observed to be potential material for wound dressing and 
tissue engineering applications [193]. Hu et al (2010) developed silk fibroin and hyaluronic 
acid based non-chemical cross-linked hydrogel with improved mesenchymal stem cell 
attachment and proliferation potential and observed to be suitable candidate for tissue 
engineering application [194]. Also various researchers developed silk fibroin and plant 
derived biopolymer such as starch, cellulose, pectin, carboxymethyl cellulose etc based blend 
scaffold for tissue engineering and other biomedical applications. Cellulose and its derivative 
based biomaterials are used for various applications such as carrier for immobilization of 
enzymes, hemodialysis and drug releasing scaffolds [195-197].  
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Cellulose and its derivatives has wide application in hard and soft tissue engineering such as 
bone regeneration, cardiac tissue engineered construct, artificial liver and connective tissue 
regeneration [151]. Also cellulose based biomaterial performance can be improved by 
functionalization  with small amount of cations [198]. Kundu et al (2011) reported fabrication 
of silk fibroin and carboxymethyl cellulose based film with improved properties such as 
hydrophilicity, surface roughness, transparent, mechanical flexibility, swelling ratio, 
homogeneous and biocompatibility and thus observed to be potential biomaterial for 
biotechnological application [199]. Numata et al (2014) demonstrated fabrication of silk 
fibroin and pectin based hydrogel with suitable mechanical property, biocompatibility, 
biodegradability and elasticity and suggested to be suitable for various biomedical 
applications [200]. Electrospun nanofibrous tubular matrices offer suitable structural integrity 
and withstand arterial pressure similar to native arterial pressure of blood vessel, thus could 
be successfully used for vascular tissue engineering applications [201]. Electrospun tubular 
silk fibroin scaffold from silk fibroin dissolved in formic acid can resist pressure up to 575 
mmHg, which is higher than the upper physiological and pathological  pressure of 120 
mmHg and 180-220 mmHg, makes it suitable for vascular grafts [202]. Also anticoagulant 
property of scaffolding matrices play important role in development of scaffold for vascular 
tissue engineering applications. Silk fibroin based matrices treated with chlorosulphonic acid 
in pyridine develop antithrombogenicity property and thus observed to be suitable artificial 
extracellular matrices for vascular tissue regeneration [203]. 
 
However, silk fibroin and natural polymer blends offer various advantages but even though 
there is various disadvantages like poor crystallinity of SF/CS based porous scaffold, poor 
thermal stability of SF/gelatin, high hydrophilicity of SF/collagen, water insolubility of 
SF/chitin and poor mechanical property of SF/hyaluronic acid. Thus researchers were also 
developed SF and synthetic polymer blends based scaffold for tissue engineering 
applications. Wang et al (2009) developed Polylactide/SF/Gelatin based fibrous tubular 
scaffold by electrospinning with appropriate mechanical strength of 2.21 ± 0.18, suitable 
biocompatibility with 3T3 mouse fibroblast, induce minor inflammatory reaction in vivo and 
thus proposed to be suitable candidate for vascular tissue engineering applications [17]. Poly 
L-lactic acid/SF/Gelatin based multilayer electrospun scaffold with desirable pliability, 
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porosity, and breaking strength, also observed to be biocompatible and biodegradable and 
suitable for tissue engineering applications [18].  
 
Fibroblast growth factor releasing SF/ Poly(glycolic-co-lactic acid) based knitted scaffold, 
was reported to support mesenchymal stem cell proliferation and tenogeneic differentiation 
and thus observed to be suitable substratum for ligament/tendon tissue engineering 
applications [34]. Mcclcure et al (2009) demonstrate fabrication of PCL/SF based 
nanofibrous scaffold with various suitable properties such as mechanical strength, 
biocompatibility and biodegradability for vascular tissue engineering applications [204]. 
Bhattacharjee et al also demonstrated development of SF/PCL based nanofibrous scaffold 
with superior biocompatibility, biomineralization, biodegradability, ECM deposition, 
Alkaline phosphatase activity and suitable mechanical property for bone tissue engineering 
[205]. However, it has been reported that SF based polymeric scaffold lacks proper 
bioactivity and osteoconductivity, which limits its application as suitable biomaterial for bone 
tissue engineering application [16]. Thus it has been observed that silk fibroin matrices of 
various forms like film, fiber and porous structure are suitable for cell adhesion and 
proliferation but poor bioactivity and osteoconductivity property limits their applications 
[16]. Thus, currently development of silk fibroin based composite scaffolds with improvised 
bioactivity, hydrophilicity and osteoconductivity are of paramount importance for bone tissue 
engineering applications. Various silk fibroin and other polymer blend based scaffold and its 
application was listed out in Table 2.2. 
 
Table 2.2: Various silk fibroin-biopolymer blend based scaffold and its application in tissue 
engineering. 
Sl. No. Polymer-Polymer 
blend 
Morphologic 
form 
Application References 
1 Silk fibroin/Chitosan Nanofiber, 
porous 
Bone and cartilage tissue 
engineering 
[188] 
2 Silk fibroin/Gelatin Nanofiber, 
cable 
Vascular and ligament 
tissue engineering 
[189, 192] 
3 Silk fibroin/Collagen Nanofiber Wound dressing and 
tissue engineering 
[193] 
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4 Silk fibroin/ Hyaluronic 
acid 
Hydrogel Tissue engineering and 
other biomedical 
applications 
[194] 
5 Silk fibroin/Pectin Hydrogel Various biomedical 
applications 
[200] 
6 Silk 
fibroin/Carboxymethyl 
cellulose 
Film Various biotechnological 
application 
[199] 
7 Polylactide/SF/Gelatin Tubular Vascular tissue 
engineering 
[17] 
8 PLA/SF/Gelatin Nanofibrous Various tissue 
engineering application 
[18] 
9 SF/PLGA Knitted Ligament/tendon tissue 
engineering 
[34] 
10 PCL/SF Nanofibrous Various tissue 
engineering application 
[204] 
11 SF/PCL Nanofibrous Bone tissue engineering [205] 
 
2.4 Silk fibroin based polymer-ceramic composite scaffold  
Various researchers have reported the limitation of bioactivity and osteogenic property 
(osteoconductivity and osteoinductivity) of polymeric scaffolds [16]. However after 
investigation of cell behaviour and its lineage specific differentiation over polymer-ceramic 
based composite scaffold, researchers have demonstrated the improvement of  cell adhesion, 
cell proliferation and differentiation when scaffold matrices were reinforced/added with 
bioceramic [206-207]. Thus, there is a growing interest for the development of ceramic-
biopolymer composites for successful bone tissue regeneration. Biocermics such as 
hydroxyapatite, beta-tricalcium phosphate and bioglass play vital role in enhancement of 
osteoblast proliferation and differentiation [208-210]. Ceramic-biopolymer composites have 
been used for coating of metallic implant surface and  to filling bone defects of dental and 
other bone tissues during orthopaedic surgery, thereby improved implant integration with 
host bone were achieved [16]. Till date researchers are not yet completely understood the 
exact signalling cascade in response of hydroxyapatite but yet various  report on signalling 
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mechanism such as ERK/SOX9, BMP/Smad, Wnt, TGF-β, MAPK and Notch pathways  
upon interaction of mesenchymal stem cells  in response of hydroxyapatite were reported 
[211]. Silk fibroin based porous scaffold  incorporated with hydroxyapatite through alternate 
soaking method of CaCl2 and Na2HPO4 or by mixing hydroxyapatite with silk fibroin solution 
has shown improved or higher bone tissue regeneration capability as compared to unmodified 
silk fibroin scaffolds [212]. Cao et al. developed 3% hydroxyapatite-silk fibroin reinforced 
calcium phosphate cement/silk fibroin scaffold with enhanced compressive strength of 50.2 ± 
1.9 MPa [213]. Silk fibroin/gelatin/nano-hydroxyapatite (nHAp) composite scaffold with 
appropriate pore size, 50% – 60% porosity and mechanical property prepared by freeze 
drying was also reported to support proliferation and attachment of mouse pre-osteoblast cells 
[214]. Such SF/gelatin/nHAp based porous scaffold may be suitable for bone tissue 
engineering applications.  
 
Silk fibroin and hydroxyapatite based composite hydrogel shows higher compression 
modulus as well as improved osteogenic potential due to scaffold reinforcement and 
osteoconductivity properties [215]. However for load bearing bone tissue engineering 
application hydroxyapatite based scaffold was also reported, where SF was used as sacrificial 
polymer and observed to be suitable for bone tissue engineering application as it support 
proliferation and differentiation of bone marrow derived mesenchymal stem cells [216]. 
 
Electrospun silk fibroin and hydroxyapatite as well as hydroxyapatite loaded with BMP-2 
based nanofibrous composite offered improved growth of mesenchymal stem cells growth 
and their osteogenic differentiation. However BMP-2 loaded hydroxyapatite shows better 
osteogenic potential than hydroxyapatite alone in silk fibroin based composite matrices [63]. 
Kim et al. developed 20 wt% hydroxyapatite loaded silk fibroin based composite electrospun 
scaffold with superior mechanical properties [217].   
 
However, bioactive glass as another class of bioceramics shows higher bioactivity and 
degradation properties as compared to hydroxyapatite and beta-tricalcium phosphate, thus it 
led to better bonding of bioglass based composite scaffold with host tissues [218]. Also 
dissolution of bioglass led to availability of bone trace element such as Si, which is reported 
to stimulate osteogenesis and improvised bone tissue regeneration [219]. Silk fibroin coated 
 28 
 
mesoporous bioglass scaffold shows improved cytocompatibility, mechanical properties, 
degradation and osteogenic potential for bone tissue engineering applications [220]. Trace 
metal ion (copper, cobalt, strontium etc.) releasing bioactive glass was also reported to be 
suitable for development of scaffold with osteogenic and angiogenic potential [221-223]. C 
Wu et al demonstrated development of copper containing mesoporous bioactive glass 
scaffolds with enhanced osteogenic and angiogenic potential for bone tissue engineering.  
Similarly, cobalt doped mesoporous bioglass scaffold was also demonstrated to be suitable 
candidate for with enhanced osteogenic and angiogenic potential for bone tissue engineering 
applications [222]. However silk fibroin and nano-bioglass based nanofibrous scaffold has so 
far not been developed and investigated for bone tissue engineering applications. Table 2.3 
depicts the various silk fibroin based composite scaffolds with improved properties reported 
earlier. 
 
Table 2.3: Silk fibroin based composite scaffolds and their advantages 
Sl. 
No. 
Scaffold content Type of 
scaffold 
Advantage and application References 
1 SF/Hydroxyapatite 
(By alternate soaking 
method) 
Porous Biocompatible, biodegradable & 
osteogenic, suitable for bone tissue 
engineering 
[212] 
2 SF/Gelatin/nHAp Porous Biocompatible, support attachment & 
proliferation of mouse pre-osteoblast, 
suitable for Bone tissue engineering.  
[214] 
3 SF/Hap Hydrogel Biocompatible, higher compression 
modulus as well as improved osteogenic 
potential 
[215] 
4 Hap/SF (SF used as 
sacrificial polymer) 
Porous High compressive strength (152 MPa), 
biocompatible and support osteogenic 
differentiation of bone marrow derived 
mesenchymal stem cell. Suitable for 
load bearing bone tissue regeneration. 
[216] 
5 SF/Calcium 
polyphosphate 
Porous Higher compressive strength (2.4 MPa), 
biocompatible and enhanced 
biodegradation, suitable for bone tissue 
regeneration 
[224] 
6 Bilayered 
SF/SF/nanoCaP 
Porous Compressive strength in wet 0.4 MPa, 
support rabbit MSCs growth and 
[225] 
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proliferation in vitro, In vivo study 
shows bone tissue and vessel formation 
after implantation in rabbit knee. 
7 SF/BMP-2/nHAp Nanofiber Improved mesenchymal stem cells 
growth and osteogenic differentiation, 
BMP-2 loaded scaffold shows better 
osteogenic potential than SF/nHAP 
scaffold lacking BMP-2. 
[63] 
8 Bioglass/SF Porous Improved cytocompatibility, mechanical 
properties, degradation and osteogenic 
potential for bone tissue engineering 
applications 
[220] 
9 SF/mesoporous 
bioglass 
Porous Compressive strength of 0.9 MPa, low 
contact angle (71.2°), improved 
bioactivity, good biocompatibility and 
ALP activity, osteogenic differentiation 
of human mesenchymal stem cells. 
[226] 
10 Copper containing 
Mesoporous bioglass 
scaffold 
Porous Pore size in range of 300-500 µm, 
possess multifunctional property such as 
osteogenic and angiogenic potential, 
antibacterial properties 
[226] 
11 Cobalt doped 1393 
Bioactive glass 
scaffold 
Porous Suitable compressive strength (4.2 MPa) 
for cancelous bone, bioactive, 
osteogenic, angiogenic, suitable for soft 
bone tissue engineering applications. 
[227] 
  
 
 
 
 
 
 
 
 
CHAPTER 3: Scope and Objectives 
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The incidence of bone tissue related disorders across the globe increases rapidly and the 
current clinical treatments are not satisfactory that led to serious concern in field of health 
sector. In recent years, bone tissue engineering has been emerged as a promising tool for the 
treatment of bone tissue defects and diseases through the development of functionalized 
bioactive scaffold via synergistic combination of suitable biomaterials. However, due to 
several factors application of bone tissue engineering has not yet been successfully practiced 
at clinical level. In this context the development of scaffold matrix from appropriate 
biomaterial is the backbone of TE. Silk fibroin derived from silk cocoon is considered as 
promising biopolymer because of its biocompatibility, biodegradability, robust mechanical 
strength and wound healing properties. However, Silk fibroin scaffold possess poor 
bioactivity and osteoconductivity property which limits their applications in bone TE. Which 
opens up the tremendous scope for developing silk fibroin based composite scaffolds to meet 
the desired scaffold property for bone tissue regeneration applications. Therefore, the present 
research focuses on the development of a novel silk fibroin based composite nanofibrous 
scaffold for bone tissue engineering application by overcoming the prevailing limitation 
associated with silk fibroin.  
 
The specific objectives of this present research work are. 
i. To develop nanofibrous silk fibroin/carboxymethyl cellulose blend scaffolds by 
electrospinning method 
 
ii. To synthesise and characterize nano-bioglass and copper doped nano-bioglass  
iii. To improve bioactivity and osteogenic potential by incorporating nano-bioglass into 
SF/CMC scaffold 
 
iv. To improve angiogenic potential by incorporating copper doped nano-bioglass. 
v. To assess biocompatibility, bioactivity, osteogenic and angiogenic potential of the 
developed scaffolds by in vitro cell study 
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Scope of the research work  
1. Preparation and characterization of silk fibroin-carboxymethyl cellulose based 
biomimetic scaffolds 
 
As discussed earlier, silk fibroin is a unique biomaterial with various superior 
properties such as biocompatibility, biodegradability and tuneable mechanical 
properties. Inspite of these favourable properties, silk fibroin lacks bioactivity, 
hydrophilicity, flexibility and osteoconductive property that limit its applications in 
bone tissue engineering. Carboxymethyl cellulose (CMC), a highly hydrophilic semi-
synthetic natural polymer has chelating abilities, biocompatibility, biodegradable, and 
finds widespread applicability in wound dressing, skin and bone tissue engineering 
applications. Therefore, this phase of research work focuses on the improvement of 
bioactivity and osteogenic ability of SF by preparing SF/CMC blend nanofibrous 
scaffold by electrospinning. Finally, developed SF/CMC nanofibrous scaffold was 
characterized for its physic-chemical property, biocompatibility, bioactivity and its 
osteogenic potential.  
 
2. Synthesis of nano-bioglass and copper doped nano-bioglass 
 
It has been reported earlier that bioglass can improve bioactivity of biopolymeric 
scaffolds and could facilitate integration with surrounding bone tissue in vivo. Thus it 
is hypothesized that incorporation of nano-bioglass may improve the cell supportive 
property of SF/CMC scaffold. So this phase of research work, deals with the synthesis 
of nano-bioglass and copper doped nano-bioglass by sol-gel method. Synthesised 
nano-bioglass was further characterized for particle size, morphology and elemental 
composition. Biodegradation and ion releases are the advantageous phenomenon of 
bioglass for bone tissue regeneration, as Si, Ca and Cu ions having gene activating 
potential. Thus, bioactivity and ion release property were further analysed after 
soaking it for desired time interval in simulated body fluid.  
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3. Development of loaded SF/CMC/nano-bioglass composite nanofibrous scaffold 
 
The present work aims to develop a novel SF/CMC/nano-bioglass composite 
nanofibrous scaffold matrix as a bioactive template with enhanced osteogenic 
potential for bone tissue regeneration.  Considering bioactivity of nano-bioglass, 
mechanical property of silk fibroin and hydrophilicity, flexibility and chelating 
abilities of CMC are aimed to bring these properties on common template for the 
development of scaffold with more robust property for bone tissue engineering. It is 
further postulated that the dissolution of bioglass results in higher calcium and 
phosphate ion concentration in surrounding environment, which was further chelated 
by hydroxyl/carboxyl group of scaffold material thereby leading to the deposition of 
nano-hydroxyapatite across the nanofibrous matrix. Developed nanofibrous scaffolds 
were evaluated in terms of physicochemical, mechanical property and 
biomineralization. The biocompatibility, bioactivity, Glycosamino glycan deposition, 
and osteogenic differentiation ability of the developed scaffolds were investigated in 
vitro. 
 
4. Development of copper doped nano-bioglass loaded SF/CMC composite 
nanofibrous scaffold 
 
The angiogenesis of the scaffold is important for the development of vascular network 
throughout the scaffold matrix that facilitates the supply of oxygen, nutrient, and 
growth factor and removal of wastes of the degraded scaffold while tissue 
regeneration. Thus it is essential to design surrogate extracellular matrix with 
appropriate structural framework with suitable bioactive agent to direct cells towards 
tissue regeneration in vivo. Thus, this phase of research work focused on the 
development of copper doped nano-bioglass incorporated SF/CMC composite 
nanofibrous scaffold. The developed scaffold was further characterized for physic-
chemical properties, mechanical property and bioactivity under physiological 
conditions. In addition, the biocompatibility, osteogenic differentiation and 
angiogenic ability of the developed scaffolds was investigated in vitro.
  
 
 
 
  
 
 
 
 
CHAPTER 4: Materials and Methods 
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4. 1 Materials  
4.1.1 Preparation of scaffold  
Bombyx mori silk cocoons were obtained from Central Tasar Research and Training Institute 
(Jharkhand, India). Tetraethyl orthosilicate (TEOS), triethyl phosphate (TEP), calcium nitrate 
tetrahydrate (Ca (NO3)2. 4H2O), N,N-(3-dimethylaminopropyl)-N′-ethyl carbodimide (EDC), 
N hydroxysuccinimide (NHS), 2-(N morpholino) ethanesulfonic acid (MES), NaCl, KCl, 
CaCl2, MgCl2, K2HPO4, NaHCO3, Na2SO4, dialysis tube, Protease XIV (from streptomyces 
griseus) and carboxymethyl cellulose as sodium salt (molecular weight ≈ 700kDa and degree 
of substitution ~ 0.65 - 0.85 )were purchased from Sigma - Aldrich Company Ltd. Lithium 
bromide (LiBr), sodium carbonate (Na2CO3), formic acid (98%), ethanol, dimethyl sulfoxide 
(DMSO), sodium hydroxide (NaOH), di-sodium hydrogen phosphate (Na2HPO4), ethanol 
(C2H5OH), nitric acid and formic acid were obtained from Merck India Ltd.  
 
4.1.2 Cell culture study 
Dulbecco’s Modified Eagle Medium (DMEM), fetal bovine serum (FBS), trypsin (0.25%), 
antibiotic – antimycotic solution, alexa-Fluor 488 conjugated phalloidin, Live/Dead staining 
kit, anti-RUNX2 antibody, anti-osteocalcin antibody and FITC-conjugated secondary 
antibody, TRIzol, high-capacity cDNA reverse transcription Kit, SYBER green RT-PCR kit, 
osteogenic culture media (dexamethasone (DEX), staurosporine, α-MEM, L-glutamine, L-
ascorbate and β-glycerophosphate (βGP)) and phosphate buffer solution were purchased from 
Invitrogen, USA. Bovine serum albumin (BSA), SIGMAFASTTM p-nitrophenyl phosphate 
(pNPP) tablets, paraformaldehyde, Triton X-100, 4’6-Diamidino-2-phenyindole (DAPI), 
MTT assay kit, Alizarin red S (ARS) solution, and cetylpyridinium chloride (CPC) were 
purchased from Sigma - Aldrich Company Ltd. 
 
4.2 Methods 
4.2.1 Preparation of regenerated silk fibroin 
  Bombyx mori cocoons were chopped and degummed in  0.02M aqueous Na2CO3 solution for 
20 min at 1000C followed by washing with distilled water for two to three times to remove 
the sericin and other impurities [228]. After degumming silk fibers were dried at 370C for 
overnight. Degummed silk fibers were dissolved in a 9.3M LiBr aqueous solution at 450C for 
2 to 3hr resulted in a 10 wt% solution. Above obtained solution was then transferred carefully 
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into dialysis cassette (molecular weight cut-off of 10000 Da) and dialyzed against deionized 
water for 2 to 3 days to remove LiBr ions. The solutions were then centrifuged at 5000 rpm to 
remove un-dissolved impurities and aggregates. Finally, the obtained solutions were dried 
and used for further study. 
 
4.2.2 Preparation of electrospun SF nanofibrous scaffold 
The SF was dissolved in formic acid to obtain homogeneous solutions of various 
concentrations such as 10wt%, 12wt% and 14wt%. The prepared solutions were electrospun 
by using Free liquid surface electrospinning machine (NS Lab 200, ELMARCO), at 45 kV 
voltage, 40% relative humidity of electrospinning chamber and 12 rpm of wire based 
spinning electrode at 20±2 °C [229]. The solution was filled in cylindrical tray and thin wire 
(200 µm) based spinning electrode was placed in solution.  The distance between collector 
and spinning electrode was set at 12, 14, and 16 cm.  The electrospun mats at various 
distances (12 - 16 cm) were collected and kept in dessicator at 37°C. The obtained SF 
nanofibrous scaffolds were further cross-linked with 3 wt% EDC-NHS  [2:1 (w/w)] in 
ethanol: water (95:5 v/v)] solution [210]. The cross-linked nanofibrous scaffold was then 
rinsed twice with deionized water to remove residual cross-linking reagent and vacuum dried 
at room temperature. The cross-linked scaffolds were further used for various 
characterizations.  
 
4.2.3 Development of electrospun SF/CMC blend nanofibrous scaffold 
Four different batches with varied compositions of SF/CMC (100/0, 99/1, 98/2 and 97/3 
(w/w)) blend solutions (10 wt%) were prepared by dissolving appropriate amount of SF  and 
CMC powder in 98% formic acid with stirring to make well dispersed homogenous solutions. 
The nanofibers were generated from these blends at 12 cm and 68 kV of applied electric 
potential as described above in section 4.2.2. The different composite scaffolds are 
designated as SF, SF/CMC1, SF/CMC2 and SF/CMC3 for 100/0, 99/1, 98/2 and 97/3 (w/w) of 
SF/CMC compositions respectively. The electrospun SF/CMC nanofibrous scaffolds were 
cross-linked with 3 wt% EDC-NHS [2:1 (w/w)] in ethanol: water (95:5 v/v)] solution and 
further treated with 0.1 M CaCl2 solution overnight at 40
°C. The cross-linked scaffolds were 
rinsed thoroughly with deionized water to remove ions like chlorine and residual cross-
linking reagent, followed by drying under vacuum at room temperature for 24 h. The 
different composite scaffolds treated with CaCl2 were designated as calcified SF1, SF/CMC1 
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and SF/CMC2 corresponding to SF, SF/CMC (99:1 w/w) and SF/CMC (98:2 w/w) 
respectively. The gelatin nanofibrous scaffold was also fabricated by electrospinning of 10 
wt% gelatin solution under similar electrospinning conditions was use as control.  
 
4.2.4 Synthesis of nano-bioglass and copper doped nano-bioglass 
Nano-bioactive glass (nBG) was synthesized by an acid mediated sol-gel method [230]. In 
brief, the molar composition considered for nBG was 60% SiO2, 36% CaO, and 4% P2O5.  
Bioglass sol was prepared by hydrolysing 4.53 ml of tetraethyl orthosilicate in water and pH 
of sol was adjusted with 2M HNO3. Solution was stirred till a clear sol was formed. Then 
3.022 gm of calcium nitrate tetrahydrate and 0.195 ml of triethyl phosphate were dissolved in 
obtained sol. The prepared sol was kept in an oven at 45°C for gelling and aged for 3-4 days. 
Finally, the gels were freeze dried and part of the obtained powder was stabilised at 600°C 
for 2hr. The rate of heating for calcination of synthesized bioglass was fixed at 30°C/min. The 
copper doped nano–bioactive glass (Cu-nBG) based on 58S bioglass was prepared by an acid 
mediated sol-gel method. The Cu-nBG with 0.5 mol% (Cu0.5-nBG) and 1 mol% (Cu1-nBG) 
copper were synthesized by using tetraethyl orthosilicate, calcium nitrate tetrahydrate, triethyl 
phosphate and copper nitrate trihydrate in water and pH was adjusted with 2M HNO3 at room 
temperature. Finally, the obtained sol was kept at 45°C for gelling followed by ageing for 3-4 
days in an oven. The gels were freeze dried and stabilized at 600°C with heating rate of 
30°C/min for 2hr.  
 
 
4.2.5 Development of electrospun SF/CMC/nBG composite nanofibrous 
scaffold 
The 10 wt% SF/CMC (98:2 (wt %)) solution was prepared by dissolving appropriate amount 
of SF and CMC in formic acid. Different bathes of 10 wt% SF/CMC/nBG composite 
solutions were prepared by adding different amount of nBG (5 wt% to 20 wt% nBG) to 
SF/CMC (98:2) solution. The nanofibrous SF/CMC/nBG scaffolds were fabricated by 
electrospinning followed as described in section 4.2.2. Each of the composite solution was 
alternately tested by filling 25 ml of the solution in rotatory spinning electrode tray at 70kV 
applied voltage and 16 cm distance. The resulting nanofibrous mat was immersed in 3 wt% 
EDC+NHS [2:1 (w/w)] in [(95:5 v/v (Ethanol:water)] solution followed by washing with 
deionized water to remove residual cross-linking reagent. The obtained cross-linked scaffolds 
were then dried in dehumidified chamber at 37°C. 
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4.2.6 Development of electrospun SF/CMC/Cu-nBG composite nanofibrous 
scaffold 
The 10 wt% SF/CMC/Cu-nBG composite solutions were prepared by adding different 
amount (5wt% and 10 wt%) of Cu0.5-nBG and Cu1-nBG respectively in SF/CMC (98:2) 
solution. Finally prepared solutions were electrospun at 70kV applied voltage and 16 cm 
distance. Finally deposited composite nanofibrous scaffolds were cross-linked with 3 wt% 
EDC+NHS [2:1 (w/w)] in [(95:5 v/v (Ethanol:water)] solution for 12 hr. After cross-linking 
scaffolds were washed thoroughly with deionised water and dried in desiccators. Thus 
obtained scaffolds were used for further study. 
 
 
4.3 Characterization of nano-bioglass 
4.3.1 Morphology 
The morphology of nBG powder with and without copper doped was examined by using 
Field emission scanning electron microscope (FE-SEM, Nova NanoSEM 450) [231]. Before 
imaging, the nBG particles were sputter coated with gold for 2.5 min.  The average particle 
size was calculated by counting at least 100 different particles based on FESEM images using 
image J software. Elemental composition of nBG was determined by energy dispersive X-ray 
analysis (EDX) (Bruker, Germany). FEI TecaiTM transmission electron microscope (TEM 
TF-30, Netherland) working at 300kV was used to examine the existence of bioactive glasses 
in nano-scale range [232].  
 
4.3.2 Bioactivity  
Bioactivity of nBG was studied in simulated body fluid (SBF) for 7 days. The SBF having 
pH of 7.35 – 7.40 was prepared according to the procedure described elsewhere [233]. In 
brief, nBG was soaked in SBF in separate batch at a concentration of 1mg ml-1. Ten millilitre 
solutions were taken out from each batch after interval of 3, 5 and 7 days.  The solutions were 
filtered through 0.2 micron syringe filter and then analysed for ionic species concentration by 
inductively coupled plasma optical emission spectrophotometer (ICP – OES, Perkin Elmer 
optima 5300 DV) [234-235]. Finally the soaked nano – bioglass powders were collected, 
washed with acetone and dried for overnight at 400°C in hot air oven. The obtained SBF 
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treated nBG powder was used for FE-SEM, XRD and FT-IR study to evaluate hydroxyapatite 
formation. 
 
4.3.3 Structural and functional characterization 
X-ray diffraction (XRD) of nBG was performed by X-ray Diffractometer (Rigaku 
Japan/Ultima-IV) using Cu-Kα radiation (λ = 0.1542 A0). X-ray diffraction (XRD) curves 
were recorded with an X’celerator counter at a scanning rate of 5°/min with a step size of 
0.03° within a scanning region of 2θ = 10–70°. Fourier transform infrared spectroscopy 
(FTIR, Shimadzu AIM-8800, Japan) was used to obtained the FTIR spectra in transmittance 
mode under the mid infrared region (4000 – 400 cm-1).  This is used to study molecular 
composition and functional groups in SF/CMC based scaffold and nano-bioglass [236]. 
 
4.4 Characterizations of scaffolds 
4.4.1 Rheological behaviour 
The rheological property of the SF, SF/CMC and SF/CMC/nBG solutions were measured by 
rotational cone (diameter = 30 mm; angle = 5.4°) and plate viscometer (Bohlin Visco-88, 
Malvern, UK) with a linear increment in shear rate from 0.1-1000 s-1 at 25°C. A constant gap 
of 0.15 mm was maintained between cone and the plate throughout the study. The data was 
analyzed with Bohlin visco-8 software using Moore model [237]. For each experiment, three 
samples were used and result was reported as the average and standard deviation of obtained 
viscosities. 
 
4.4.2 Morphological study 
Characterization of the developed SF, SF/CMC, SF/CMC/nBG and SF/CMC/Cu-nBG 
scaffold was done before and after the in-vitro mineralization. Nanofibrous scaffolds with 
0.5×0.5 cm2 sizes were sputter coated with gold, and observed under field emission scanning 
electron microscope (FESEM) (NOVA NANO SEM, USA) for morphological assessment 
[231, 238]. The average fiber diameters were measured from ten different FESEM images of 
≥5000 magnification using Image J software. A minimum of 50 pores were considered for 
calculating the average pore size of the developed scaffolds by using Image J software. 
Energy dispersive X-ray analysis (EDX) was used to ensure the presence of bioglass 
reinforcement within the scaffolds. FEI TecaiTM transmission electron microscope (TEM TF-
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30, Netherland) working at 300kV was used to examine the presence of bioactive glasses in 
composite scaffold [232, 239]. 
 
4.4.3 Structural and functional analysis 
X-ray diffraction (XRD) of nanofibrous scaffolds (1.0 × 1.0 cm) were performed by X-ray 
Diffractometer (Rigaku Japan/Ultima-IV) using Cu-Kα radiation (λ = 0.1542 A0). X-ray 
diffraction (XRD) curves were recorded with an X’celerator counter at a scanning rate of 
5°/min with a step size of 0.03° within a scanning region of 2θ = 10–70°. The nature of 
interactions among the functional groups of the prepared scaffolds and their interaction with 
nBG were determined using Fourier transforms infrared (FTIR) spectroscopic analysis 
(FTIR, Shimadzu AIM-8800, Japan) operated in the transmittance mode in 4000–400 cm-1 
region. Hydraulic press was used to pelletize the scaffold specimens by mixing them with dry 
KBr powder. The prepared mixture was pressed into transparent disks like structure and used 
for FT-IR analysis [236]. 
 
4.4.4 Surface roughness analysis 
The topography or roughness of the developed nanofibrous scaffold surface was studied 
using a scanning probe microscope operated in atomic force microscopy (AFM, NTEGRE 
(NTMDT)) semi-contact mode at microscopic level [236]. In this technique, the probe tip 
made up of quartz is attached to a flexible micro-fabricated 225 μm long silicon cantilever 
with a spring constant of 3 N/m, the deflection of which is measured by optical method. The 
reflected light beam is focused to a particular position by moving the surface of the scaffold 
and a constant force is maintained between the surfaces that produces topographical images. 
 
4.4.5 Mechanical strength measurement 
Universal testing machine (Instron 3369, Bioplus, USA) was used to determine the tensile 
strength and tensile strain at break of the developed nanofibrous scaffolds both in dry and wet 
conditions. The scaffolds were cut into small rectangular shapes (30×5×0.05 ± 0.03 mm3) and 
loaded between the clamps of the tensile tester. Tensile testing was performed with a load cell 
of 1000 N at cross head speed of 5 mm/min [236]. For measurement in wet condition, the 
samples loaded between the clamps were immersed in bioplus bath filled with 3 litres SBF 
solution maintained at 37±1 °C. The value reported is the average of measurement taken with 
three specimens.  
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4.4.6 Contact angle measurement 
The contact angle of the nanofibrous scaffolds (1×1 cm2) was measured using K100MK3 
tensiometer (Kruss GmbH, Hamburg, Germany) operating at 6 mm/min detection speed and 
3 mm/min measuring speed [240]. Three specimens were used for single set of scaffold and 
the average result was reported. All the measurement was done at room temperature and 
water was used as the solvent for measuring contact angle.  
 
4.4.7 Equilibrium water uptake capacity measurement 
The water uptake capacity was measured by immersing small pieces (2×2 cm2) of pre-
weighed dried nanofibrous scaffolds in PBS solution at room temperature. After particular 
time interval of 2 h to 24 h specimen was removed and then weighed. By dividing the 
difference in weight before (wD) and after the soaking (wT) by the original dry specimen 
weight (wD), we obtained the equilibrium water uptake percentage of the scaffolds using 
equations 1 [241].  
𝑤𝑎𝑡𝑒𝑟 𝑢𝑝𝑡𝑎𝑘𝑒% =
𝑤𝑇−𝑤𝐷
𝑤𝐷
× 100 ........ (1) 
 
4.4.8 In vitro biodegradation of scaffolds 
The initial dry weight of the nanofibrous scaffold samples were weighed and noted as (Wo) 
The nanofibrous scaffolds were incubated at 37°C in Protease XIV (from Streptomyces 
griseus) solution (1.0 mg/ml) prepared in PBS solution as well as in PBS without enzyme 
[242]. After incubation for particular designated time period (3 days to 28 days) scaffolds 
were taken out, washed with deionised water and lyophilized. Finally percentage of 
degradation was calculated using initial weight (WO) and final weight (WF) of scaffolds by 
using equation 2. 
𝑃𝑒𝑟𝑐𝑒𝑛𝑡𝑎𝑔𝑒 𝑜𝑓 𝑑𝑒𝑔𝑟𝑎𝑑𝑎𝑡𝑖𝑜𝑛 =
𝑊𝑜−𝑊𝐹
𝑊𝑜
× 100 ............... (2) 
 
4.4.9 In vitro bioactivity study 
In vitro bioactivity of the scaffold was assessed by incubating 1×1 cm2 sizes of scaffolds in 
20 ml simulated body fluid (SBF) for 7 days. SBF was prepared following the earlier reported 
method by adding NaCl (7.995 g), KCl (0.224 g), CaCl2·2H2O (0.368 g), MgCl2·6H2O (0.305 
g), K2HPO4  (0.174 g), NaHCO3 (0.349 g), and Na2SO4·10 H2O (0.161 g) to 1 L of distilled 
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water in the same order as mentioned [243]. The pH of the fluids was adjusted to 7.4 at 36.5 
°C. After 7 days, the scaffolds were taken out, gently rinsed in distilled water and dried at 
room temperature. FESEM was used to observe the apatite deposition over the scaffold 
surface and elemental composition was determined using EDX.  
 
4.5 In vitro cell study 
4.5.1 Isolation and culture of hMSCs 
Umbilical cord blood (UCB) was collected from the local Ispat General Hospital, Rourkela, 
India with prior consent of the full-term delivery patients. The Institutional Ethical Board 
approved the collection procedure. The mononuclear cells (MNCs) were isolated from UCB 
following the Ficoll Hypaque method described in literature [244]. The isolated mononuclear 
cells (MNCs) from umbilical cord blood cultured in complete media (Dulbecco’s Modified 
Eagle Medium supplemented with 10% FBS and 1% antibiotic solution) [245]. The culture 
condition was 37°C, 5% CO2 with 80% relative humidity in CO2 incubator. During culture 
period, cell culture medium was replaced with fresh medium, also non adherent cells were 
washed out. The adhered cells were cultured for 4 – 6 passages, mean while non-adherent 
cells were completely removed. The cells were characterized for multilineage differentiation 
potential using osteogenic [236], chondrogenic [246] and adipogenic [247] culture medium. 
 
4.5.2 Cell seeding and culture 
Disk shaped scaffold specimens of 6 mm in diameter were sterilized in 75% ethanol 
overnight and then extensively rinsed with PBS. The scaffolds were incubated for overnight 
in complete medium in 24-well plate and hMSCs (105cells/cm2) were seeded on the scaffolds 
after 24 hr of incubation. The cell seeded scaffolds were incubated at 37 °C for 4-6 h to allow 
cell adhesion. After the cell attachment, the cell seeded nanofibrous scaffolds were cultured 
for two weeks in complete media, at 37°C in humidified atmosphere containing 5% CO2 
[236]. 
 
4.5.3 Cell morphology and cell attachment 
The cell attachment and cell morphology of hMSCs seeded on each of the prepared 
nanofibrous scaffolds were monitored during 7 to 14 days of culture under FESEM. For 
FESEM study, the cultured cell-seeded scaffolds were fixed with 2.5% glutaraldehyde for 20 
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min and dehydrated consecutively for 5 min using gradient ethanol concentrations (30%, 
50%, 70%, 90% and 100% (v/v) in water). After drying at room temperature, the scaffolds 
were sputter coated with gold and observed under FESEM [248]. 
 
4.5.4 Cell viability 
MTT assay 
The metabolic activity of the cells seeded on the scaffolds (104 cells/cm2) was done by MTT 
assay during 7 days of culture period following the standard protocol described elsewhere 
[249]. After 3, 5, and 7 days, the culture medium (complete media) was removed and rinsed 
with 100 µl PBS and 100 µl MTT solution (0.5 mg/ml) was added to each well (96 wells 
plate) and incubated for 4 hr at 37 °C in 5% CO2. After incubation, MTT solution was 
replaced with 100 µl of DMSO and finally the absorbance was measured at 490 nm using 
UV-Visible spectrophotometer (Double beam spectrophotometer 2203, Systronics).  
 
Fluorescent Microscopy  
The cell viability of hMSCs seeded over scaffolds (105 cells/cm2) was done by live/dead 
staining during culture period. The cell seeded scaffolds were incubated for 20 min in 
live/dead staining solution (calcein AM and EthD-1) and then observed under confocal 
microscope (Leica TCS SP5 X Super continuum) [250]. 
 
4.5.5 Cell distribution and cytoskeleton organization 
Morphological, cytoskeleton organisation and cellular distribution were assessed by confocal 
microscopy. The hMSCs seeded scaffolds were fixed with 4% paraformaldehyde for 30 min 
and incubated in 3% BSA for another 30 min. The fixed specimens were permeabilized using 
0.1% Triton X-100 for 5 min and then incubated with Alexa-Fluor 488 conjugated phalloidin 
at room temperature for 15 min in dark condition. After rinsing with PBS and staining with 
DAPI for 15 min, the specimens were mounted over the glass slides and the images were 
taken by Leica TCS SP5 X Super continuum Confocal Microscope [245]. The penetration 
and proliferation of hMSCs within the scaffolds were determined from the 3D-Z-stack 
images composed by arranging all Z-sections developed during the scanning of cell-seeded 
scaffolds under the confocal microscope. 
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4.5.6 Osteogenic differentiation potential 
Alkaline Phosphatase assay (ALP) 
The osteogenic differentiation activity of hMSCs (104 cells/cm2) seeded on the nanofibrous 
scaffolds and cultured in osteogenic media (complete media, which additionally 
supplemented with 5 mM β-glycerol phosphate, 50 mg/mL ascorbic acid-2-phosphate and 1 
nM dexamethasone) were quantitatively estimated by measuring alkaline phosphatase (ALP) 
secretion by the cultured hMSCs using pNPP solution as the reaction substrate for ALP. 50 µl 
of  Lysis solution (0.5% TritonX-100) and subsequently, 200 µl of 1 mg/ml p-NPP solution 
were added to each well and incubated for 1.5 h at 37 °C. The absorbance was later measured 
at 405 nm after 7 and 14 days using UV-Visible spectrophotometer (Double beam 
spectrophotometer 2203, Systronics) [236]. 
 
In-vitro biomineralization  
The formation of mineralized nodules on the cell-seeded nanofibrous scaffolds cultured in 
osteogenic media was confirmed by FESEM analysis and alizarin red assay. Alizarin red S 
stain (ARS) solution was prepared by dissolving 0.5 g ARS in 25 ml MiliQ water and pH of 
the solution was adjusted to 4.1-4.3 by adding 10% NH4OH. The cell-seeded scaffolds after 
culturing in osteogenic media for 7 days and 14 days of culture duration was taken out 
washed twice with PBS and fixed with 2.5% glutaraldehyde for 2 hr and 1 ml ARS solution 
was added to each well. The specimens were incubated at 37 °C for 1 h and then washed in 
MiliQ water to remove excess dye adsorbed on the scaffold surface. Biomineralization of 
hMSCs on the SFC nanofibrous scaffolds was qualitatively evaluated by examining the 
intensity of the red colour developed on the scaffold surface by using inverted phase contrast 
microscope (Axiovert 40 CFL) at 20X magnification. The degree of biomineralization was 
estimated through calcium quantification which involved the aspiration of ARS stain from 
specimen by incubating with 500 µL of cetylpyridinium chloride (CPC) for 1 hr and 
recording the absorbance at 550 nm [251] using UV-Visible spectrophotometer (Double 
beam spectrophotometer 2203, Systronics). 
 
Estimation of GAG (Glycosamino glycan) 
The hMSCs seeded (105 cells/cm2) scaffolds were cultured in osteogenic differentiation 
media (complete media suplimented with 5 mM β-glycerol phosphate, 50 mg/mL ascorbic 
acid-2-phosphate and 1 nM dexamethasone) for two weeks. 
 43 
 
On day 7 and 14, intracellular GAG was removed from the hMSCs seeded scaffold by 
digestion with papain digestion solution (125 μg/mL of papain, 5 mM L-cystein, 100 mM 
Na2HPO4, 5 mM EDTA) at pH 6.8, 65°C for 3 hrs. The total GAG content on scaffolds was 
determined by BlyscanTM assay (Biocolor) following the manufacturer’s protocol [252]. 
Finally the absorbance recorded at 656 nm using UV-Visible spectrophotometer (Double 
beam spectrophotometer 2203, Systronics) and matched with a standard calibration curve to 
determine the GAG content.  
 
Osteocalcin and RUNX2 expression using Immunocytochemistry  
The hMSCs seeded scaffolds were cultured in osteogenic media and analysed both 
qualitatively and quantitatively for the expression of RUNX2 transcription factor (Runt-
related transcription factor 2) and osteocalcin differentiation markers by 
immunocytochemistry. The scaffolds were fixed with 4% paraformaldehyde for 15 min and 
rinsed well in PBS, followed by permeabilization with 0.5% TritonX-100 for 5 min at room 
temperature. The permeabilized scaffolds were rinsed with 1X PBS and incubated for 30 min 
at RT in 3% BSA solution. After blocking the non-specific sites, each specimen was 
separately incubated with anti-RUNX2 antibody and anti-osteocalcin for 1 h at RT followed 
by thorough washing. FITC-conjugated secondary antibody (1:200) was then added to it and 
incubated for 30 min. Counter staining with DAPI was performed for 5-10 min after washing 
in 1X PBS and  image was taken by confocal microscopy [236]. Finally quantitative analysis 
of the osteocalcin and Runx2 expression from confocal images was done by using Image J 
software. 
 
Expression of osteogenic specific genes 
The RUNX2 transcription factor, osteocalcin and type1 collagen (Col1) gene expressions of 
the hMSCs (105 cells/cm2) seeded on the SF and SFC nanofibrous scaffolds were 
quantitatively evaluated in real time quantitative polymerase chain reaction (RT-PCR). After 
two weeks of culture in osteogenic medium, cell-scaffold construct was immersed in TRIzol 
and homogenised by vortexing to isolate RNA. These isolated RNAs were converted to 
cDNA using High-capacity cDNA Reverse Transcription Kit according to the manufacturer’s 
instructions. A SYBER Green RT-PCR kit was used for quantitative estimation of gene 
expression. The 2∆∆ct relative quantification method was used for the estimation of gene 
expression. The relative expressions of each gene were normalized against Ct value of the 
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house-keeping gene [236]. The selected primer sequence for the gene of interest and house-
keeping gene are shown in Table 4.1. 
 
Table 4.1: Selected primer sequence for the gene of interest and house-keeping gene 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
4.5.7 Angiogenic potential analysis 
Hypoxia-inducible factor 1α (HIF1α) expression analysis via immunocytochemistry  
The hMSCs seeded scaffolds were cultured for 7 and 14 days and then stained for HIF1α 
expression analysis. The cultured scaffold was taken out and washed twice with PBS after 7 
and 14 days followed by the incubation for 2-4 min in 0.5% TritonX 100 solution. Then 
permeabilized scaffold was washed twice with PBS and incubated in BSA solution (2%) for 
15 min. After blocking the non-specific sites, scaffolds were washed twice with PBS and 
incubated with HIF1α antibody (mouse antihuman antibody 1:200) for 20 min. Then the 
scaffold was washed twice with PBS and incubated with FITC-conjugated secondary 
antibody (1:200) for 10 min. The FITC stained specimens were washed twice with PBS and 
stained with DAPI for 5-10 min. Finally, the samples were washed twice with PBS and image 
was taken by using Leica TCS SP5 X Super continuum confocal microscopy. Finally 
quantitative analysis of the HIF1α expression from confocal images was done by using Image 
J software. 
 
Genes 5’-3’ Primers 
Runx2 Forward 
Reverse 
 
GTCTCACTGCCTCCCTTCTG 
CACACATCTCCTCCCTTCTG 
Osteocalcin 
 
 
Type 1 collagen 
 
Forward 
Reverse 
 
Forward 
Reverse 
 
GTGACGAGTTGGCTGACC 
TGGAGAGGAGCAGAACTGG 
 
GACCTCTCTCCTCTGAAACC 
AACTGCTTTGTGCTTTGGG 
 
Β-actin  Forward 
Reverse 
TTCCAGTCCTTCCTG 
GCCCGACTCGTCATACTC 
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VEGF Immunoassay 
The in vitro release of VEGF by hMSCs (1 × 105) seeded scaffold was quantified on day 7 of 
culture by using a human VEGF ELISA kit (Abcam 100662). On day 7 culture media from 
12 well plates were collected from each well and added to each well of a pre-coated ELISA 
plate. Finally ELISA for VEGF release was done according to the manufacturer protocol 
[253].  
 
4.6 Statistical analysis 
The experiments were done in triplicate, and data were presented as mean ± SD. Statistical 
significance was determined by one way ANOVA. ‘p’ Value less than 0.05 was considered as 
significant. 
 
 
 
 
  
  
 
 
 
 
 
 
 
 
 
 
CHAPTER 5: Results and Discussion  
  
 
 
 
 
 
 
 
 
CHAPTER 5A: Development and characterization 
of SF/CMC blend scaffold 
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Silk fibrin (SF) of Bombyx mori origin is one of the most attractive natural biopolymers was 
investigated for developing tissue engineering scaffolds over the past decade because of its 
several inherent properties such as tuneable mechanical strength and biological properties 
namely biocompatibility and biodegradability [254]. However, SF lacks adequate 
hydrophilicity [255-256], flexibility [257], bioactivity and osteoconductivity [16] which limit 
its use in TE. The blending of SF with other polymers has received considerable attention of 
the researchers to improve physico-chemical and biological property of SF [258].  
 
Carboxymethylcellulose (CMC), a natural polymer (polysaccaharade) is highly hydrophilic, 
biodegradable, biocompatible, non-toxic and has mucoadhesive and chelating properties 
because of which it has widespread applications in biomedical and pharmaceutical industries 
[259-261]. Recently, CMC has been considered as an attractive candidate for potential 
application as wound dressing, artificial bone and skin [262].  
 
Considering the above, CMC was chosen as blending polymer with silk fibroin. Besides 
material property, fabrication of scaffold with nanofiber architecture is another important 
aspect, which can mimic the body tissue. In this context, electrospinning has been evolved as 
the most suitable method for the generation of  polymer nanofibers so far [263]. Therefore, 
research work in this phase of thesis work focuses on the development of a novel SF/CMC 
blend electrospun nanofibrous scaffolds for bone tissue engineering application. The 
scaffolds were subjected to morphological, physico-chemical and various in vitro biological 
characterisations to prove their potentiality to act as cell career for bone tissue regeneration. 
The result and discussion of these experimental studies is presented in this chapter. 
 
5.1.1 Preparation & characterization of electrospun pure SF and cross-
linked SF nanofibrous scaffolds 
Preparation of pure SF nanofibers 
The concentration of polymer solution has a great influence on its spinnability, thereby 
affects the formation of nanofiber and its morphology [264]. Therefore, the effect of SF 
polymer concentration on fiber formation and morphology was investigated at varying 
concentration range of 8 - 14 wt% to establish the optimal polymer concentration that favours 
fiber formation. The electrospinning condition was maintained at 45 kV and 16 cm distance 
between the electrodes. As indicated in figure 5.1A, the fiber diameter was increased with 
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increase in polymer solutions and the nanofiber generation was most favourable in the 
polymer concentration between 10 wt% to 12 wt%.   
 
 
 
Figure 5.1: The graphs showing the effect of concentration of SF solution (A) and distance 
between the electrodes (B) on the fiber formation. Effect of SF concentration on viscosity (C). 
Average fiber diameter decreases with increasing distance between the electrodes and increases 
with increasing solution concentration. The nanofiber generation was favourable in the 
concentration between 10 wt% - 12 wt%. 10% SF solution was established as the optimal 
solution generating nanofibers with average fiber diameter of 86 ± 21 nm. 
 
It has been observed that as the concentration of SF solution increases from 10 wt% to 12 
wt%, the average fiber diameter of electrospun SF mat increased from 86 ± 21 nm to 128 ± 
29 nm. There was no fiber formation observed at lower polymer concentration of 8 wt%. At 
this concentration, the solution was not spinnable which may be due to its very low viscosity 
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(Figure 5.1C). Furthermore, the polymer solution was difficult to electrospun at higher 
polymer concentration beyond 12wt% as the solution is too viscous and obtained fiber 
diameter (499±178 nm) was higher than those generated at lower concentrations. Overall, 
10% SF solution was the optimal concentration providing continuous fiber formation and 
superior fiber diameter. The SF nanofiber formation was also drastically changed when the 
distance between the electrodes was varied from 12cm to 18cm (Figure 5.1B). SF solution 
with 10 wt% concentration shows linear decrement in average fiber diameter from 112 ± 26 
nm to 86 ± 21 nm as the distance between electrode increases from 12cm to 16 cm. The fiber 
formation either below (12cm) or above (18cm) 16cm was not favourable which was on the 
basis of either fiber diameter or continuous fiber generation. 
 
 
Figure 5.2: (A) SEM images of electrospun SF nanofiber generated from different SF 
concentration (10 -14%) SF solutions at 16 cm distance between the electrodes. (B) SEM images 
of electrospun SF nanofiber formed from 10 wt% solutions at varying distances between the 
electrodes. Decrease in fiber diameter of SF nanofiber with increase in distance between the 
electrodes is noticed. Also 10wt% solution shows lowest average fiber diameter (86 ± 21 nm ) at 
16 cm distance between the electrodes. 
 
Figure 5.2 shows the morphological structure of the electrospun SF nanofiber. The SF 
nanofiber obtained from various solution (10 wt% to 14 wt %) shows random fiber 
distribution. From Figure 5.2A it has been observed that fiber diameter increases with 
increasing solution concentration, where 14 wt% SF nanofibers was not successfully 
electrospun and posse’s fiber with higher fiber diameter. Figure 5.2B shows uniform and 
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continuous deposition of 10 wt% SF nanofiber at various distances between the electrodes. 
The fiber diameter was also observed to be reduced as the distance between the electrodes 
increases. Thus 10 wt% SF solution electrospun at 16cm was observed to be appropriate to 
fabricate nano-scale fibers for tissue engineering applications. 
 
Preparation & Characterisation of cross-linked SF nanofibrous scaffold 
Cross-linking is important for the development of scaffold as it improves the chemical, 
thermal and mechanical stability of scaffold. EDC/NHS is a non-toxic cross-linking agent 
which was extensively studied and reported to improve the flexibility and tensile strength of 
SF scaffold. The cross-linking method using EDC/NHS has been successfully applied to 
recombinant human collagen matrix to produce bio-artificial grafts, that have been evaluated 
in a phase I clinical trial [265].  Thus, developed nanofibrous SF scaffold was cross-linked 
with EDC/NHS solution.  
 
Morphological study 
SEM images as shown in Figure 5.2, reveals that the generated nano fibers from cross-linked 
SF solution were closely packed and intertwined. Due to cross-linking well defined pores 
with varying pore sizes were formed compare to un-cross-linked SF scaffold. 
 
 
Figure 5.3: SEM images of cross-linked electrospun SF scaffold. The nanofiber was 
observed to be closely packed and intertwined after cross-linking, which provides 
stability to the nanofibrous mat. Due to cross-linking well defined pores were formed in 
the scaffold. 
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Structural and functional characterization 
The structural and functional property of scaffold determined by XRD and FT-IR is 
important for designing functional scaffold for tissue engineering application [266-267].  
These properties determine the stability and mechanical property of the scaffold. The 
assessment of any conformational or phase change that might have occurred in the developed 
SF scaffold due to cross-linking was done by XRD.  Silk fibroin exhibits conformations such 
as random coil, silk I and silk II as major molecular structures. Silk II conformation 
commonly thought to be constituted of β-sheet and endows silk nanofiber with superior 
mechanical properties. The assessment of conformational property of scaffolds was done 
from XRD diffractogram of the scaffolds as shown in Figure 5.4 (A).  The peaks at 20.8º (2θ) 
and 24.3º (2θ) indicate the silk II conformation [268] contributing to superior stability and 
mechanical properties of the nanofiber. A weak peak at 27.6º (2θ) indicates the silk I 
structure [229, 268-269].  
 
The presence of characteristic functional groups in SF scaffolds was confirmed by FT-IR 
analysis as shown in Figure 5.4(B).  As indicated, the amide I, amide II and amide III 
conformations of pure SF correspond to the characteristic peaks at 1627 cm-1, 1519 cm-1and 
1236 cm-1 respectively after cross-linking with EDC/NHS [270]. Thus, it confirms that the SF 
scaffold possess β-sheet conformation which improves its mechanical properties. 
 
 Mechanical strength 
The mechanical properties of the scaffold play important role in neo bone tissue regeneration. 
Scaffold must have desired mechanical properties that facilitate osteogenic differentiation of 
cells over the scaffold. The mechanical property such as tensile strength and tensile strain at 
break of the prepared cross-linked scaffold was measured. The ultimate tensile strength 
(UTS) of SF nanofibrous scaffolds obtained from 10 wt% SF solution was 13.68 ± 1.2 MPa, 
whereas the corresponding tensile strain at break was 10.48 ± 2.6% (Figure 5.4 (C)). Thus, 
the β-sheet conformation as assessed by XRD analysis augments the tensile property of SF 
nanofibrous mat. 
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Figure 5.4: XRD spectrum (A), FT-IR spectrum (B) and Load Vs Extension curve (C) for cross-
linked electrospun pure SF scaffold  
 
5.1.2 Development of SF/CMC nanofibrous scaffold 
The SF/CMC blend nanofibrous scaffolds were prepared by electrospinning with varied 
compositions of SF/CMC (100/0, 99/1, 98/2 and 97/3 (w/w)) blend solutions. The scaffolds 
are designated as SF (100/0), SF/CMC1 (99/1), SF/CMC2 (98/2) and SF/CMC3 (97/3). The 
prepared blend solutions and scaffolds were further characterized by using various 
techniques. 
 
Rheological behavior of SF/CMC blend solution 
The rheological property of polymer solution is an important factor which governs successful 
electrospinning and morphology of generated fiber [271]. Thus, the rheological behaviour of 
the prepared pure SF and SF/CMC blend solutions was studied by viscosity measurement 
under varied shear stress as the flow behaviour depends on the composition and stability of 
polymer blends.  Figure 5.5 shows the shear thinning or thickening property of the pure SF 
and blend with CMC. The pure SF solution viscosity was determined to be 0.042 PaS and 
exhibits non-newtonian flow behaviour, as shear thickening occurred at lower shear rate 
followed by shear thinning behaviour at higher shear rate. The viscosity of SF/CMC1 blend 
solution was 0.032 PaS and exhibited similar trend as SF solution, whereas SF/CMC2 (0.092 
PaS) solution showed faster shear thickening at lower shear rate and slower shear thinning 
behaviour at higher shear rate. Thus, pure SF and SF/CMC (99/1 and 98/2 w/w) blend 
solutions show similar behaviour of shear thickening and shear thinning as of natural silk 
dope[272].  
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The polymeric chains of SF/CMC2 solution might be organised either parallel or entangled 
due to the suppression of repulsive forces between the negative charges of polymeric chains 
at low pH of formic acid [273-275] resulting in increased viscosity and shear thickening 
behaviour was observed at lower shear rate of SF/CMC solutions. Whereas, as the 
concentration of CMC increased (> 2 wt%) shear thickening started early with lower shear 
rate followed by  early shear thinning after reaching maximum shear viscosities. Thus, 
SF/CMC3 solutions with 3 wt% CMC content possess viscosity of 0.173 PaS and exhibited 
higher shear thinning behaviour at lower shear rate due to the strong interaction between SF 
and CMC, which leads to increasing the solution inertia and hinders the electrospinning[276]. 
Therefore, SF/CMC2 is more favourable because of the spinnability of the blend solution 
containing the maximum CMC content which is expected to provide higher hydrophilicity, 
biomineralization activity and the flexibility of the scaffold.  
 
 
Figure 5.5: (A) Rheological behaviour of the pure SF and SF/CMC blend solutions at different 
shear rate. Both SF and SF/CMC blend solutions show non-newtonian fluid behaviour. The 
viscosity of SF/CMC blends solution is observed to be increases with increasing CMC content. 
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5.1.3 Characterization of SF/CMC scaffold 
Morphological study  
The microstructures of SF, SF/CMC1 and SF/CMC2 scaffolds were assessed by FESEM 
image analysis as shown in Figure 5.6. The FESEM image shows the irregular distribution of 
nanofibers in the form of non-woven mats. The SF/CMC3 blend failed to produce nanofibers 
because the solution was highly viscous owing to the increased CMC content in it. The fiber 
diameter was increased with the gradual addition of CMC as shown in Figure 5.6A. The 
majority of SF/CMC nanofibers are within 100 - 300 nm diameter range, where pure SF 
exhibits an average diameter of 146.6 ± 38.3 nm. The average fiber diameter of SF/CMC1 
and SF/CMC2 shows a linear increment of average diameters from 183.7 ± 82 nm to 227.8 ± 
87 nm respectively. Thus the developed SF/CMC1 and SF/CMC2 scaffolds possess fiber 
diameter favourable to cell adhesion as the range of body tissue fiber diameter is 50 - 500 nm 
[45].  
 
The average pore size for SF, SF/CMC1 and SF/CMC2 was measured to be 3.5 ± 1.6 µm, 4.2 
± 1.3 µm and 4.7 ± 1.9 µm respectively. Thus, the pore size of scaffold was increased with 
increase in fiber diameter of electrospun mat [175]. The SF/CMC electrospun scaffolds were 
cross-linked with 3 wt% EDC-NHS [2:1 (w/w)] in ethanol: water (95:5 v/v)] solution as a 
post-treatment step. Silk fibroin protein consists of both carboxyl and amino groups, whereas 
CMC a polysaccharide also contains carboxyl and hydroxyl groups. When the polymeric 
scaffold is soaked in cross-linking solution swelling occurs, which provides sufficient space 
for the rearrangement of molecular chains. EDC activates the carboxylic acid residues of 
CMC and amide bonds are formed by nucleophilic attack of free amine groups of SF on the 
activated carboxylic groups (Figure 5.6D). Whereas NHS is used in combination with EDC, 
to prevent quick hydrolysis of O-acylisourea intermediate group, through the formation of 
stable NHS-ester intermediate [210, 277-278]. Thus, EDC/NHS solution helps cross-linking 
of SF/CMC scaffold through covalent bonding. 
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Figure 5.6: FESEM images of electrospun SF (A), SF/CMC1 (B) and SF/CMC2 (C) scaffolds. 
The fiber diameter of SF/CMC nanofiber increases with increasing CMC content is noticed.  
The pore size of the scaffolds in turn increased with increase in fiber diameter. (D) Schematic 
diagram of SF/CMC cross-linking using EDC/NHS. 
 
Structural and Functional analysis 
XRD diffractogram representing the changes in chemical structure in SF/CMC blend scaffold 
is depicted in Figure 5.7A. The peaks at 20.8º (2θ) and 24.3º (2θ) (Figure 2A-a) indicate the 
anti parallel β-sheet (silk II) conformation [268] contributing to superior stability and 
mechanical properties of the nanofibers [279]. A weak peak appeared at 27.6º (2θ) indicates 
the repeated β-turn (silk I) structure [229, 268-269]. Moreover, the diffractogram clearly 
shows the change in the respective peak intensity of the SF scaffolds with gradual addition of 
CMC and this phenomenon is possibly due to the interactions between the amide groups of 
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SF and the hydroxyl/carboxyl groups of CMC chains. The peak intensity for silk I and silk II 
conformation was reduced as the CMC content increased from 1 wt% to 2 wt% due to 
amorphous characteristic of CMC [280]. 
 
The characteristic functional groups in SF, SF/CMC1 and SF/CMC2 are represented by FTIR 
spectra as shown in Figure 5.7 (B). The characteristic peaks of amide I, amide II and amide 
III of SF were observed at 1627 cm-1, 1519 cm-1 and 1236 cm-1 respectively [270]. The peaks 
at 1627 cm-1 ,  1519 cm-1 and 1236 cm-1  in SF/CMC2 became intensified, indicating the 
ability of CMC in facilitating the conformational transition from random coils to β-sheets by 
forming additional intermolecular hydrogen bonds between the carboxyl groups of CMC and 
amide groups of SF. However, the peak intensified and narrowed at 1236 cm-1 in SF/CMC2 is 
attributed to the overlapping of amide III band with the acetyl ester band of CMC [281].  
 
 
Figure 5.7: (A) XRD and (B) FT-IR spectrum of SF, SF/CMC1 and SF/CMC2 nanofibrous 
scaffolds. The peak at 1060 cm-1 is dominated by the incorporation of CMC. 
 
The FT-IR peak at 1060 cm-1 is due to >CH-O-CH2 stretching of CMC[282]. The peak 
intensity at 1060 cm-1 in SF/CMC2 was observed to be higher as compared to SF/CMC1, 
which is due to higher content of CMC in SF/CMC2.  
 
Mechanical property 
The ultimate tensile strength (UTS) of SF and SF/CMC blend nanofibrous scaffolds in dry 
and wet states are depicted in Figure 5.8. The UTS of pure SF was measured as 12.7 ± 1.5 
MPa and 10.54 ± 1.3 MPa that of SF/CMC2 in dry state, whereas the corresponding values in 
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wet state were 3.82 ± 0.7 MPa and 3.46 ± 0.6 MPa respectively. The lower tensile strength 
shown by polymer blend scaffold may be attributed to its higher fiber diameter as compared 
to SF [283].  A slight variation in UTS observed with both the scaffolds in wet state suggests 
that the addition of CMC can improve mineralization without much affecting the mechanical 
property of the scaffold. Moreover, in wet state, the tensile strain at break of SF/CMC2 was 
measured to be 18.37 ± 3.8 %, which is quite higher than the pure SF scaffold (8.36 ± 3.3 %) 
that reflects the higher flexibility of the blend scaffold. The corresponding increase in tensile 
strain with addition of 2 wt% of CMC is 118%.  Thus, the addition of 2 wt% CMC to SF may 
improve the cell retention ability and increase the number of cell penetration inside the 
scaffold during cell-seeding [284]. Furthermore, SF/CMC1 exhibits tensile strength of 9.15 ± 
0.19 MPa and 2.71 ± 1.3MPa in dry and wet state, however tensile strain at break in dry and 
wet state was measured to be 2.19 ± 0.13 % and 3.97 ± 1.08 %. The stiffness of SF and 
SF/CMC2 was measured to be 253.031 ± 41.3 MPa and 580.36 ± 58 MPa respectively. The 
higher stiffness of the developed SF/CMC2 scaffold as compared to SF might be due to the 
formation of strong covalent bond between SF and CMC after cross-linking with EDC/NHS. 
  
 
 Figure 5.8: (A) Load Vs Extension curve for SF and SF/CMC2 scaffolds in dry and wet 
condition. (B) Distribution of tensile strength and tensile strength at break of SF and SF/CMC2 
scaffold. The tensile strain at break of SF solution was improved by the addition of CMC. 
However, the tensile strength of SF/CMC2  scaffold  was slightly reduced due to its higher fiber 
diameter. 
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Thus it has been concluded that CMC at 1wt% is not sufficient to improve flexibility of SF 
scaffold, this might be due to weak intermolecular interaction between silk fibroin and CMC, 
which was also observed from amide I, amide II and amide III peaks of SF/CMC1 in FT-IR 
spectra ( Figure 5.7B). 
 
Surface roughness analysis 
The surface roughness is an important characteristic which influences cellular adhesion and 
differentiation over the scaffold [48]. Moreover, surface roughness has direct impact on cell 
morphology, proliferation and phenotype expression both in vitro and in vivo [48]. The 
surface roughness of the prepared scaffolds was measured by AFM analysis as shown in 
Figure 5.9. Both SF and SF/CMC2 nanofibrous mat had a microrough surface with the 
average surface roughness (Ra) of 0.142 µm and 0.101 µm respectively representing the 
suitability of the scaffolds for successful tissue regeneration providing desired cellular 
interaction and protein adsorption [285-286]. 
 
 
Figure 5.9: The AFM images of fabricated SF (A) and SF/CMC2 (B) nanofibrous 
scaffolds. The AFM images clearly show the formation of ridges and grooves that 
augment the surface roughness of nanofibrous mat. 
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Hydrophilicity and swelling behaviour 
Hydrophilicity of scaffold is a key factor which governs cell adhesion [287], cell spreading 
and differentiation over the scaffold [48]. The surface hydrophilicity of the scaffold was 
assessed by measuring the contact angle through spreading behaviour of water over the 
surface of scaffold [48, 288]. Table 5.1 shows mean contact angle measurements of the 
prepared scaffolds, where the mean advancing contact angle (MACA) and mean receding 
contact angles (MRCA) (a measure of wettability and de-wettability) of SF/CMC2 is lower 
than pure SF scaffold representing the higher hydrophilicity of the blend scaffold.  
 
Table 5.1: Mean conta angle measurement of SF and SF/CMC2 nanofibrous scaffolds 
Scaffolds MACA  [°] MRCA  [°] Hysteresis  [°] 
SF 64.2 ± 4.2 36.9 ± 3.8 26.6 ± 3.0 
SF/CMC2 57.4 ± 0.3 18.5 ± 1.8 38.9 ± 3.2 
 
This phenomenon is also corroborated from Figure 5.10B, where the receding contact angles 
for SF/CMC2 attained 0º after certain time period, whereas the measured value is around 30º 
for SF scaffold. The mean contact angle hysteresis plays an important role in the intrusion 
and extrusion of body fluids through the scaffolds. This will further augment the cell 
adhesion property of SF/CMC2 scaffolds in comparison to pure SF, as the optimum contact 
angle of the surface for cell adhesion is reported in the range between 55°  and 75° [289].   
The increase in hysteresis of SF/CMC2 in comparison to pure SF scaffold indicates an 
increased in surface roughness or chemical in- homogeneity along the contact line.  
 
The water uptake (Figure 5.10 A) determined for SF/CMC2 is in the range of 361% - 417% 
which is higher than the control (180% - 270%). This suggests the better uptake capacity of 
nutrients into the interior of the SF/CMC2 scaffold thereby an enhanced cell migration and 
proliferation is expected to be achieved during the culture of cell scaffold construct. The cell 
adhesion, proliferation and tissue integration are greatly influenced by the hydrophilicity of 
the scaffolds [290]. Thus the addition of a small amount of CMC improves the hydrophilic 
property of SF based nanofibrous scaffolds, thus facilitates biofluid transport, cell migration, 
prevention from dehydration, exudates accumulation across the wound and maintenance of 
microenvironment and pH [42, 291].  
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Figure 5.10: (A) Swelling behaviour at different time interval observed with SF and SF/CMC2 in 
PBS solution. (B) Variation of contact angle measured with SF and SF/CMC2 scaffolds. The 
results represent the superior hydrophilic and water uptake capacity of SF/CMC2 than the 
control.  
 
 5.1.4 In vitro bioactivity analysis 
Osteogenic property is one of the key factors for the neo bone tissue regeneration, which is 
assessed by measuring the deposition of apatite crystals over the scaffold surface [292]. The 
bioactivity of scaffold was assessed by using simulated body fluid with ion concentration 
similar to human blood plasma [293]. Also it was reported that the negatively charged or 
neutral surface hinders osteoblast attachment and spreading as compared to positively 
charged surface [294]. So, calcified SF/CMC scaffold was prepared to neutralize the 
negatively charged carboxylate group of SF/CMC scaffold thereby improved biomimetic 
potential [151, 295]. The bioactivity of pure and calcified SF, calcified SF/CMC1 and 
calcified SF/CMC2) was assessed by SBF treatment for 7 days at room 37
°C. After in vitro 
mineralization, the scaffold surfaces were observed under  
 
FESEM (Figure 5.11A-a, b). As revealed by the FESEM images, the scaffold surfaces were 
rough indicating the nucleation of Ca/P crystals on the scaffolds. Furthermore, the varied 
extent of roughness observed with different scaffolds indicates the different level of Ca/P 
nucleation. As for example, the surfaces of pure and calcified SF nanofibers were hardly 
rough suggesting its marginal biomineralization ability (random and weak) in forming Ca/P 
crystals. However, calcified SF/CMC1 and SF/CMC2 (Figure 5.11 A-c, d) demonstrated 
higher nucleation sites with uniform and spherical Ca/P crystal formations of sizes ≤ 100 nm. 
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Figure 5.11B illustrates in situ mineralization of calcified SF/CMC nanofibrous scaffolds. 
The mineralization of the nanofibers can be attributed to the formation of free hydroxyl 
groups/carboxyl groups during the electrospinning of SF/CMC blends in formic acid 
(derivatizing solvent for CMC) contributing to the increased number of Ca2+ ion nucleation 
sites on the nanofibers. After that, PO4
3- ions from surrounding SBF solution was adsorbed by 
calcium ion resulting in the formation of nanosized Ca/P crystals in SBF (1X)  solutions 
[296-297]. The gradual increase in CMC content augments the content of free hydroxyl 
groups/ carboxyl groups and thus calcified SF/CMC2 exhibits the highest mineralization. The 
biomineralization of electrospun SF/CMC based nanofibrous scaffold shows a controlled 
nucleation of Ca-P crystal. Whereas, when the scaffold was coated with CMC, most of the 
Ca2+ nucleation sites were exposed to SBF leading to the uncontrolled mineralization of 
scaffold. Furthermore, in  electrospinning under high shear rate (in range of 104 1/s) 
polymeric chains of SF and CMC get entangled or parallelly aligned [298], because of which 
CMC was well distributed over the surface as well as within the fiber leading to the exposure 
of Ca2+ nucleation sites on the scaffold surface in controlled manner. The controlled 
mineralization of matrix provides superior osteogenic differentiation of hMSCs in 
comparison to the matrix with uncontrolled biomineralization [299]. Thus too low or too 
much mineralization is not favourable for human bone tissue regeneration.  
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Figure 5.11: (A) FESEM images of pure and calcified SF, calcified SF/CMC1 and calcified 
SF/CMC2 after SBF treatment for 7 days (a, d). (B) Illustration of in situ mineralization of 
calcified SF/CMC1 and blend nanofibrous scaffolds. Incorporation of CMC led to the uniform 
nanosized Ca/P mineralization of the SF scaffold. In comparison, SF/CMC2 exhibits superior 
biomineralization activity than its counterpart SF/CMC1 scaffold  and the control. 
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Structural and functional analysis of biomineralized scaffold 
After 7 days of SBF treatment, X-ray diffractogram (Figure 5.12A) depicts Ca/P bone like 
apatite formation over the scaffolds, where calcified SF/CMC2 shows prominent peak at 2θ 
equal to 31.8°, 45.52º, 56.37º and 66.36º in close proximity with reference spectrum for 
hydroxyapatite as compared to other scaffolds.  Thus, it has been confirmed that, calcified 
SF/CMC2 offers higher mineralization in comparison to calcified SF/CMC1 and SF, whereas 
pure SF shows minimal level of mineralization. This confirms our hypothesis that the 
addition of CMC can enhance the mineralization property, which was further investigated by 
FT-IR analysis with mineralised nanofibrous scaffold.  
 
As observed in FT-IR spectra (Figure 5.12B) the Ca/P deposition on the scaffolds is reflected 
by the characteristic peak at 1062 cm-1  corresponding to the P-O asymmetric stretching mode 
of vibration of PO4
-3
 group [300-301]. The P-O stretching mode has been observed at 1012 
cm-1 and 976 cm-1 which correspond to major band for phosphate group. The peaks observed 
at about 610 cm-1 and 568 cm-1 are due to O-P-O bending and stretching respectively [301-
302]. The absorbed CO2 corresponding to 1400-1450 cm
-1 peak indicates the deposition of 
carbonated Ca/P on the nanofibers. Since the characteristic peak for deposited Ca/P was 
observed much more prominent in calcified SF/CMC2 (Figure 5.12B) in comparison to other 
scaffolds thus indicating that CMC plays significant role in the improvement of 
biomineralization of nanofibrous scaffold. Most of the peaks observed with calcified 
SF/CMC2  show more peak broadening in comparison to calcified SF and calcified SF/CMC1 
with time, thereby indicates that the calcified SF/CMC2 supports superior mineralization and 
intermolecular bonding with developed Ca/P [303]. 
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Figure 5.12:  XRD (A) and FTIR (B) spectrum of pure and calcified SF, calcified SF/CMC1 and 
calcified SF/CMC2 after incubation in SBF for a week. The prominent peaks at 2θ=31.8º in 
XRD diagram and peaks at 1062 cm-1 , 1012 cm-1 and 976 cm-1  in FT-IR diagram confirm the 
apatite like deposition on the scaffold surface. Overall, the bioactivity of SF scaffold is shown to 
be remarkably enhanced by the incorporation of CMC and trend is SF/CMC2 > SF/CMC1 >SF 
scaffolds 
 
Surface roughness analysis of biomineralized SF and SF/CMC2 scaffold 
The structure and surface morphology of calcified SF/CMC2 scaffolds after biomineralization 
were examined by AFM analysis and the results were compared with calcified SF as the 
control. An enhanced Ca/P deposition and improved surface roughness were exhibited by the 
calcified SF/CMC2 than that observed with calcified SF, as revealed by the AFM images 
(Figure 5.13A, B). As indicated calcified SF shows comparatively smooth surface with 
average surface roughness of 0.247 µm whereas calcified SF/CMC2 possess the average 
roughness of 0.322 µm.  The growth of Ca/P crystals over calcified SF/CMC2 improves its 
surface roughness and thus, it may promote better adhesion, proliferation and differentiation 
of hMSCs [304].  
 
5.1.5 In vitro biodegradation of scaffold 
Biodegradation of scaffold is one of the major strategies in tissue engineering approaches for 
neo tissue regeneration [305].  The scaffold should have controlled degradation rate so that it 
matches with the new tissue formation [53]. More importantly, the degradation was reported 
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to be a major concern when scaffold is made of silk based material [13]. Thus, the developed 
SF and SF/CMC2 nanofibrous scaffolds were investigated for biodegradation in both PBS and 
protease XIV enzymatic solutions. Figure 5.13 shows the biodegradation behaviour of both 
the scaffolds in PBS (Figure 5.13C) and enzymatic solution (Figure 5.13D).  
 
 
Figure 5.13: AFM images of (A) calcified SF and (B) calcified SF/CMC2 after treatment in SBF 
for 7 days. Observed degradation behaviour of SF and SF/CMC2 scaffolds by soaking in PBS 
(C) and enzymatic solution (D) for 28 days. The AFM images show the higher surface roughness 
of SF/CMC2 which confirms the improvement of biomineralization ability of SF based scaffold 
with the incorporation of CMC. 
 
 From these studies it has been observed that SF scaffold was degraded faster and up to 45% 
to 50% degradation occurred in presence of enzyme, where as in PBS it degraded slower 
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showing 26% - 28% degradation. The SF/CMC2 scaffold shows a slightly lower degradation 
rate of 20% to 22% and 42% to 47% in PBS and in presence of enzyme respectively.  
 
5.1.6 In-vitro cell culture study 
Isolation, culture and differentiation of hMSCs  
The isolated mononuclear cells from Umbilical cord blood (UCB) by Ficoll hypaque method 
were cultured upto 4 to 6 passages to produce hMSCs which were used to evaluate biological 
property of the developed scaffolds. The mononuclear cells were observed to be spherical in 
morphology (Figure 5.14A-a), whereas after culturing for various passages, cells were 
observed to be spindle shape fibroblast like in morphology (Figure 5.14A (b-d)). The isolated 
hMSCs also show multilineage differentiation potential such as osteogenic, chondrogenic and 
adipogenic, which has been assayed by Alizarin red S, Alcian blue and Oil red staining 
assays respectively during 14 days of culture (Figure  5.14B). The osteoblastic differentiation 
of hMSCs in osteogenic culture media was confirmed by mineralized calcium nodule 
deposition stained in bright orange-red colour [306-307]. The adipogenic differentiation of 
hMSCs is confirmed by the presence of lipid vacuole as observed in Figure 5.14B-c [306-
307]. Whereas, chondrogenic differentiation of hMSCs was confirmed by 
glycosaminoglycans deposition [308].    
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Figure 5.14: (A) Morphological changes of hMSCs (a) MNCs, (b) after passage 1, (c) after 
passage 2 and (d) after passage 3 as observed under phase contrast microscope at magnification 
10X and scale bar 50μm. Initially the cells are found to be spherical in shape and slowly 
changed to fibroblast like morphology. (B) Multilineage differentiation potential of hMSCs 
assessed by alizarin red S staining (a), Alcian blue staining (b) and Oil red staining (c).  
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Cell adhesion and cell morphology  
Cell adhesion and cellular morphology are the important indicators which reflect the affinity 
of the cells to the scaffold thereby forming the cell scaffold construct and finally neo tissue 
regeneration [309]. These cell supportive properties of the pure SF and calcified SF/CMC2 
composite nanofibrous scaffolds were evaluated in term of cellular attachment, spreading and 
proliferation of hMSCs cultured on the scaffold surface. A positive control was taken by 
culturing hMSCs on gelatin nanofiber. As can be seen from the FESEM images (Figure 
5.15A-C), the hMSCs attached to the scaffolds attained a more or less elliptical shape after 12 
h of culture thereby demonstrating their initial signs of spreading. The measured aspect ratios 
for gelatin (2.23 ± 0.46) and silk fibroin (2.08 ± 0.04) scaffolds are comparable whereas a 
lower aspect ratio of 1.725 ± 0.091 was shown by calcified SF/CMC2 scaffold.  The lower 
aspect ratio of cells over calcified SF/CMC2 was expected due to the negatively charged 
carboxylate group of CMC [294] and the effect was gradually reduced with time due to the 
progress of the mineralization over the surface of SF/CMC scaffold. After 7 days (Figure 
5.15D-F), most of the cells were appeared elongated and spindle like in morphology over SF, 
whereas cells over gelatin was less elongated.   On 14th day (Figure 515G-I), the cells were 
observed to be proliferated and a strong cell attachment was evident from filopodia 
protrusions from cell surface thereby formation of a monolayer was observed over the surface 
of the scaffolds.  
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Figure 5.15: FESEM images of hMSCs on gelatin (A), SF (B) and calcified SF/CMC2 (C) after 
12 h of culture. FESEM micrographs of cells cultured on gelatin (D), SF (E) and calcified 
SF/CMC2 (F) after 7 days. FESEM images of cells cultured on gelatin (G), SF (H) and calcified 
SF/CMC2 (I) on day 14. Change in cell morphology from spherical to elongated is observed 
during the progress of the culture representing the cell supportive property of the scaffolds.    
 
Cytoskeletal organization 
Figure 5.16 shows the fluorescence images of cytoskeleton development and distribution 
after 7 and 14 days of cell culture on the electrospun gelatin (Figure 5.16A, D), SF (Figure                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             
5.16B, E) and calcified SF/CMC2  blend (Figure 5.16C, F) scaffolds. On day 7, it was 
observed that cells were attached and elongated, whereas cells were proliferated and 
monolayer coverage of scaffold surface was evident on day 14.  Furthermore, SF and 
calcified SF/CMC2 nanofibrous scaffolds showed better development of filamentous actins 
compared to gelatin.  
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The formation of stable thin filamentous actins and its termination at focal contact further 
help in cell spreading and osteogenic differentiation of hMSCs [310].  Similar trends with 
more aggregated cells and absence of gap between cell boundaries (interconnected cells) 
were noticed on day 14.  
 
 
Figure 5.16: Cell proliferation and distribution are visualized under confocal microscope on 
gelatin (A), SF (B) and calcified SF/CMC2 (C) after culture for 7 days, and gelatin (D), SF (E 
and calcified SF/CMC2 (F) after culture for 14 days. Nuclei of the cells were stained with DAPI 
(blue) and actin filaments with phalloidin (green). Change in cell morphology from spherical to 
elongate is observed with increase in culture time. (Scale bar- 25µm)   
 
Metabolic activity by MTT assay 
The metabolic activity which represents the potentiality of cells to progress in the cell cycles 
was quantitatively estimated during 7 days of hMSCs cultured over the scaffolds by MTT 
assay [311]. As can be seen from Figure 5.17 that on day 3 the optical density (OD) measured 
with hMSCs seeded calcified SF/CMC2 is higher than pure SF and gelatin (p ˂ 0.05) 
scaffolds. The cell viability was gradually increased with time irrespective of the type of 
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scaffolds. However, maximum viability was obtained with blend scaffold up to 7 days of 
culture. On day 7, higher cell viability was shown by calcified SF/CMC2 scaffold followed by 
SF and gelatin scaffolds. The overall trend of cell viability follows as-calcified SF/CMC2 
>SF>gelatin. 
 
 
Figure 5.17:  MTT assay of hMSCs cultured on gelatin, SF and calcified SF/CMC2.   The trend 
of cell viability over nanofibrous scaffolds follows as -calcified SF/CMC2 >SF>gelatin. 
 
Live/dead assay and cellular distribution 
The confocal images were taken to observe the viability of hMSCs cultured on the developed 
gelatin, SF and calcified SF/CMC2. The cell viability of hMSCs seeded over scaffolds was 
done by live/dead staining solution (Calcein AM and EthD-1), where green signal indicates 
viable cells and red signal indicate dead cells. Figure 5.18A shows that the hMSCs are viable 
and healthy over the entire scaffold irrespective of their composition. However, cells were 
observed more elongated over SF and calcified SF/CMC2 in comparison of gelatin. 
 
The penetration and proliferation of hMSCs within the scaffolds were determined from the 
3D-Z-stack images composed by arranging all Z-sections developed during the scanning of 
cell-seeded scaffolds under the confocal microscope. The images (Figure 5.18B) indicate that 
the cells were not only proliferated well over the scaffolds but also penetrated inside the 
scaffold at varying depth of penetration of hMSCs colonization. The highest penetration was 
occurred in gelatin up to 35- 40 µm and comparable intensity of cell penetration up to 30- 35 
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µm was shown by calcified SF/CMC2 scaffold, while SF shows the lowest penetration depth 
of 15-20 µm. All these taken together, it has been observed that calcified SF/CMC2 
nanofibrous scaffold has the superior cellular activity than the other scaffold developed under 
study. The improved hydrophilicity, higher tensile strain (in wet state) and swelling property 
of calcified SF/CMC2, along with its higher standard deviation in fiber diameter in 
comparison to pure SF, contribute to increased penetration and proliferation of hMSCs 
towards the interior of the scaffold without much affecting cell attachment and proliferation 
on the surface.  
 
 
Figure 5.18: (A) Calcein AM and EthD-1 staining of hMSCs cultured for 7 days on Gelatin (a), 
SF (b) and calcified SF/CMC2 (c). (B) 3D laser scanning confocal images were observed while 
live/dead staining (Z stacks) of hMSCs cultured for 7 days on Gelatin (a), SF (b) and calcified 
SF/CMC2 (c). Green signals indicate viable cells and red signal for dead cells. (Scale bar = 25 
µm) 
 
Glucosamino glycan (GAG) analysis 
The differentiation of hMSCs towards the osteogenic lineage is indicated by the synthesis and 
deposition of GAG over the scaffold [312]. GAG is also known to play a crucial role in 
sequestering growth factors in scaffold matrices [313]. Figure 5.19 shows GAG accumulation 
over Gelatin, SF and calcified SF/CMC2 scaffold. The GAG production was shown to be 
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increased over culture period. The scaffolds used under study showed the formation of GAG 
with varied level of secretion. On day 7, the GAG content was slightly higher over calcified 
SF/CMC2 than SF and gelatin scaffolds. On day 14, GAG content on calcified SF/CMC2 
(0.298 µg/mg) nanofibrous scaffold was 2.2 fold higher than day 7. Whereas, on day 14 GAG 
content (0.175 µg/mg) on SF nanofibrous scaffold was 1.8 fold higher than day 7. However, 
gelatine shows 1.9 fold higher GAG content (0.185µg/mg) on day 14 as compared of day 7. 
Thus, calcified SF/CMC2 provides better GAG deposition reflecting its superior osteogenic 
differential than SF nanofibrous scaffold.  
 
 
Figure 5.19: Estimation of intracellular GAG secreted by hMSCs cultured in the osteogenic 
media for  7 and 14 days of culture over gelatin, SF and calcified SF/CMC2. Calcified SF/CMC2 
promotes better GAG deposition in comparison to SF nanofibrous scaffold is noticed. 
 
5.1.7 Osteogenic differentiation 
Alkaline Phosphatase assay  
The alkaline phosphatase enzyme was assessed to evaluate the early osteogenic 
differentiation of hMSCs. The characteristic marker of early osteoblastic differentiation is 
attributed to the cellular secretion of ALP. ALP enzymes catalyse the hydrolysis of 
extracellular pyrophosphates and increase the local concentration of inorganic phosphates 
which facilitate biomineralization [314]. The ALP activity of hMSCs over the scaffolds was 
studied during 14 days of culture period.  An increase in enzyme activity was observed with 
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all the scaffold with varied activity level with increasing culture period from 7 to 14days. 
This icrease in ALP activity represents the cells in a more differentiated stage (Figure 5.20). 
As compared to gelatin and SF, hMSCs show significantly higher ALP activity on calcified 
SF/CMC2 on 14
th day (p < 0.05). Hence, calcified SF/CMC2 is confirmed to provide a 
superior supportive platform for osteogenic differentiation of hMSCs. The superior ALP 
activity over calcified SF/CMC2  was observed because of its superior Ca/P nucleation ability. 
 
 
Figure 5.20: Alkaline phosphatase (ALP) activity in hMSCs cultured on the gelatin, SF and 
calcified SF/CMC2 in osteogenic culture medium over time (n=3). From ALP activity analysis it 
has been observed that calcified SF/CMC2 provides a better platform for osteogenic 
differentiation of hMSCs as compared to pure SF and gelatine scaffold. 
 
Biomineralization of hMSCs seeded nanofibrous scaffold 
The mineralization and formation of bioactive Ca/P like nodule over the surface of scaffold is 
the prime target to provide time dependent improved osteogenic environment for cultured 
cells. To assess the level of mineralized matrix produced by hMSCs over the developed 
scaffold after culturing for 14 days was assessed by ARS assay (Figure 5.21A). The uniform 
distribution of Ca/P was observed over calcified SF/CMC2 nanofibrous scaffold surface 
which may promote better cell growth and differentiation as bone tissues exhibit orderly 
distribution of Ca/P over nanofibrous collagen matrix [169, 315].  As can be seen from the 
FESEM images (Figure 5.21B), the degree of biomineralization on day 7 is higher on 
calcified SF/CMC2 than on SF. Further EDX analysis showed that hMSCs on pure SF formed 
a mineral phase with Ca/P ratio: 0.8-1.2 whereas on calcified SF/CMC2, the Ca/P ratio was 
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1.4-1.5 which is similar to the mineral phase of the human bone that consists mostly of Ca 
and P in the ratio 1.4 - 1.7 [316]. The quantification of ECM mineralization was performed 
through ARS where it binds with calcium and forms ARS-calcium complex in a chelation 
process. It can be observed from the inverted phase contrast microscopic images (Figure 
5.21A) that on day 7, the ARS-calcium complex (red colour) covered a greater percentage of 
calcified SF/CMC2 surface than the other scaffolds. However on 14
th day of culture, all the 
scaffolds show higher level of formation of the ARS-calcium complex than that of day 7 but 
with varied degree of complex formation. However, the intensity of ARS complex was the 
highest in case of calcified SF/CMC2. Also calcified SF/CMC2, on day 14 (Figure 5.21C), 
showed greater OD as compared to gelatin and SF (p < 0.05). This suggests that the degree of 
ECM mineralization depends both on culture duration and the scaffold material. The analysis 
of EDX and ARS assay results demonstrate the ability of calcified SF/CMC2 to mimic the 
osteogenic environment and found substantial superiority of calcified SF/CMC2 over gelatin 
and SF scaffolds for bone tissue engineering application.  
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Figure 5.21: (A) Alizarin red S staining of hMSCs cultured over gelatin, SF and calcified 
SF/CMC2 for 7 and 14 days. (B) FESEM images and EDX spectra of mineral deposition of SF 
and calcified SF/CMC2 cultured for 7 days. (C) Alizarin Red S staining assay for quantitative 
evaluation of hMSCs mineralization on nanofibrous scaffolds after 14 days of culture. Calcified 
SF/CMC2 shows enhanced biomineralization than  pure SF and gelatin scaffolds. 
 
Runx2, Osteocalcin and Collagen type I expression analysis 
The osteogenic differentiation of hMSCs seeded on the scaffolds was further assessed by    
Runx2 transcription factor, osteocalcin and type1 collagen expression by the cells. The 
hMSCs seeded on the nanofibrous scaffolds tend to aggregate and form committed 
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osteoprogenitor cells. With time, they differentiate into pre-osteoblasts, early osteoblasts and 
mature osteoblasts. Runx2 is the key regulator for early osteoblastic differentiation of hMSCs 
[317]. With time, they differentiate into preosteoblasts, early osteoblasts and mature 
osteoblasts. Runx2 is the key regulator for early osteoblastic differentiation of hMSCs.  
Runx2 binds specific DNA sequences and regulates the transcription of various genes to 
orchestrate the osteogenic differentiation [318]. The immunocytochemistry for Runx2 
transcription factor expression in hMSCs on the scaffolds for 7 (Figure 5.22A) and 14 days 
(Figure 5.22B) of culture depicted in the confocal images. As co-localization of Runx2 and 
DAPI immunostainning show that the expression of Runx2 was localized to the cell nuclei. 
From Integrated density (ID) evaluation, it was observed that the expression of RunX2 
transcription factor at higher level on day 7 (Figure 5.22C) as compared to day 14. Runx2 is 
pro-terminal marker of osteogenesis and its level of expression on calcified SF/CMC2  was 
the highest on day 7 and then decreased by day 14 as osteogenesis enhanced thereby, 
exhibiting the advantage of using calcified SF/CMC2 composite scaffolds. The osteocalcin 
expression a late stage marker was studied over a period of 14 days to assess the osteogenic 
cell differentiation potential of the scaffold as shown in figure 5.22B. The confocal images 
revealed that hMSCs demonstrate the highest level of osteocalcin expression on calcified 
SF/CMC2 on 14
th day. Moreover, the integrated density quantification of osteocalcin (Figure 
5.22D) confirms that the calcified SF/CMC2 shows significantly (p < 0.05) higher level of 
expression in comparison to other scaffolds at day 7 and day14.  
 
On day 14, RT-PCR analysis shows significantly (p < 0.05) higher level of expression of 
OCN (1.67 fold) and Col1 (3.5 fold) on calcified SF/CMC2 than SF (Figure 5.22E), whereas 
a decrease in Runx2 (1.7 fold) expression was observed on calcified SF/CMC2 on day 14 
(Figure 5.22E) with no significant difference at this point. Since osteocalcin is an abundant 
calcium binding protein and adsorbs Ca/P, calcified SF/CMC2  facilitates higher degree of 
Ca/P nucleation sites and growth over the nanofibrous structure and cause the activation of 
calcium sensing receptor signalling leading to a higher level of osteocalcin expression in 
hMSCs. Thus, the in vitro stem cell study reveals the superior osteogenic potential of 
SF/CMC2 with significantly higher ALP activity, biomineralization and expression of 
osteogenic marker such as OCN and Collagen type I. This might be due to the superior Ca/P 
nucleation ability and stiffness of developed SF/CMC2 nanofibrous scaffold. 
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Figure 5.22: Immunocytochemistry for Runx2 and osteocalcin on hMSCs cultured on 
gelatin, pure SF and calcified SF/CMC2 scaffolds. (A) Confocal images showing RunX2 
expressions of hMSCs on day 7 and day 14 (B) Confocal images for osteocalcin 
expressions were observed in hMSCs on day 7 and day 14 in the osteogenic culture 
medium. Integrated density evaluation for RunX2 and osteocalcin are depicted in 
graphs (C) and (D) respectively. Scale bar = 25 µm. (E) The osteoblastic differentiation 
of hMSCs on nanofibrous scaffolds was assessed by measuring the mRNA expression of 
Runx2, osteocalcin and type1 collagen. The immunocytochemistry and gene expression 
study confirm the superior osteogenic potential of calcified SF/CMC2 nanofibrous 
scaffold than SF scaffold. 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
CHAPTER-5B: Synthesis and Characterisation of 
nano-bioglas and Copper-doped nano-bioglass 
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Recent research has focused on the improvement of bioactivity and osteogenic property of 
polymeric biomaterial for bone tissue engineering applications. One of the promising ways to 
improve these properties by the addition of bioceramic to the biopolymer. Among the various 
bioceramics, bioactive bioglass has attracted much attention of the researchers for  use in 
developing biopolymer- ceramic composites because of its several advantages like 
biodegradation, high apatite formation ability [319], osteoinductivity and osteoconductivity 
properties [135, 320].  It has also been demonstrated that there is a genetic control of human 
osteoblast cellular response to bioglass molecule [321]. Furthermore, the nanoscale structure 
is reported to be superior than its microscale counterpart [322] [323]. Therefore, this phase of 
research work focuses on the preparation of bioglass with nanoscale microstructure by sol-gel 
method. The prepared bioglass was characterized for morphology, structural and functional, 
bioactivity and ion release ability. 
 
Very recently, it has been reported that the inorganic ions has the beneficial effect when these 
are added to the bioglass and enhances the osteogenic and angiogenic property of the polymer 
scaffold upon the incorporation of these components [324-325].  Furthermore, among the 
inorganic ionic components, Cu2+  seems to be the most attractive [324]. Therefore, research 
effort was also given to prepare and characterize Cu2+ doped nano-bioglass by following 
appropriate method.  
 
The present chapter describes the above experimental result and discussion. 
 
5.2.1 Synthesis and characterization of nano-bioglass 
Bioactive bioglass in nano-size range was synthesised by acid-catalyzed sol-gel method. The 
choice of sol-gel process is based on its several advantages over the other conventional melt-
quench method such as homogeneity, higher purity, higher surface area of the particles, 
superior degradation and high rate of apatite formation [326-327]. The molar composition of 
the prepared bioglass was 60% SiO2, 36% CaO, and 4% P2O5. 
 
Morphological Characterization of nano-bioglass 
The FE-SEM images (Figure 5.23A) were used to assess the size, morphology and 
homogeneity of nano-bioglass (nBG) samples. The particle size distributions of nBG were 
observed to be in the range of 40 - 50 nm. Some of the conglomerated particles were also 
noticed in both FE-SEM and TEM images of nBG. The TEM images (Figure 5.23B) shows 
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the presence of particles with sizes ≤ 50 nm and conglomerated particle size was ≤100 nm. 
The selected area electron diffraction (SAED) pattern and HRTEM confirm their amorphous 
nature (Figure 5.23D, C) as SAED pattern lacks any ring like pattern and HRTEM images 
show absence of fringes. 
 
 
Figure 5.23: Showing the morphology of nBG by FESEM (A) and TEM images (B).  HRTEM 
(C)images and SAED pattern(D) of nanobioglass.  The presence of particles with sizes ≤ 50 nm 
and conglomerated particle size ≤100 nm was observed. 
 
Structural and functional analysis of nBG 
The structural and functional characteristics of synthesized nano-bioglass were assessed by 
XRD and FT-IR analysis. As observed from Figure 5.24A, the synthesized nano-bioglass 
shows wide diffraction peak (X-ray diffractogram) between 20° and 40°, which confirms 
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their amorphous feature [230]. The FT-IR (Figure 5.24B) spectrum of nBG shows the 
characteristic bands of Si-O-Si bonds at 1060 cm-1 (stretch vibration), 798 cm-1 (bending 
vibration) and 480 cm-1 (bending vibration). From the structural and functional analysis of 
nano-bioglass it has been confirmed that amorphous silicate based bioglass has been 
synthesised.  
 
 
Figure 5.24: Showing the XRD diffractogram (A) and FT-IR spectra(B) of nano-
bioglass. Synthesised nBG represents amorphous characteristics of glass system. 
5.2.2 In vitro apatite forming ability of nano-bioglass 
In vitro apatite forming ability is one of the important characteristic of bioactive glass. The 
bioactivity of bioglass was assessed by using simulated body fluid with ion concentration 
similar to human blood plasma [293]. Finally, SBF treated bioglass was characterized for 
morphological, structural and functional and ion release property. 
 
Morphological analysis  
After 7 days of soaking in SBF, FESEM analysis revealed the formation of fine granules like 
particles over the surface of the bioglasses (Figure 5.25A).  Whereas, HR-TEM images as 
shown in Figure 5.25B depicts the amorphous as well as lattice fringes with d-spacing of 0.28 
nm corresponding to the 211 plane for apatite formation over bioglass particles [328]. The 
SAED image (Figure 5.25C) of bioglasses shows visible diffraction ring formation. Thus, 
HR-TEM and SAED analysis support the bioactivity property of synthesized nano-bioglass. 
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Figure 5.25: Showing the FESEM image (A), HRTEM image(B) and SAED pattern(C) for the 
developed nBG after SBF treatment. Formation of apatite like granules and its characteristic 
features (d-spacing of 0.28 nm corresponding to the 211 plane was observed from FESEM and 
TEM images respectively. The SAED image shows visible diffraction ring formation. 
 
Structural and functional analysis 
XRD diffractogram for nBG before and after SBF soaking is shown in Figure 5.26A. The 
new characteristic peaks were observed at 2θ = 26° (002), 32° (211), 39° (310), 46° (222), 49° 
(213) and 53° (004), which were assigned to hydroxyapatite[329-330]. The EDS studies 
showed the surface deposition of hydroxyapatite with Ca/P ratio of 1.80, suggesting the 
bioactivity characteristic of nBG in SBF (Figure 5.26C).  
 
 
 Figure 5.26: Showing the XRD diffractogram (A), FT-IR spectra(B) and EDS spectra(C) of 
nano-bioglass before and after SBF treatment. The characteristic hydroxyapatite peaks were  
observed at 2θ = 26° (002), 32° (211), 39° (310), 46° (222), 49° (213) and 53° (004). This was 
supported by FTIR analysis. The EDS studies showed the surface deposition of hydroxyapatite 
with Ca/P ratio of 1.80, suggesting the bioactivity characteristic of nBG. 
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The FT-IR (Figure 5.26B) spectrum of nBG shows the characteristic bands of Si-O-Si bonds 
at 1060 cm-1 (stretch vibration), 798 cm-1 (bending vibration) and 480 cm-1 (bending 
vibration). Whereas FT-IR spectra of nBG after SBF treatment shows the characteristic band 
of P-O bonds of PO4
3- group of hydroxyapatite at 562 cm-1, 595 cm-1 , 620 cm-1, 962 cm-1  and 
1026 cm-1.  The bands at 873 cm-1and 1460 cm-1 were characteristic peaks of CO3 
2- group 
and band between 3300 cm-1 and 3600 cm-1 associated with the presence of hydroxyl groups 
[331]. 
 
 Inductively coupled plasma atomic emission spectrophotometer (ICP-OES) analysis 
The ion release behaviour of bioactive nano-bioglass was evaluated by the simulated body 
fluid treatment for 7 days followed by ICP-OES analysis. The dissolution experiments of 
nBG in SBF solution were performed to study its dissolution rate. The experimental results 
are depicted in Figure 5.27A. During dealkalinization process, Ca was rapidly released during 
the 3 day of soaking in SBF, reaching to 242.29 ± 3.44 ppm in SBF. This was followed by a 
decrease in the Ca2+ ion concentration with slower rate reaching to 215. 76 ± 3.82 ppm. The 
concentration of Si released from the nBG by breakdown of Si-O-Si bonds leading to 61.88 ± 
1.14 ppm of Si, after 3 days and remained stable after soaking for 7 days (58.82 ± 1.4 ppm). 
Biodegradation and Si ion releases are the advantageous phenomenon of bioglass for bone 
tissue regeneration, as Si and Ca2+  ions having gene activating potential[83, 332]. This was 
followed by a decrease in the phosphorus ion concentration to 3.44 ± 0.464 ppm after 3 days 
of soaking in SBF, which shows the migration of Ca2+ and PO4
3- through silica rich layer 
resulted in a formation of carbonated hydroxyapatite. 
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Figure 5.27: The graph showing the rate of ion release from nBG during the 7 days of SBF 
treatment 
 
5.2.3 Synthesis and characterization of copper doped nano-bioglass  
Bioactive bioglass in nano-size range was synthesised by acid-catalyzed sol-gel method. 
Different batches of copper doped nano–bioactive glass (Cu-nBG) with 0.5 mol% (Cu0.5-
nBG) and 1 mol% (Cu1-nBG) based on 58S bioglass were prepared.   
 
Morphological Characterization  
The prepared copper doped nano-bioglasses (Cu0.5-nBG and Cu1-nBG) were successfully 
synthesised by using sol-gel method and their morphologies were observed under FESEM.  
The formation of agglomerated spherical shaped nano-bioglass with nanoscale sizes (< 100 
nm) was evident from FESEM images as shown in Figure 5.28A. There is no significant 
change in morphology and particle size of nBG by the doping of Cu 2+ ions as well as their 
concentration (0.5 % and 1 %). The TEM analysis of synthesized copper doped nBG further 
reveals that the bioglass particle size was in range of 50 nm (Figure 5.28C, D). Furthermore, 
the selected area electron diffraction (SAED) pattern (Figure 5.28C, D) obtained for all the 
synthesised nBG confirms their amorphous nature as SAED pattern lacks any ring like 
pattern and HRTEM images shows the absence of fringes.  
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Figure 5.28: FESEM and EDX images showing the morphology and elemental composition of 
Cu0.5-nBG (A) and Cu1-nBG (B). TEM image and SAED pattern of Cu0.5-nBG(C) and Cu1-
nBG(D) 
 
 
Structural and functional analysis of copper doped nBG 
The synthesized Cu2+ ion doped nano-bioglasses(Cu0.5-nBG and Cu1-nBG) showing the 
(Figure 5.29A) wide diffraction peak between 20° and 40°, thereby confirms their amorphous 
features [230]. Also peaks at 2θ equal to 35.5° and 38.7° which correspond to copper oxide 
(CuO) is absent in XRD pattern of copper doped glasses, thus confirming  the presence of 
copper ions (Cu2+) in the silicate glass network [333-334].  The FT-IR (Figure 5.29B) 
spectrum of nBG shows the characteristic bands of Si-O-Si bonds at 1060 cm-1 (stretch 
vibration), 798 cm-1 (bending vibration) and 480 cm-1 (bending vibration). The P-O 
antisymmetric stretching was associated to a band at 1000-1100 cm-1. However, the band for 
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P-O antisymmetric stretching was overlapped with that of Si-O-Si asymmetric stretching [335-
336]. The antisymmetric bending of PO4
3- was observed for both the glasses at 570 cm-1 – 600 
cm-1 due to the  interaction between calcium ion and orthophosphate [337]. The band at 3400 
cm-1 was assigned to the O-H symmetric stretching vibration H2O [338]. 
 
 
Figure 5.29: Showing the XRD diffractogram(A) and FT-IR spectra(B) of the 
synthesized two varieties of copper doped nanobioglasses. The presence of copper ions 
(Cu2+) in the silicate glass network [333-334]and the amorphous characteristics of the 
modified nBG were confirmed. 
 
 
5.2.4 In vitro apatite forming ability of copper doped nano-bioglass 
Similar to nBG the in vitro apatite forming ability of the modofied nBGs was assessed by 
SBF treatment. The SBF treated bioglasses were characterized for morphological, structural 
and functional and ion release property. 
 
Morphological Characterization 
After 7 days of exposure in SBF, FESEM analysis revealed the formation of fine granules 
like particles over the surface of the bioglasses was observed (Figure 5.30A, B).  The HR-
TEM images (Figure 5.30C, D) of  modified bioglasses (Cu0.5-nBG and Cu1-nBG) after 
soaking for 7 days shows well resolved lattice fringes with d-spacing of 0.285 nm correspond 
to 211 plane for nano-crystalline apatite formation over bioglasses particles [328]. The SAED 
image of bioglasses shows visible diffraction rings formation. The diffraction rings were 
observed to be more prominent in case of Cu1-nBG as compared to Cu0.5-nBG, representing 
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the improved bioactivity with copper doping of bioglass. Thus HR-TEM and SAED analysis 
support the bioactivity properties of synthesized nano-bioglasses. 
 
 
Figure 5.30: FESEM images showing the morphology of Cu0.5-nBG (A) and Cu1-nBG 
(B) after SBF treatment. HRTEM image and SAED pattern of Cu0.5-nBG(C) and Cu1-
nBG (D) after SBF treatment 
 
Structural and functional analysis 
X-ray diffraction pattern of copper doped nBG was recorded after 7 days of treatment in SBF 
to investigate the in vitro apatite formation ability. Synthetic hydroxyapatite (Sigma-Aldrich) 
XRD pattern was used as a reference to analyse formation of apatite layer over the particles. 
X-ray diffractogram obtained for the modified bioglass samples treated with SBF shows the 
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peaks at 2θ equal to 25.8°, 31.8°, 32.8°, 46.6° and 53.2° correspond to hydroxyapatite (HA) as 
shown in Figure 5.31A [339]. The FT-IR (Figure 5.31B) spectrum shows the characteristic 
bands of Si-O-Si bonds at 1060 cm-1 (stretch vibration), 798 cm-1 (bending vibration) and 480 
cm-1 (bending vibration). Whereas FT-IR spectra of Cu-nBG  shows the characteristic band of 
P-O bonds of PO4
3- group of hydroxyapatite at 562 cm-1, 595 cm-1 , 620 cm-1, 962 cm-1  and 
1080 cm-1.  The bands at 873 cm-1and 1460 cm-1 were characteristics of CO3 
2- group and 
band between 3300 cm-1 and 3600 cm-1 associated with the presence of hydroxyl groups 
[331]. 
 
 
Figure 5.31:  Showing the XRD diffractogram (A), FT-IR spectra (B), EDX analysis(C) and  
EDX analysis (D) of copper doped Cu0.5-nBG and Cu1-nBG bioglasses after 7 days of SBF 
treatment 
 
Inductively coupled plasma atomic emission spectrophotometer (ICP-OES) analysis 
The copper ion release behaviour of Cu-nBG was evaluated after treatment in simulated body 
fluid for 7 days and analysed by using ICP-OES.  Figure 5.32 shows the ion release from the 
copper doped bioglass samples while soaking in SBF for a period of 3, 5 and 7 days at room 
temperature. During dealkalinization process, Ca was observed to be rapidly released from 
Cu0.5-nBG and Cu1-nBG on 3
rd day of soaking in SBF, reaching to 158 ± 13.56 ppm and 353 
± 18.13 ppm in SBF.   This was followed by a decrease in the Ca2+ ion concentration to 124 ± 
2.32 ppm and 185 ± 13.8 ppm for Cu0.5-nBG and Cu1-nBG after 7 days of incubation 
respectively. However, the release of calcium ion from copper doped nano-bioglass is 
significantly higher as compared to nBG because of higher surface reactivity of copper doped 
bioglass than the undoped nBG during initial phase of reaction, which was also reported 
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earlier with different glass system [340].The concentration of Si released from Cu0.5-nBG and 
Cu1-nBG by breakdown of Si-O-Si bonds leading to 64 ± 2.21 ppm and 68 ± 3.5 ppm of Si, 
after soaking for 3 days in SBF and further reduced to 46 ± 3.89 ppm and 48 ± 1.35 ppm after 
soaking for 7 days.  
 
 
Figure 5.32: The graphs showing the rate of ion release from Cu0.5-nBG and Cu1-nBG 
during the 7 days of SBF treatment 
 
Furthermore, a decrease in the phosphorus ion concentration was observed which shows the 
migration of Ca2+ and PO4
3- through silica rich layer resulted in a formation of carbonated 
hydroxyapatite. However, the level of PO4
3- in SBF collected from Cu0.5-nBG and Cu1-nBG 
treatment after soaking for 7 days was found to be 6.11± 0.41 ppm and 4.1 ± 0.24 ppm 
respectively. The bioglass sample without copper doped shows constant and negligible level 
of copper ion release during soaking period of 7 days in SBF. Whereas Cu0.5-nBG was 
observed to release 7.06 ± 0.02 ppm of copper ion by 3 days, which was reduced to 6.09 ± 
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0.015 ppm by 7 days. In case of Cu1-nBG, the copper ion release was observed to be 11.18 ± 
0.51 ppm and 4.25 ± 0.24 ppm after 3 and 7 days respectively. The higher level of Cu ion 
release from Cu1-nBG was due to higher surface reactivity; however it reduces rapidly as the 
apatite layer developed over the glass surfaces. Thus it has been concluded from the above 
study that doping of Cu ion in bioglass improves its bioactivity.  
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
CHAPTER 5C: Development of nano-bioglass 
incorporated electrospun SF/CMC composite 
nanofibrous scaffold  
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In the previous chapter, a novel SF/CMC blend nanofibrous scaffold was developed which is 
proven to be a good substrate for bone tissue engineering application. It is further reported that 
the development of composite biopolymeric materials derived from natural or synthetic 
polymers and bioceramics like nanohydroxyapatite is a promising approach to overcome some 
of the limitations of the polymeric scaffold thereby improving the scaffold property [341-342]. 
These polymer-bioceramic matrices are proven to prompt the differentiation of mesenchymal 
stem cells to an osteogenic lineage and thus provides bone tissue like microenvironments 
[343]. Furthermore, nanofibrous polymeric composite scaffolds containing osteogenic 
inorganic phases, fabricated by electrospinning technique has been reported to be the most 
appropriate structures that mimic ECM of bone tissue [344-346]. Therefore, in this work, for 
the first time an attempt was made to fabricate natural biopolymer based composite 
nanofibrous scaffold by combining silk fibroin (SF)/carboxymethyl cellulose (CMC) and nano-
bioglass as the promising bioactive ceramic with the intention to bring the mechanical property 
of silk fibroin, strong ability to absorb and transport fluids as well as chelation property of 
CMC and the bioactivity of nano-bioglass to a common template thereby developing a 
nanofibrous scaffold with robust property for bone tissue engineering applications. 
 
Keeping in view of the multiple promising properties, bioactive glass in nanoscale was 
synthesised in the previous chapter and this was used to increase the apatite formation ability 
and osteogenic (osteoinductive and osteocounductive) properties of the polymeric SF/CMC 
blend in this phase of work. The developed nanofibrous nanocomposite scaffolds were 
evaluated for their various physicochemical, mechanical, biomineralization, in vitro 
biocompatibility and osteogenic differentiation ability using umbilical cord blood derived 
human mesenchymal stem cell. The result and discussion of this research work is described 
below- 
 
5.3.1 Fabrication and characterization of SF/CMC/nBG nanofibrous 
composite scaffold 
Various batches of SF/CMC/nBG composite mixtures with different nano-bioglass (5 wt% - 20 
wt%) content were prepared by dissolving in formic acid as solvent. The prepared polymer-
ceramic composite solutions were successfully electrospun. The effect of nBG concentration  
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on the viscosity of the electrospinnable composite solution and the electrospun nanofiber 
diameter is shown in Table 5.1. It is depicted that the increase in nBG concentration 
significantly increases the viscosity of the composite solution from 0.092 ± 0.0016 to 0.316 ± 
0.018. This result is corroborated with the study reported earlier using different polymer 
system like poly-caprolactone/nano-bioglass [347]. This increase in viscosity may be attributed 
to the increase in shear viscosity due to the presence of nBG in the polymer suspension [347]. 
A significant effect of the viscosity change due to the combined effect of SF/CMC polymer 
blend and nBG as additive on the fiber diameter and morphology was also observed. These 
experimental findings are evident from Table 5.2 and FESEM images as in Figure 5.33A. The 
average fiber diameter was increased steadily from 233.60 ± 83 nm to 594.66 ± 157 nm, when 
nBG content was increased from 0 wt% to 20 wt%. An increased fiber diameter was also 
exhibited by SF/CMC/nBG composite solution containing higher nBG content of 20 wt% but 
the difference in fiber diameter obtained with SF/CMC/10%nBG and SF/CMC/20%nBG is 
statistically in significant, which is also due to the increased viscosity resulting from the 
addition of more nBG. As evident from published  literature, at higher concentration of nBG 
greater interaction (hydrogen bonding and ionic bonding) between the fibers occurs which 
leads to the deposition of fused fibers [348]. The pore size of (4.51 ± 1.65 µm) of 
SF/CMC/0%nBG scaffold was gradually increases with increasing nBG content from 0 wt% to 
20 wt%. The measured average  pore size for SF/CMC/5%nBG, SF/CMC/10%nBG and 
SF/CMC/20%nBG are 4.57 ± 1.3 µm, 4.64 ± 2.1 µm and 5.4 ± 1.7 µm respectively.  
 
The distribution of the nBG over the surface of fiber matrix was further examined by TEM 
images. The TEM images of SF/CMC/0%nBG, SF/CMC/5%nBG, SF/CMC/10%nBG and 
SF/CMC/20%nBG composite nanofibers are presented in Figure 5.33B. As indicated, 
SF/CMC/0%nBG (Figure 5.33B) shows the absence of nBG over the surface of blend 
nanofibrous scaffold. As revealed by TEM image (Figure 5.33B) nano-bioglass (≤ 100 nm) 
was successfully electrospun with SF/CMC and well incorporated over the surface of 
nanofibers. The TEM images clearly show the presence of nBG over the SF/CMC/nBG 
composite nanofibrous scaffold. However, the content of nano-bioglass over 
SF/CMC/5%nBG, SF/CMC/10%nBG and SF/CMC/20%nBG composite scaffold increases as 
the concentration of nano-bioglass increases from 5 to 20 wt%. The distribution of nBG in 
nanofibers was observed from FESEM and TEM images (Figure 5.33A, B) shows that nBG 
was uniformly distributed over SF/CMC/5%nBG and SF/CMC/10%nBG composite scaffolds. 
However, nBG was observed to be agglomerated and distributed as clumps over the composite 
 92 
 
nanofibers with higher nBG content. Thus, at higher content of nBG, agglomeration of 
nanoparticle occurs. 
 
Table.5.2. Fiber diameter of electrospun composite mats and viscosity of various solutions 
prepared for fabrication of the respective electrospun mats 
   
 Scaffolds         Fiber 
diameter(nm) 
 
 
Viscosity 
 (Pas) 
SF/CMC/0%nBG 233.60 ± 83  0.09265 ± 0.00165 
SF/CMC/5%nBG 350.39 ± 147 0.1557 ± 0.015608 
SF/CMC/10%nBG 589.68 ± 161 0.249 
SF/CMC/20%nBG 594.66 ± 157 0.316 ± 0.0185 
 
 
 
Figure 5.33: Showing the FESEM(A) and TEM(B) images of fabricated SF/CMC/0%nBG, 
SF/CMC/5%nBG, SF/CMC/10%nBG and SF/CMC/20%nBG nanofibrous scaffolds. Fiber 
diameter was found to increase from 233.60 ± 83 nm to 594.66 ± 157 nm as the nBG content 
increases from 0 wt% to 20 wt%. TEM images confirm the presence and well distribution of  
nano-bioglass (≤ 100 nm)  throughout the SF/CMC blend nanofibrous mats. 
 
Structural and functional analysis 
XRD and FT-IR were used as efficient techniques to investigate the structural and functional 
characteristics of the modified SF/CMC/0%nBG scaffolds resulted by the incorporation of 
nBG thereby SF/CMC/nBG composite scaffold was developed. The X-ray diffractogram 
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pattern of SF/CMC/nBG composite scaffolds with different content of nBG is depicted in 
Figure 5.34A. As indicated, the diffraction peaks at 2θ values of  20.8° and 24.3° indicating β-
sheet conformation of the SF/CMC nanofibrous scaffolds were intensified as nBG introduced 
(5 – 10 wt %) which may be due to the enrichment in the transformation of randomly 
arranged to crystalline β – sheet structure. Whereas at higher concentration of nBG (20 wt %) 
the amorphous glassy structure were dominant that led to reduced intensity at respective 
angle.  
 
The change in structural and functional conformation that might have occurred in band 
position due to the incorporation of nBG was shown by FT-IR spectrum of SF/CMC/nBG 
nanofibrous scaffolds as depicted in Figure 5.34B.  The FT-IR spectra of SF/CMC/nBG 
showed vibration bands at 470 cm-1, 1060 cm-1  and 1100 cm-1  which are associated with Si-
O-Si bending mode[331, 349]. The peak at 970 cm-1 was assigned to the non-bridging oxygen 
together with the surface active silanols (Si-OH) groups, which facilitate the enhanced rate of 
apatite formation.  The shoulder peak at 958 cm-1 belongs to the Si-O-Ca vibration 
mode[230]. The peak at 920 cm-1  is the result of  stretching vibration of the phosphate group 
(O-P-O)[349]. It has been noticed that as the nBG incorporated in SF/CMC/nBG scaffold 
peak for amide I, amide II and amide III get narrowed due to conformational change in 
SF/CMC in presence of nBG. However, in case of SF/CMC/20%nBG peaks were broader 
due to dominance of amorphous glassy structure of nBG [350]. Also peak at 1060 cm-1 
associated with Si-O-Si bending mode get intensified and broader as the nBG content 
increases. 
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Figure 5.34: XRD diffractogram(A) and FT-IR spectrum (B) showing the change in structural 
and functional conformation of the fabricated SF/CMC/0%nBG, SF/CMC/5%nBG, 
SF/CMC/10%nBG and SF/CMC/20%nBG nanofibrous scaffolds due to the incorporation of 
nano-bioglass.  
 
Mechanical property 
The mechanical property of scaffold plays distinctive roles in modulation of cell behaviour 
and its lineage determination as well as also improve osteogenic property [351]. Therefore, 
the assessment of mechanical properties of the developed nBG incorporated 
SF/CMC/0%nBG nanofibrous scaffold both at dry and wet condition is essential for 
understanding the performance of the scaffold in bone tissue regeneration. The measured 
mechanical properties in term of tensile strength and tensile strain at break of SF/CMC/nBG 
composite scaffold are depicted in Figure 5.35 and compared with the SF/CMC blend 
scaffold. Figure 5.35A shows ultimate tensile strength (UTS) of SF/CMC/0%nBG and 
SF/CMC/nBG composite scaffolds in dry condition. The tensile strength and tensile strain at 
break were decreased with the addition of nBG. The tensile strength and tensile strain at 
break for SF/CMC/0%nBG composite scaffold was measured to be 9.49 ± 1.83 MPa and 8.54 
± 0.91 % respectively. Among the composite scaffolds the SF/CMC10%nBG composite 
nanofibrous scaffold shows higher tensile strength in comparison to scaffold with 5 and 20 wt 
% nBG. The SF/CMC/5%nBG scaffold posses tensile strength of 5.5 ± 1.8 MPa and tensile 
strain at break of 1.9 ± 0.5 %, whereas the SF/CMC/10%nBG shows tensile strength of 7.591 
± 1.23 MPa and tensile strain at break of 9.62 ± 0.85 %.  Since SF/CMC/20%nBG composite 
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scaffold was highly fragile it broke apart immediately even at low load and thus exhibited 
lower tensile strength of 4.28 ± 0.76 MPa and tensile strain at break of 8.8 ± 2.5 %. The 
overall trend of the mechanical behaviour of the developed scaffolds is as follows 
SF/CMC/0%nBG> SF/CMC/10%nBG > SF/CMC/5%nBG > SF/CMC/20%nBG. This may 
be attributed to the improvement of interaction (hydrogen bonding or ionic bonding) with the 
increasing content of nBG [350] however the decrease in tensile strength of 
SF/CMC/20%nBG is attributed to the higher fiber diameter and weak link between 
continuum matrices because of the inclusion of nBG [352].  
 
However, the trend for tensile strain at break was observed to be SF/CMC10%nBG > 
SF/CMC/20%nBG > SF/CMC/0%nBG> SF/CMC/5%nBG, which may be attributed to the 
improved ductility of composite nanofiber because of yielding phenomenon as a result of 
debonding between nBG particles and SF/CMC blend matrix [350].  Furthermore, a decrease 
in stiffness of SF/CMC scaffolds was observed when loaded with nBG and also increased 
nBG content. The stiffness of developed composite scaffold was measured to be 531.81 ± 17 
MPa, 208.9 ± 83 MPa, and 149.8 ± 24 MPa for SF/CMC/0%nBG, SF/CMC/5%nBG, 
SF/CMC/10%nBG and SF/CMC/20%nBG respectively. The lower stiffness of developed 
composite scaffold with increasing nBG content might be due to the debonding between nBG 
and SF/CMC polymeric matrix [350]. Which may affect stem cell response during cell 
culture due to lower cell scaffold interaction [284]. Furthermore, in wet condition tensile 
strength recorded for SF/CMC/0%nBG, SF/CMC/5%nBG and SF/CMC/10%nBG are 3.46 ± 
0.66 MPa, 2.49 ± 0.25 MPa and 3.6 ± 0.135 MPa respectively. However, due to highly fragile 
nature SF/CMC/20%nBG broke apart immediately upon applying force, thus values could 
not be measured [353]. Figure 5.35C and Figure 5.35D shows mechanical characteristic of 
developed scaffold in wet condition. These results indicate that 10 wt % nBG could be used 
to improve properties like biomineralization and osteogenic activity of SF/CMC composite 
nanofibrous scaffold.  
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Figure 5.35: (A) Load Vs Extension curve for composite scaffolds in dry condition. (B) 
Distribution of tensile strength and tensile strength at break of SF/CMC/0%nBG, 
SF/CMC/5%nBG, SF/CMC/10%nBG and SF/CMC/20%nBG scaffolds in dry condition. (C) 
Load Vs Extension curve for composite scaffolds SF/CMC/0%nBG, SF/CMC/5%nBG, 
SF/CMC/10%nBG and SF/CMC/20%nBG in wet condition. (D) Distribution of tensile strength 
and tensile strength at break of SF/CMC/0%nBG, SF/CMC/5%nBG, SF/CMC/10%nBG and 
SF/CMC/20%nBG scaffolds in wet condition. The tensile strength of SF/CMC/10nBG composite 
scaffold was found to be more suitable in comparison to SF/CMC/0%nBG and other composite 
scaffolds. 
 
Surface roughness analysis of composite scaffold 
The analysis of surface roughness of SF/CMC/nBG scaffolds was performed to assess their 
performance towards cell supportive property and bone tissue regeneration. The roughness of 
SF/CMC/nBG (5-20 wt %) scaffold surfaces were improved gradually with the addition of 
nBG from 0.214 µm to 0.309 µm respectively (Figure 5.36). The obtained surface roughnes for 
developed composite scaffold follows trend as SF/CMC/0%nBG (0.101 µm) < 
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SF/CMC/5%nBG (0.214 µm) < SF/CMC/10%nBG (0.219 µm) < SF/CMC/20%nBG (0.309 
µm).  
 
 
Figure 5.36: Surface roughness of fabricated SF/CMC/5%nBG, SF/CMC/10%nBG and 
SF/CMC/20%nBG composite nanofibrous scaffolds. An enhanced surface roughness of SF/CMC 
scaffold surfaces was obtained with the addition of nBG. 
 
Thus, as the nBG content increases wrinkles, grooves and pits on the nanofibrous composite 
scaffold were found to be developed, which in turn resulted in improved surface roughness 
[354-355]. This study was in accordance with the result of FESEM analysis. Thus, the 
enhanced surface roughness of composite nanofibrous scaffold with addition of nBG is 
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expected to  induce changes in cell membrane interaction and promote cell attachment, 
proliferation and direct differentiation of hMSCs, thereby favouring osteogenesis [356]. 
 
Hydrophilicity and swelling behaviour 
The hydrophilicity of scaffold is important factor which determines its cell supportive property 
and ability for neo tissue regeneration. Thus, the contact angle of the developed SF/CMC 
scaffold loaded with nBG was measured and the values are shown in Table 5.2. As indicated, 
an decrease in contact angle representing the enhanced hydrophilicity of the scaffold was 
obtained by increasing the nBG content which is due to the hydrophilic nature of the later. The 
contact angle of SF/CMC/0%nBG, SF/CMC10%nBG and SF/CMC/5%nBG was 57.4° ± 0.3, 
55° ± 0.5 and 52° ± 1.4 respectively. The overall trend of these contact angle as follows 
SF/CMC10%nBG > SF/CMC/5%nBG > SF/CMC/0%nBG. However, SF/CMC/20%nBG get 
folded while coming into contact with water thus its contact angle value was not possible to be 
recorded in our study.  
 
The swelling behaviour of SF/CMC/nBG composite scaffold is shown in Figure 5.37. The 
water uptake property of SF/CMC blend scaffold was observed to be in the range of 352 – 389 
(%). The SF/CMC/nBG (5 wt%, 10wt% and 20 wt %) shows lower water uptake capacity than 
SF/CMC, which may be attributed to the structural stability of the composite scaffolds [357]. 
The water uptake capacity of SF/CMC/nBG was increased sharply up to 8 hr and then slightly 
decreased which is due to the occurrence of dissolution of nBG. The swelling ratio of 
SF/CMC/20%nBG was observed to be the lowest. However, swelling behaviour of composite 
scaffolds is not in coordination with the contact angle as the incorporation of bioglass results in 
maintaining structural integrity and inhibits excess swelling. This observation supports that 
SF/CMC/nBG composite scaffolds shall provide better uptake of nutrients to the interior of 
scaffold thereby facilitate cell migration and proliferation in the interior region of the 
composite scaffold without much affecting mechanical integrity of the scaffold [48, 357]. 
 
Table 5. 2: Mean contact angle measurement of nanofibrous scaffolds 
Scaffolds MACA  [°] MRCA  [°] Hysteresis  [°] 
SF/CMC/0%nBG 57.4 ± 0.3 18.5 ± 1.8 38.9 ± 3.2 
SF/CMC/5%nBG 55 ± 0.5 30.0 ± 1.45 26.2 ± 2.1 
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SF/CMC/10%nBG 52 ± 1.4 41.7 ± 2.5 12.3 ± 1.8 
SF/CMC/20%nBG Failed to measure Failed to measure Failed to measure 
 
 
Figure 5.37: Swelling behaviour at different time interval observed with 
SF/CMC/0%nBG, SF/CMC/5%nBG, SF/CMC/10%nBG and SF/CMC/20%nBG 
composite nanofibrous scaffolds in PBS solution. Incorporation of nBG in composite 
scaffold resulted into improved hydrophilicity and structural stability. 
 
5.3.2 In vitro bioactivity analysis 
In chapter 5A, the bioactivity of SF scaffold was increased by the addition of CMC. In this 
study, the effect of incorporation of the nBG in SF/CMC blend was investigated. The ability of 
the composite scaffold containing different content of nBG to induce apatite formation on their 
surface was assessed by FESEM image analysis before and after soaking in SBF for 7 days. As 
expected, the nBG incorporated SF/CMC composite scaffold shows improved apatite like 
deposition throughout the surface, whereas SF/CMC/0%nBG shows less deposition as can be 
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seen from Figure 5.38A. Furthermore, as the concentration of nBG increases from 5 to 20 wt% 
the surface of composite scaffold shows improved mineral deposition as observed from 
FESEM images.  Thus, as the concentration of nBG increases the formation of spherical nano-
hydroxyapatite like nodule (size ≤ 50 nm as measured by using image J software) were 
improved.  The negatively charged carboxyl groups of CMC interact with positively charged 
calcium ion released by the dissolution of nBG. As the calcium ions associated with carboxyl 
group, it further promotes adsorption of phosphate ions of SBF and leads to the growth of 
hydroxyapatite particle over composite scaffolds [358]. The EDX analysis showed that the 
mineral phase with Ca/P ratio: 0.8-1.3 was deposited over SF/CMC/0%nBG whereas on 
SF/CMC/nBG, the Ca/P ratio was 1.6-1.8 which is similar to the mineral phase of the human 
bone that consists mostly of Ca and P in the ratio 1.4 - 1.7 [316]. 
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Figure 5.38: FESEM images of SF/CMC/0%nBG, SF/CMC/5%nBG, SF/CMC/10%nBG and 
SF/CMC/20%nBG composite matrices after SBF treatment for 7 days (A). EDX spectra depicts 
the mineral deposition over SF/CMC/0%nBG (B) and SF/CMC/10%nBG (C) after 7 days of SBF 
treatment. The apatite like mineral deposition over scaffold increases with increasing nBG 
content.  
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Structural and functional analysis of biomineralized scaffold 
The formation of apatite on the surface of the nanofiberous scaffold was also examined by 
XRD and FT-IR study as shown in Figure 5.39. The diffractogram of SF/CMC (Figure 5.39A) 
shows the presence of peak at 2θ = 28.4° and broad weak scattering peak at 32° which 
implicates the presence of amorphous apatite to some extent. Whereas, in case of 
SF/CMC/nBG as the concentration of nBG increases the characteristic peaks of the apatite at 
31.7° attributed to 211 plane got intensified thereby resulted in better biomineralization at 
higher concentration of nBG [359]. Thereby, the characteristic peak at 31.7° was observed to be 
broader and intense in case of SF/CMC/20%nBG as compared of SF/CMC/5%nBG and 
SF/CMC/10%nBG respectively. 
 
After in vitro mineralization the prepared scaffolds were also characterized by FT-IR to 
analyse their ability towards in vitro apatite formation. As observed in FT-IR spectra (Figure 
5.39B) the hydroxyapatite like deposition on the scaffolds is reflected by the characteristic 
peak at 1070 cm-1 which corresponds to the P-O asymmetric stretching mode of vibration for 
PO4
-3
 group [300-301]. The P-O stretching mode has been observed at 1012 cm
-1 and 976 cm-1 
which correspond to major bands for phosphate group. The sharpening of peaks observed at 
610 cm-1 and 556 cm-1 are due to O-P-O bending and stretching respectively [301-302]. The 
absorbed CO2 corresponds to the 1400-1450 cm
-1 peaks indicating the deposition of carbonated 
HAp on the nanofibers. Furthermore, the characteristic peaks of the apatite were improved at 
higher concentration of nBG. Thereby, the characteristic peak of PO4
-3
 group at 1070 cm
-1 was 
observed to be broader in case of SF/CMC/20%nBG as compared to SF/CMC/5%nBG and 
SF/CMC/10%nBG respectively. 
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Figure 5.39: Showing the XRD spectrum (A) and FT-IR spectrum(B) of SF/CMC/0%nBG, 
SF/CMC/5%nBG, SF/CMC/10%nBG and SF/CMC/20%nBG after incubation in SBF for 7 
days 
 
5.3.3 In vitro biodegradation of scaffold 
The in vitro biodegradation result of the bioglass loaded composite scaffolds obtained by 
measuring the loss of weight during exposure in PBS and protease XIV enzymatic solution 
for 28 days is presented in Figure 5.40. The study has shown that bioglass incorporated 
SF/CMC scaffold degraded faster as compared to the scaffold without bioglass. Furthermore, 
the extent of degradation was observed to be depended on the bioglass content. As expected 
the degradation rate of SF/CMC scaffold was remarkably enhanced by the increase of nBG 
concentration. The corresponding degradation was measured as 53% to 60% in presence of 
enzyme, where as 28% to 35% degradation was obtained in PBS.  The increase in scaffold 
degradation by the incorporation of nBG may be attributed to the augmentation of 
hydrophilicity that resulted in the increase in hydrolytic degradation of composite polymer 
matrix thereby causing higher weight loss than that shown by SF/CMC scaffold without 
bioglass. 
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Figure 5.40: Observed degradation behaviour of SF/CMC/0%, SF/CMC/5%nBG, 
SF/CMC/10%nBG and SF/CMC/20%nBG scaffolds by soaking in enzyme (A) and PBS solution 
(B) for 28 days. The result shows that the bioglass incorporated SF/CMC scaffold degraded 
faster than the scaffold without bioglass. Furthermore, the extent of degradation was observed 
to be depended on the bioglass content. 
 
5.3.4 In-vitro cell culture study 
All the above assessments taken together, SF/CMC/10nBG composite scaffold found to 
possess a desired set of superior scaffold properties namely hydrophilicity, apatite forming 
ability, biodegradability and mechanical property and hence it was selected for in-vitro cell 
study to evaluate its potentiality for bone tissue regeneration. 
 
hMSCs adhesion, morphology and spreading 
The cellular affinity to the scaffold representing the indication of the ability towards the neo 
tissue regeneration was visualized through the observation of attached cells and the 
morphological changes during the culture of MSCs by FESEM image analysis.   From Figure 
5.41A, it has been observed that hMSCs seeded on SF/CMC/0%nBG and SF/CMC/10%nBG 
were more or less round in shape after 12 h with aspect ratio of 1.32 ± 0.078 and 1.59 ± 0.221 
respectively. The higher aspect ratio shown by SF/CMC loaded with nBG reflects the slightly 
higher cellular attraction than SF/CMC scaffold. However, on day 7, the cells were found to 
gradually well attached and spread over all the scaffolds indicating the active cell 
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proliferation potential. Furthermore, the spindle shaped morphology of hMSCs was observed 
over the SF/CMC/0%nBG nanofibrous mats, whereas cells morphology was observed to be 
polygonal in shape when SF/CMC/10%nBG was used as the substrate.  
 
The prominent development of outgrowths leading to the formation of filopodia as observed 
confirms the stronger interaction between the hMSCs and SF/CMC/10%nBG scaffold 
thereby favours strong cell attachment.  The hMSCs morphology tends to changes in to 
polygonal shape is primary indication for osteogenic differentiation potential of 
SF/CMC/10%nBG [360]. Thus SF/CMC/0%nBG promotes cell growth and deposition of 
ECM to some extent, whereas SF/CMC/10%nBG possessed additional advantage of 
bioactive glass which promotes not only the growth and cellular attachment but also 
facilitates cell proliferation and differentiation.  The cultured hMSCs are observed to be 
polygonal in shape (Figure 5.41) along with the formation of filopodia like extension from 
cell surface over SF/CMC/10%nBG indicating higher osteogenic differentiation potential of 
composite scaffold was partly because of higher surface roughness of the composite scaffold 
[350] and partly due to superior mineralization ability of scaffold containing nBG. Though 
the stiffness of composite scaffold decreases with increasing nBG, the dissolution of nBG 
favoured the deposition of apatite layer over the fibers, thereby improves the stiffness of 
scaffold which triggered cells towards osteogenic differentiation. 
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Figure 5.41:FESEM images of hMSCs cultured over the SF/CMC/0%nBG and 
SF/CMC/10%nBG scaffolds after 12 hour (A) ,7 days (B) and 14 days (C).  
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Cytoskeletal organization 
Figure 5.42 shows the fluorescence images of cytoskeleton development and distribution 
after 7 and 14 days of cell culture on the electrospun SF/CMC/0%nBG (Figure 5.42A, C), 
and SF/CMC/10%nBG (Figure 5.42B, D) composite scaffolds. On day 7, it was observed that 
cells were attached and elongated, whereas cells were proliferated and monolayer coverage of 
scaffold surface was evident on day 14.  However, the cells were polygonal in shape and 
show more spreading over SF/CMC/10%nBG as compared of SF/CMC/0%nBG counterpart. 
Furthermore, the development of filamentous actins was superior with the nBG incorporated 
composite scaffolds compared to SF/CMC/0%nBG. Thus, as expected developed composite 
scaffold provides superior cell supportive property then SF/CMC/0%nBG blend scaffold and 
maintaining the cytoskeletal organization of the hMSCs. 
 
 
Figure 5.42: hMSCs proliferation and distribution are visualized under confocal microscope on 
SF/CMC/0%nBG (A and C) and SF/CMC/10%nBG (B and D) on 7 and 14 days of culture, 
Nuclei of the cells were stained with DAPI (blue) and actin filaments with phalloidin (green). 
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Composite scaffold SF/CMC/10nBG shows better elongation and spreading of cells in 
comparison to SF/CMC scaffold. (Scale bar = 25 µm) 
 
Metabolic activity by MTT assay 
The cytocompatibility and cell proliferation of the developed nano composite scaffold were 
assessed during 7 days of hMSCs culture over the scaffolds by MTT assay [311]. As can be 
seen from Figure 5.43B that, on day 3, the optical density (OD) measured with hMSCs 
seeded SF/CMC/10%nBG is higher than pure SF/CMC (p˂0.05) scaffolds. However, during 
the progress of the culture OD values were observed to be steadily increased with both 
SF/CMC with and without nBG. However, the metabolic activity of hMSCs on 
SF/CMC/10%nBG was significantly higher (p<0.05) in comparison to SF/CMC/0%nBG 
blend scaffold throughout the culture period on day 14 in particular. Thus, the metabolic 
activity study shows superior biocompatibility of the developed SF/CMC/10%nBG 
composite scaffolds due to the presence of nBG. Overall, the result confirms that no toxic 
leachable from nBG loaded SF/CMC scaffold was released which could be detrimental to 
cellular activity.  
 
Live/dead assay  
The confocal images were used to assess the viability of hMSCs cultured for 24h on the 
developed SF/CMC/0%nBG and SF/CMC/10%nBG scaffolds. The live/dead staining 
solutions (calcein AM and EthD-1), where green signal indicates viable cells and red signal 
indicates dead cells as shown in Figure 5.43A. The images show that the hMSCs are viable 
and look healthy over the entire scaffold irrespective of their composition, however cells 
were observed to cover higher surface area of SF/CMC/10%nBG as compared to 
SF/CMC/0%nBG representing the superior hMSCs recruitment to the nBG loaded composite 
scaffold moiety.  
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Figure 5.43: Live/dead confocal microscopy images (A) and MTT reduction assay(B) of hMSCs 
cultured on SF/CMC/0%nBG(control) and SF/CMC/10%nBG nanofibrous scaffolds. The cell 
viability over nano bioglass incorporated SF/CMC/10%nBG was higher than the control.  
 
Glucosamino glycan (GAG) analysis 
Figure 5.44 shows the GAG deposition over SF/CMC/0%nBG and SF/CMC/10%nBG 
scaffolds. The GAG production was shown to be increased over culture period irrespective of 
the scaffold composition but with a varied degree of GAG synthesis. On day 7, the GAG 
content was significantly higher over SF/CMC/10%nBG (0.317 µg/mg) than 
SF/CMC/0%nBG (0.109 µg/mg) scaffold. A drastic increase in GAG secretion on 
SF/CMC/10%nBG (0.714 µg/mg) composite nanofibrous scaffold was obtained which was 
2.25 fold higher than day 7. Whereas, on day 14, the GAG content on SF/CMC/0%nBG 
(0.183 µg/mg) nanofibrous scaffold was only 1.6 fold higher than day 7. Thus, 
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SF/CMC/10%nBG has been proven to promote higher GAG deposition indicating the 
superior ECM production ability of SF/CMC/10%nBG [361].  
 
 
Figure 5.44: Estimation GAG secreted by hMSCs cultured in osteogenic media during 7 and 14 
days of culture over SF/CMC/0%nBG and SF/CMC10%nBG nanofibrous scaffolds. The nano 
composite scaffold loaded with nano-bioglass (SF/CMC/10%nBG) promotes GAG secretion 
which is higher than SF/CMC scaffold without nano bioglass. 
 
5.3.5 Osteogenic differentiation 
Alkaline Phosphatase assay 
The alkaline phosphatase enzyme is analysed to evaluate the early osteogenic differentiation 
of hMSCs. The characteristic marker of early osteoblastic differentiation is attributed to the 
cellular secretion of ALP. The ALP activities of hMSCs over the scaffolds were studied 
during 14 days of culture period and the obtained ALP result is shown as Figure 5.45. An 
increase in enzyme activity level with increasing culture period from 7 days to 14 days 
represents the more differentiated stage of hMSCs seeded on the scaffold. A gradual increase 
in ALP activity in all the scaffolds was shown during the 14 days of culture period which 
indicates the osteogenic differentiation of hMSCs. However, the ALP activity of hMSCs on  
SF/CMC/10%nBG was significantly (p˂0.05) higher than SF/CMC/0%nBG throughout the 
culture period. Hence, it is confirmed that nano bioglass incorporated SM/CMC provides 
superior osteogenic platform for hMSCs than the SF/CMC scaffold containing no bioglass. 
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Figure 5.45: Alkaline phosphatase (ALP) activity in hMSCs on SF/CMC/0%nBG and 
SF/CMC/10%nBG in an osteogenic culture medium over time (n=3). From ALP activity 
analysis it has been observed that SF/CMC/10%nBG provides a better supportive platform for 
osteogenic differentiation of hMSCs than the SF/CMC scaffolds 
 
Biomineralization of hMSCs seeded composite nanofibrous scaffold 
The level of mineralized matrix produced by hMSCs over the developed scaffold after 
culturing for 14 days in osteogenic differentiation media was assessed by observation under 
inverted phase contrast microscope and further quantified by ARS assay.  The inverted phase 
contrast microscopic image (Figure 5.46A) clearly shows that the biomineralization of 
scaffolds by hMSCs depends on both culture duration as well as scaffold composition. The 
extent of mineralization was observed to be increased with culture time over all the scaffolds. 
The intensity of stained calcium nodules was observed to be higher on SF/CMC/10%nBG 
compared to the control throughout the culture period which signifies the superior bioactivity 
of the nano composite scaffold. 
 
The quantitative ARS assay shows that biomineralization increases with time from day 7 to 
day 14. As indicated from Figure 5.46B, the optical density (OD) for SF/CMC/10%nBG was 
significantly higher (p < 0.05) than SF/CMC/0%nBG on both 7 and 14 days of culture period. 
The higher degree of biomineralization on SF/CMC/10%nBG is due to the dissolution of 
bioglass, leading to the formation of osteoconductive hydroxyapatite. This also suggests that 
the degree of ECM mineralization depends on culture duration as well as the scaffold 
material. Thus, it demonstrates that nano-bioglass containing SF/CMC composite 
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nanofibrous scaffolds not only facilitate the hMSCs recruitment but also triggers hMSCs 
towards osteogenic lineages and invoke the biomineralization of scaffold. 
 
 
Figure 5.46: (A) Alizarin red S staining of SF/CMC/0%nBG and SF/CMC/10%nBG 
nanofibrous scaffolds cultured for day 7 (a) and day 14 (b). (B) Alizarin Red S staining assay for 
quantitative evaluation of hMSCs mineralization on SF/CMC/0%nBG and SF/CMC/10%nBG 
nanofibrous scaffolds after 14 days of culture. The nano-bioglass incorporated composite 
scaffold SF/CMC/10%nBG shows enhanced biomineralization than the control. (Scale bar = 50 
µm) 
 
Osteogenic differentiation of hMSCs seeded on composite nanofibrous scaffold 
The expression of Runx2, osteocalcin and collagen type1, which are well known markers for 
osteogenic differentiation of human mesenchymal stem cells were investigated to confirm the 
bone tissue regeneration ability of the nanofibrous composite scaffold. Runx2 is an osteoblast 
specific transcription factor that acts intracellularly and controls the expression of bone tissue 
specific genes such as collagen 1 and osteocalcin respectively [362]. The 
immunocytochemistry for Runx2 expression during 7 and 14 days of culture (Figure 5.47A) 
was examined through the confocal microscopic laser assisted image analysis. As co-
localization of Runx2 and DAPI immunostainning shows that the expression of Runx2 was 
localized mostly to the cell nuclei. The fluorescent signals for Runx2 immunostainning were 
quantified and statistically analyzed (Figure 5.47C). From integrated density plot (Figure 
5.47C) it was observed that Runx2 expression level was higher on day 7 and down regulated 
further on day 14. Furthermore, the Runx2 expression level was significantly (p<0.05) higher 
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in hMSCs seeded on SF/CMC/10%nBG on day 7 and then decreased significantly (p<0.05) 
on day 14 as compared to SF/CMC/0%nBG. Thus the bioglass containing nanofibrous 
composite scaffolds shows improved bioactivity that triggers the differentiation of hMSCs 
toward osteogenic lineages through Runx2 dependent pathways. As Runx2 is an early stage 
marker of osteogenic differentiation and observed to be well expressed by hMSCs seeded on 
nanofibrous composite scaffolds, the  OCN expression, as a late marker and depend on 
degree of mineralization was measured [363]. Figure 5.47B reveals that the OCN expressions 
were consecutively increased in hMSCs seeded on SF/CMC/0%nBG and SF/CMC/10%nBG 
scaffolds from day 7 to 14 of culture. The Integrated density plot (Figure 5.47D) shows that 
OCN expression level was significantly (p<0.05) higher in SF/CMC/10%nBG in comparison 
of other scaffolds at day 7 and day 14.  
 
The osteoblastic differentiation of hMSCs on the scaffolds was further assessed by RT-PCR 
for Runx2, osteocalcin (OCN) and collagen type1 gene expressions. On day 14 of culture, 
RT-PCR analysis shows significantly (p<0.05) higher level of OCN expression on 
SF/CMC/10%nBG (Figure 5.47F) then SF/CMC/0%nBG nanofibrous scaffolds. The OCN 
expression on SF/CMC/10nBG was observed to be 4.1 fold higher than pure SF/CMC 
scaffold. The Runx2 gene expression (Figure 5.47E) was observed to be lower with 
insignificant difference among scaffolds after two weeks of culture. Whereas for collagen 
type1 SF/CMC/10%nBG shows 3.3 fold higher expressions than pure SF/CMC (Figure 
5.47G).  This can be explained as- the nano-bioglas dissolution resulted into higher silicon, 
Ca2+ and PO4
2- ion concentration as observed by ICP-OES analysis, which were beneficial for 
osteogenic differentiation and extracellular matrix formulation.     
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Figure 5.47: Immunocytochemistry for Runx2 and osteocalcin expression by hMSCs cultured on 
SF/CMC/0%nBG and SF/CMC/10%nBG nanofibrous scaffolds. (A) Confocal images for Runx2 
expressions (scale bar = 50 µm) (A) and Confocal images for osteocalcin expressions of hMSCs 
(scale bar = 25 µm) on day 7 and day 14 in the osteogenic culture medium. Integrated density 
evaluation for RunX2 and osteocalcin were shown in graphs (C) and (D) respectively. The 
osteogenic differentiation of hMSCs on SF/CMC and SF/CMC/10nBG scaffolds was assessed by 
RT-PCR for Runx2 (E), osteocalcin (F) and collagen type1 (G) expression after 14 days of 
culture. 
  
 
 
 
 
 
 
 
 
CHAPTER 5D 
Development of copper doped nano bioglass 
incorporated SF/CMC composite scaffolds 
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Development of bioactive scaffold, which provides appropriate osteogenic and angiogenic 
microenvironment for osteogenic cells growth and bone tissue regeneration is important 
paradigms in current approaches of bone tissue engineering. To fulfil the needed requirement 
of organic and inorganic containing microenvironment for osteogenic cell growth, biopolymer 
-bioceramic composite scaffold proves to be beneficial. Therefore, in the previous chapter 
nanofibrous SF/CMC/nBG nanocomposite scaffold with appropriate composition was 
developed which has been proven to be a potential artificial ECM matrix with enhanced 
osteogenic and biomineralization (apatite formation ability) property. Angiogenesis is another 
crucial factor in bone tissue regeneration because blood vessels provide a means to supply 
nutrients and oxygen which are essential for growth of neo tissue formed. Therefore, 
vascularisation is essential for the survival of the cells seeded in the scaffold. In this context,  
different approaches have been advocated to stimulate angiogenesis in tissue engineering, e.g. 
the delivery of vasculogenic growth factor (VEGF). However, side effects of using the growth 
factor and high expenditure involved in this approach limit their uses[364]. Recently, the 
doping of inorganic ions has been considered as a novel approach to increase the intrinsic 
angiogenesis potential of the scaffold by stimulating angiogenesis. Furthermore, among the 
inorganic ions, Cu2+ is an attractive choice in enhancing vascularisation. Very recently, in-vitro 
and in-vivo studies has further reported the promising role of Cu2+ ions in enhancing 
angiogenesis and also osteogenesis thereby, increased bone tissue regeneration [365-366]. 
 
Therefore, efforts have been given in this phase of research work to improve the angiogenic 
potential of the SF/CMC scaffold by incorporating Cu2+ doped nano-bioglass prepared in the 
chapter 5B. In this study, several batches of SF/CMC scaffolds with varied percentage of Cu2+ 
doped nBG  were prepared and the performance of the Cu doped scaffolds were evaluated for 
their various physiochemical features and biological functionality which are described in this 
chapter. 
 
5.4.1 Fabrication and characterization of SF/CMC/Cu-nBG nanofibrous     
        composite scaffold 
 
Different batches of SF/CMC/Cu-nBG composite mixtures are prepared by dissolving 
SF/CMC blend and copper doped nano-bioglass with different compositions in formic acid as 
shown in Table 5.3. Electrospun nanofibers were successfully generated from the prepared 
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nano composite solutions. The effect of Cu-nBG concentration on the viscosity of the 
electrospinnable composite solution and the fiber diameter of the generated electrospun fiber 
were observed to be in similar trend to the nBG incorporated SF/CMC composite nanofibrous 
scaffolds developed in chapter 5C. The different composite solutions, there viscosity and the 
corresponding fiber diameter are shown in Table 5.4. These experimental findings are evident 
from FESEM images that are depicted in Figure 5.48. As indicated, the average fiber diameter 
was increased steadily from 233.60 ± 83 nm to 568.40 ± 172 nm and 233.60 ± 83 nm to 572.87 
± 158 nm with the incorporation of Cu0.5-nBG and Cu1-nBG at 5 wt% to 10 wt% respectively. 
The average pore size of SF/CMC/Cu0.5-5%nBG, SF/CMC/Cu0.5-10%nBG, SF/CMC/Cu1-
5%nBG and SF/CMC/Cu1-10%nBG measured from FESEM images (Figure 5.48)  are 4.55 ± 
1.7 µm, 4.62 ± 2.3 µm, 4.49 ± 1.1 µm and 4.58 ± 1.5 µm respectively. However, the difference 
in pore size between SF/CMC/Cu-nBG and SF/CMC/nBG composite scaffolds is not 
statistically significant.  As revealed by TEM image, the copper doped nano-bioglass (≤ 100 
nm) was successfully electrospun with SF/CMC and well dispersed over the surface of 
nanofibers. Furthermore, the amorphous nature of both polymeric as well as copper doped 
nano-bioglass components of composite nanofibrous scaffold was confirmed by SAED pattern 
as no ring like pattern was found in obtained SAED images. Furthermore, FESEM and TEM 
images (Figure 5.48) reveal that Cu-nBG is uniformly distributed over all the Cu-nBG loaded 
composite scaffolds. However, agglomeration of Cu-nBG over SF/CMC/Cu1-10%nBG 
scaffold is observed to a certain extent.  
 
Table 5. 3: Composition of various composite nanofibrous scaffold 
Scaffold SF/CMC (wt%) Cu0.5-nBG (wt%) Cu1-nBG(wt%) 
SF/CMC/0%nBG 100 0 0 
SF/CMC/ Cu0.5-5%nBG 95 5 0 
SF/CMC/ Cu1-5%nBG 95 0 5 
SF/CMC/ Cu0.5-10%nBG 90 10 0 
SF/CMC/ Cu1-10%nBG 90 0 10 
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Figure 5.48: FESEM, TEM and SAED pattern images of fabricated SF/CMC/0%nBG, 
SF/CMC/Cu0.5-5%nBG, SF/CMC/Cu0.5-10%nBG, SF/CMC/Cu1-5%nBG and SF/CMC/ Cu1-
10%nBG nanofibrous scaffolds.  
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Table 5. 4: Viscosity, average fiber diameter and average pore size of various composite 
nanofibrous scaffolds with and without Cu-nBG 
 
 
 
 
 
 
 
Structural and functional analysis 
The respective XRD (Figure 5.49A) and FT-IR (Figure 5.49B) patterns were used to 
investigate the structural and functional characteristics of the SF/CMC scaffolds modified by 
the incorporation of Cu0.5-nBG and Cu1-nBG respectively. The diffraction peaks at 2θ values 
of 20.8° and 24.3° indicating the β-sheet conformation of the developed nanofibrous scaffold 
were intensified as Cu-nBG introduced up to 5 wt%. This phenomenon may be attributed to 
the conformational transformation of randomly arranged coil to β – sheet structure. However, 
at 10wt% Cu-nBG incorporation, the amorphous nature of nBG was prominently noticed. 
The FT-IR spectra of SF/CMC/Cu-nBG showed vibration bands at 470 cm-1, 1060 cm-1  and 
1100 cm-1  which are associated with Si-O-Si bending mode[331, 349]. The peak at 970 cm-1 
was assigned to the non-bridging oxygen together with the surface active silanols (Si-OH) 
groups, which facilitate apatite formation.  The shoulder peak at 958 cm-1 belongs to the Si-
O-Ca vibration mode [230]. The peak at 920 cm-1  is the result of  stretching vibration of the 
phosphate group (O-P-O) [349]. From FT-IR spectra it has been observed that as the Cu-nBG 
content increases the peak at 1060 cm-1  which are associated with Si-O-Si bending mode 
became more broader due to the improvement in interaction such as hydrogen bonding or 
ionic bonding between the fibers and nano-bioglass [348] 
Scaffold Average fiber 
diameter (nm) 
Average pore size 
(µm) 
SF/CMC/0%nBG 233.60 ± 83 4.51 ± 1.6 
SF/CMC/ Cu0.5-5%nBG 362.23 ± 134 4.55 ± 1.7 
SF/CMC/ Cu0.5-10%nBG 568.40 ± 172 4.62 ± 2.3 
SF/CMC/ Cu1-5%nBG 347.53 ± 142 4.49 ± 1.1 
SF/CMC/ Cu1-10%nBG 572.87 ± 158 4.58 ± 1.5 
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Figure 5.49: (A) XRD diffractogram and (B) FT-IR spectra of SF/CMC/0%nBG, 
SF/CMC/Cu0.5-5%nBG, SF/CMC/Cu0.5-10%nBG, SF/CMC/Cu1-5%nBG and SF/CMC/ Cu1-
10%nBG nanofibrous scaffolds.  
 
5.4.2 In vitro bioactivity 
In this study, the effect of incorporated Cu0.5-nBG and Cu1-nBG at varying contents of each 
one from 5 to 10 wt% in SF/CMC blend (SF/CMC/Cu0.5-5%nBG, SF/CMC/Cu0.5-10%nBG, 
SF/CMC/ Cu1-5%nBG and SF/CMC/ Cu1-10%nBG) was investigated and the experimental 
results are depicted in Figure 5.50. The ability of the composite scaffold containing different 
Cu-nBG content to induce apatite formation on their surface was assessed by FESEM study 
after soaking in SBF for 7 days. In comparison, the SF/CMC/Cu0.5-10%nBG shows better 
mineral deposition over the scaffold matrix than SF/CMC/Cu0.5-5%nBG. Similarly, SF/CMC/ 
Cu1-10%nBG shows greater extent of mineral deposition than that shown by SF/CMC/ Cu1-
5%nBG scaffold. Thus, as the concentration of Cu-nBG increases, the surface of the nano 
composite scaffold exhibited improved mineral deposition which is clearly seen in FESEM 
images. Furthermore, the extent of mineral deposition over SF/CMC/Cu1-5%nBG scaffold 
matrix was similar to SF/CMC/Cu0.5-5%nBG, whereas a slightly higher mineral deposition 
over the scaffold matrix was observed in SF/CMC/Cu1-10%nBG in comparison to 
SF/CMC/Cu0.5-10%nBG, the phenomena of which is attributed to the higher bioactivity of 
copper doped bioglass. Furthermore, the level of copper doping has independent effect on the 
apatite forming ability of copper doped nano-bioglass as reported earlier with other bioglass 
system (copper doped 45S5) [340].  
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Figure 5.50: FESEM images of SF/CMC/0%nBG, SF/CMC/Cu0.5-5%nBG, SF/CMC/Cu0.5-
10%nBG, SF/CMC/Cu1-5%nBG and SF/CMC/Cu1-10%nBG nanofibrous scaffolds after SBF 
treatment for 7 days (A-E). 
 
Structural and functional analysis of biomineralized scaffold 
The X-ray diffraction pattern of the developed Cu doped nanobioglass incorporated scaffolds 
were recorded after SBF treatment for 7 days to investigate the mineralization of scaffolds 
and compared with the standard XRD peak of synthetic hydroxyapatite as shown in Figure 
5.51A. The diffractogram of SF/CMC/Cu-nBG shows that as the Cu-nBG content increases 
from 5 to 10wt% the characteristic peaks of the apatite at 31.8° attributed to 211 plane get 
intensified thereby resulted superior biomineralization at higher concentration of Cu-nBG 
[359]. Thus, the peak height and width were increased for SF/CMC/0.5Cu-10nBG and 
SF/CMC/1Cu-10nBG than those were shown by SF/CMC/0.5Cu-5nBG and SF/CMC/1Cu-
5nBG respectively. Furthermore, the peak height and width at 31.8° was higher for SF/CMC/ 
Cu1-10%nBG than SF/CMC/Cu0.5-10%nBG which is because of the improved bioactivity of 
Cu-nBG with increasing copper doping from 0.5 mol% to 1 mol%.  
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As observed in FT-IR spectra Figure 5.51B, the hydroxyapatite deposition on the scaffolds is 
reflected by the characteristic peak at 1070 cm-1 which corresponds to the P-O asymmetric 
stretching mode of vibration for PO4
-3
 group [300-301]. However, the peak at 1070 cm
-1 was 
broader in case of Cu-nBG loaded composite scaffold which may be due to the interaction 
between deposited hydroxyapatite and SF/CMC. The P-O stretching mode has been observed 
at 1012 cm-1 and 976 cm-1 which correspond to the major bands for phosphate group. The 
sharpening of peaks observed at 610 cm-1 and 556 cm-1 are because of O-P-O bending and 
stretching respectively[301-302]. The absorbed CO2 corresponds to the 1400-1450 cm
-1 peaks 
indicating the deposition of carbonated hydroxyapatite on the nanofibers. Furthermore, the 
peak intensity at 1070 cm-1   correspond to phosphate group was observed to be higher for 
SF/CMC/Cu0.5-10%nBG and SF/CMC/Cu1-10%nBG in comparison to SF/CMC/Cu0.5-
5%nBG and SF/CMC/Cu1-5%nBG respectively which may be attributed to the increasing  
Cu-nBG content. However, SF/CMC/Cu1-10%nBG shows prominent peak at 1070 cm
-1    
because of higher apatite forming ability as compared to SF/CMC/Cu0.5-10%nBG composite 
scaffold. The FESEM, XRD and FT-IR analysis of nanofibrous scaffolds confirm re-
precipitation of released ions after dissolution of Cu-nBG as carbonated nano hydroxyapatite 
on the composite scaffold matrix [367]. 
 
 
Figure 5.51: (A) XRD diffractogram and (B) FTIR Spectra of SF/CMC/0%nBG, 
SF/CMC/Cu0.5-5%nBG, SF/CMC/Cu0.5-10%nBG, SF/CMC/Cu1-5%nBG and SF/CMC/ Cu1-
10%nBG nanofibrous scaffolds after SBF treatment for 7 days.  
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5.4.3 In vitro biodegradation of scaffold 
The developed SF/CMC, SF/CMC/Cu0.5-5%nBG, SF/CMC/Cu0.5-10%nBG, SF/CMC/Cu1-
5%nBG and SF/CMC/Cu1-10%nBG nanofibrous scaffolds were investigated for their  
biodegradation by treatment in PBS (Figure 5.52A) and protease XIV enzymatic (Figure 
5.52B) solutions. The study has shown that the copper doped bioglass incorporated composite 
SF/CMC scaffold was degraded at higher rate than the scaffold without bioglass. 
Furthermore, an enhance rate degradation profile of scaffold occurs in presence of enzyme 
than the degradation obtained using PBS.  The degradation was also found to be Cu-doped 
nano bioglass concentration dependent. The composite scaffold incorporated with Cu1-nBG 
shows degradation of 54.12 ± 2.14 % for SF/CMC/Cu1-5%nBG and 56.21 ± 2.34 % for 
SF/CMC/Cu1-10%nBG, whereas Cu0.5-nBG incorporated scaffold shows degradation of 
53.21 ± 2.11 % for SF/CMC/Cu0.5-5%nBG and 57.27 ± 3.21 % for SF/CMC/Cu0.5-10%nBG 
in presence of enzyme after incubation for 28 days. However in presence of PBS,   Cu1-nBG 
incorporated scaffold shows degradation of 35.21 ± 3.25 % for SF/CMC/Cu1-5%nBG and 
36.43 ± 2.54 % for SF/CMC/Cu1-10%nBG, whereas Cu0.5-nBG shows degradation of 30.32 ± 
2.31 % for SF/CMC/Cu0.5-5%nBG and 33.25 ± 2.89 % for SF/CMC/Cu0.5-10%nBG. Thus, an 
enhanced but controlled biodegradation of composite scaffold can be achieved by inclusion 
of Cu doped nano bioglass into the scaffold matrices.  
 
 
Figure 5.52: Observed degradation behaviour of SF/CMC, SF/CMC/Cu0.5-5%nBG, 
SF/CMC/Cu0.5-10%nBG, SF/CMC/Cu1-5%nBG and SF/CMC/ Cu1-10%nBG scaffolds by soaking 
in enzyme (A) and PBS solution (B) for 28 days. 
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5.4.4 In-vitro cell culture study 
Metabolic activity   
The metabolic activity represents the potential of cells to adhere and proliferate over scaffold 
surfaces, which was quantitatively estimated during the 7 days culture of hMSCs by MTT 
assay as shown in Figure 5.53B. The SF/CMC/Cu0.5-5%nBG and SF/CMC/Cu1-5%nBG 
composite nanofibrous scaffolds showed better metabolic activity or cell viability as 
comparison to SF/CMC/Cu0.5-10%nBG and SF/CMC/Cu1-10%nBG throughout the culture 
duration. This may be attributed to the higher copper ion concentration released from 10wt% 
of Cu-nBG modified SF/CMC blend scaffold.  
 
Live/Dead assay 
The viability of hMSCs seeded over scaffolds was further assessed by live/dead cell staining 
using confocal microscopy. Figure 5.53A shows that the hMSCs were well attached and 
viable after 1 day of culture over SF/CMC, SF/CMC/Cu0.5-5%nBG and SF/CMC/Cu1-
5%nBG scaffolds, whereas SF/CMC/Cu0.5-10%nBG and SF/CMC/1Cu-10%nBG was found 
to be less efficient showing lesser cell viability as most of the cells were found to be dead. 
hMSCs were also well attached and distributed over SF/CMC/Cu0.5-5%nBG and 
SF/CMC/Cu1-5%nBG in comparison to SF/CMC/Cu0.5-10%nBG and SF/CMC/Cu1-
10%nBG. MTT assay (Figure 5.53B) shows significantly lower metabolic activity of hMSCs 
over SF/CMC/Cu1-5%nBG than SF/CMC/Cu0.5-5%nBG composite scaffold which may be 
due to higher copper ion release from Cu1-nBG in comparison to Cu0.5-nBG. Similar 
metabolic activity of hMSCs over SF/CMC/Cu0.5-10%nBG and SF/CMC/1Cu-10%nBG 
composite scaffold was also observed. Thus, the cell metabolic activity and live/dead cell 
staining assays indicate that the SF/CMC/Cu0.5-5%nBG and SF/CMC/Cu1-5%nBG provide 
superior surface for cell attachment than SF/CMC/Cu0.5-10%nBG and SF/CMC/Cu1-
10%nBG scaffolds. Thus SF/CMC, SF/CMC 5%nBG, SF/CMC/Cu0.5-5%nBG and 
SF/CMC/Cu1-5%nBG scaffolds were selected for further study. 
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Figure 5.53:  (A) Live/dead confocal microscopy images of hMSCs cultured on 
SF/CMC/0%nBG, SF/CMC/Cu0.5-5%nBG, SF/CMC/Cu0.5-10%nBG, SF/CMC/Cu1-5%nBG 
and SF/CMC/ Cu1-10%nBG nanofibrous scaffolds. (B) MTT reduction assay of hMSCs 
cultured on SF/CMC, SF/CMC/Cu0.5-5%nBG, SF/CMC/Cu0.5-10%nBG, SF/CMC/Cu1-5%nBG 
and SF/CMC/ Cu1-10%nBG nanofibrous scaffolds 
 
hMSCs adhesion, morphology and spreading 
Figure 5.54 shows the FESEM images of hMSCs seeded scaffold cultured for 14 days period. 
After 12 hour of cell seeding, the obtained aspect ratios for cells grown on SF/CMC, 
SF/CMC/5%nBG, SF/CMC/Cu0.5-5%nBG and SF/CMC/Cu1-5%nBG were 1.325 ± 0.078, 
1.40 ± 0.12, 1.38 ± 0.45 and 1.29 ± 0.31 respectively.  On day 7, cells were seen to be 
attached and proliferated over all types of scaffolds. The seeded hMSCs over the SF/CMC 
nanofibrous scaffold shows spindle shape like morphology. However, on SF/CMC/5%nBG, 
SF/CMC/0.5Cu-5nBG and SF/CMC/1Cu-5nBG, cell morphology was observed to be 
polygonal shape at the same time shows growth of filopodia that reflects the strong 
attachment and spreading of cells. The MSCs morphology tends to changes in to polygonal 
shape is primary indication for osteogenic differentiation potential of, SF/CMC/5%nBG, 
SF/CMC/0.5Cu-5nBG and SF/CMC/1Cu-5nBG [360]. However, by day 14, the proliferated 
cells were observed to cover the scaffold by formation of monolayer like structure.  
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Figure 5.54: FESEM images of hMSCs cultured on the SF/CMC/0%nBG, 
SF/CMC/5%nBG, SF/CMC/Cu0.5-5%nBG and SF/CMC/Cu1-5%nBG scaffolds after 12 
hour, 7 and 14 days of culture in DMEM media supplemented with FBS.  
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Cytoskeleton organization 
Figure 5.55 shows the acquired fluorescence images of cytoskeleton development and their  
distribution after 14 days of cell culture on the electrospun SF/CMC/0%nBG, 
SF/CMC/5%nBG, SF/CMC/Cu0.5-5%nBG and SF/CMC/Cu1-5%nBG composite scaffolds. 
On day 14, it was observed that cells were proliferated and form monolayer like coverage 
over the scaffold surfaces.  However, cells were more polygonal in shape and more cells were 
spread over SF/CMC/Cu0.5-5%nBG and SF/CMC/Cu1-5%nBG composite scaffolds as 
compared to SF/CMC/0%nBG and SF/CMC/5%nBG nanofibrous scaffolds Thus, the study 
demonstrates that the developed composite scaffold incorporated with copper doped nano-
bioglass could be used as potential cell supportive matrix for neo bone tissue regeneration. 
 
 
Figure 5.55: hMSCs proliferation and distribution are visualized under confocal microscope 
over SF/CMC/0%nBG, SF/CMC/5%nBG, SF/CMC/Cu0.5-5%nBG and SF/CMC/Cu1-5%nBG 
after 14 days of culture. Nuclei of the cells were stained with DAPI (blue) and actin filaments 
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with phalloidin (green). Overall, better elongation and spreading of cells were observed over 
SF/CMC/Cu0.5-5%nBG in comparison to SF/CMC and SF/CMC/5%nBG. (Scale bar = 25 µm) 
 
Glucosamino glycan (GAG) estimation 
The accumulation of synthesized GAG over SF/CMC/0%nBG, SF/CMC/5%nBG, and 
SF/CMC/Cu0.5-5%nBG and SF/CMC/Cu1-5% nBG composite scaffolds was evident from 
Figure 5.56. On day 7, GAG content was significantly higher over SF/CMC/Cu0.5-5%nBG 
(0.311 ± 0.013 µg/mg) composite scaffold than SF/CMC/0%nBG (0.109 ± 0.011µg/mg), 
SF/CMC/5%nBG (0.209 ± 0.011 µg/mg) and SF/CMC/Cu1-5%nBG (0.249 ± 0.004 µg/mg) 
scaffold. However, by day 14 of culture GAG content increases significantly for the entire set 
of scaffold. The production of GAG was increased with the progress of culture. The GAG 
content of 0.56 ± 0.02 µg/mg was estimated on SF/CMC/Cu0.5-5%nBG scaffold which was 
1.8 fold higher than day 7. Whereas, comparatively lesser amount of GAG was secreted over 
SF/CMC/0%nBG (0.1835 ± 0.008 µg/mg) and SF/CMC/Cu1-5%nBG (0.405 ± 0.015 µg/mg) 
scaffolds which were also approximately 1.6 fold higher than day 7 respectively. However, 
SF/CMC/5%nBG significantly increased GAG production (0.318 ± 0.0065 µg/mg), which is 
1.7 and 1.2 fold lower than SF/CMC/Cu0.5-5%nBG and SF/CMC/Cu1-5%nBG respectively. 
The Cu-nBG incorporated SF/CMC composite scaffold support superior cell viability and 
cell growth, which further augment the GAG deposition during the culture period.  Thus, 
SF/CMC/Cu0.5-5%nBG composite nanofibrous scaffold promoted better GAG deposition as 
compared to entire set of nanofibrous scaffolds.  
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Figure 5.56: Estimation GAG secreted by hMSCs cultured in osteogenic media during 7 and 14 
days of culture over over SF/CMC/0%nBG, SF/CMC/5%nBG, SF/CMC/Cu0.5-5%nBG and 
SF/CMC/Cu1-5%nBG. The SF/CMC/Cu0.5-5%nBG composite nanofibrous scaffold shows 
significantly higher GAG deposition as compared of other set of scaffolds. 
 
5.4.5 Osteogenic differentiation 
Alkaline Phosphatase assay 
Figure 5.57 shows that the ALP activities of hMSCs cultured over the scaffolds and indicate 
the progressive differentiation of hMSCs towards osteogenic lineages. The ALP activity of 
hMSCs on SF/CMC/5%nBG and SF/CMC/Cu0.5-5%nBG was higher than SF/CMC/0%nBG 
and SF/CMC/Cu1-5%nBG on day 7 of culture. However, by day 14 all the composite 
scaffolds containing nanobioglass showed higher bioactivity than SF/CMC scaffolds and the 
bioactivity level was comparable.  Thus, it has been demonstrated that the addition of Cu2+ 
did not show any significant role in enhancing bioactivity. This finding is also corroborated 
with the published literature that reported the insignificant role of Cu 2+  when it was doped 
with nanobioglass  which was used as scaffold for bone tissue regeneration [325].  
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Figure 5.57: Alkaline phosphatase (ALP) activity in hMSCs on SF/CMC/0%nBG, 
SF/CMC/5%nBG, SF/CMC/Cu0.5-5%nBG and SF/CMC/Cu1-5%nBG nanofibrous scaffolds in 
an osteogenic culture medium over time (n=3).  
 
Biomineralization of hMSCs seeded composite nanofibrous scaffold 
The biomineralization of extracellular matrix deposited by hMSCs cultured on the scaffolds 
in osteogenic medium for two weeks were assessed by inverted phase contrast microscope 
and ARS assay. As revealed from Figure 5.58A, the biomineralization of scaffolds by hMSCs 
were varied depending upon time period of culture as well as scaffold composition. A gradual 
increase in the extent of mineralization was observed with culture time for all the scaffolds. 
The intensity of stained calcium nodules was observed to be higher on SF/CMC/Cu1-5%nBG 
compared to SF/CMC/Cu0.5-5%nBG by day7. However, the intensity for calcium nodules 
was observed to be almost similar to the intensity observed on day 14. The quantitative ARS 
assay shows that biomineralization increases with time from day 7 to day 14. Figure 5.58B 
shows the optical density (OD) for SF/CMC/0.5Cu-5nBG and SF/CMC/1Cu-5nBG was 
significantly higher than that of SF/CMC/0%nBG and SF/CMC/5%nBG on day14. The 
higher degree of biomineralization on SF/CMC/Cu1-5%nBG and SF/CMC/Cu0.5-5%nBG 
may be due to the synergistic action of copper ions with other ionic dissolution products 
released from bioglass.  
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Figure 5.58: Showing the microscopic images of Alizarin red S staining of SF/CMC/0%nBG, 
SF/CMC/5%nBG, SF/CMC/Cu0.5-5%nBG and SF/CMC/Cu1-5%nBG nanofibrous scaffolds 
cultured for 14 days (A). Alizarin Red S staining assay for quantitative evaluation of 
mineralization on SF/CMC/0%nBG, SF/CMC/0.5Cu-5nBG and SF/CMC/1Cu-5nBG 
nanofibrous scaffolds after 14 days of culture. SF/CMC scaffold modified with Cu-nBG shows 
superior biomineralization as compared to other scaffolds due to its superior bioactivity 
potential. (Scale bar = 50 µm) 
 
Osteogenic differentiation of hMSCs seeded on nanofibrous scaffold 
Similar to the study in previous chapter, the immunocytochemistry for RUNX2 expression as 
shown in Figure 5.59A on the developed Cu-doped nanobioglass incorporated scaffolds was 
evaluated based on confocal microscopic. As co-localization of Runx2 and DAPI 
immunostainning shows that the expression of Runx2 was localized mostly to the cell nuclei. 
From confocal images and integrated density graph (Figure 5.59C) it has been observed that 
Runx2 expression was higher on SF/CMC/5%nBG, SF/CMC/Cu0.5-5%nBG and 
SF/CMC/Cu1-5%nBG composite scaffold on day 7 and 14 in comparison SF/CMC/0%nBG. 
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Furthermore, the expression of Runx2 was observed to be significantly higher on 
SF/CMC/5%nBG as compared of other set of scaffold while culture duration of 14 days. 
However, the florescence intensity was observed to be decreases by day 14 for the entire set 
of scaffold, this indicates the osteogenic differentiation of hMSCs seeded over the scaffold.  
Furthermore, the immunocytochemistry for OCN expression (Figure 5.59B) on the developed 
nanocomposite scaffold during 14 days culture period assessed by confocal microscopy 
study. OCN expression was observed to be significantly (p<0.05) higher on copper doped 
bioglass incorporated SF/CMC/Cu0.5-5%nBG scaffold than the other scaffolds used under 
study on day 14. However, the expression of OCN over SF/CMC/5%nBG and SF/CMC/Cu1-
5%nBG was observed to be significantly higher (p<0.05) than SF/CMC/0%nBG on day 7 
and 14.  
 
The osteoblastic differentiation of hMSCs on the scaffolds was further assessed by RT-PCR 
for Runx2 and osteocalcin (OCN) gene expressions. On day 14 of culture, RT-PCR analysis 
shows insignificantly higher level of OCN expression on SF/CMC/Cu0.5-5%nBG (Figure 
5.59E) in comparison to SF/CMC/5%nBG and SF/CMC/Cu1-5%nBG nanofibrous scaffolds 
respectively and significantly higher than SF/CMC/0%nBG. However, The Runx2 gene 
expression (Figure 5.59E) was observed to be significantly higher on SF/CMC/5%nBG, 
SF/CMC/Cu0.5-5%nBG and SF/CMC/Cu1-5%nBG in comparison of SF/CMC/0%nBG. Thus, 
copper doping at low level might not be sufficient to bring significant changes in osteogenic 
gene expression, however it might be useful to evaluate using culture media without adding 
osteogenic growth factors [325].   
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Figure 5.59: Immunocytochemistry for Runx2 and osteocalcin expression in hMSCs cultured on 
SF/CMC/0%nBG, SF/CMC/5%nBG, SF/CMC/Cu0.5-5%nBG and SF/CMC/Cu1-5%nBG 
scaffolds. Confocal images for Runx2 (Scale bar = 50 µm) (A) and osteocalcin expressions (Scale 
bar = 25 µm) (b) observed in hMSCs on day 7 and 14 in the osteogenic culture medium. 
Confocal images contain insets which represents distribution of cell nuclei stained with DAPI 
over the scaffold. Integrated density evaluation for RunX2 and osteocalcin were shown in 
graphs (C) and (D) respectively. (E) The osteogenic differentiation of hMSCs on the scaffolds 
was assessed by RT-PCR for Runx2 and osteocalcin expression after 14 days of culture 
 
HIF-1α and VEGF expression analysis 
The expression of hypoxia inducible factor was analysed by using confocal microscopy to 
determine the level of expression on various composite scaffolds developed in this study as 
shown in Figure 5.60. The expression of HIF-1α was observed to be higher over SF/CMC/Cu1-
5%nBG as compared of the entire scaffold on day 7. In comparison, the expression of HIF-1α 
by hMSCs seeded on SF/CMC/Cu0.5-5%nBG and SF/CMC/Cu1-5%nBG was significantly (p < 
0.05) higher than SF/CMC/5%nBG and SF/CMC/0%nBG. Whereas, the expression level was 
decreased on both the scaffolds by 14th day of culture. Both on day 7 and 14, the expression of 
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HIF-1α was observed to be low on SF/CMC/0%nBG than SF/CMC/5%nBG. Furthermore, 
copper ion is reported to influence angiogenesis of bone tissue graft. The effect of release of 
copper ion from Cu-nBG on HIF-1α expression and VEGF secretion by hMSCs over 
developed composite scaffold was evaluated. The expression of HIF-1α was observed to be 
higher over SF/CMC/Cu1-5%nBG as compared to other scaffold on day 7 due to higher copper 
ion release from Cu1-nBG. The overall trend was observed to be SF/CMC/Cu1-5%nBG > 
SF/CMC/Cu0.5-5%nBG > SF/CMC/5%nBG > SF/CMC. This shows higher Cu ion releases 
from Cu1-nBG than Cu0.5-nBG, playing significant role in maintaining stable HIF-1α 
expression and higher VEGF expression by hMSCs [325]. Thus, it has been demonstrated that 
the release of copper ion from Cu-nBG plays significant role in expression of HIF-1α and the 
expression is dependent on the level of copper doping. Furthermore, nBG also trigger 
expression of HIF-1α but at low level thus this can be further enhanced by the doping of Cu2+ 
in nano-bioglass. However, Cu-nBG shows better stability of HIF-1α expression and 
maintained up to day 14 of culture, which will further augment VEGF expression thereby 
leading to superior angiogenic potential of SF/CMC/Cu0.5-5%nBG and SF/CMC/Cu1-5%nBG 
composite scaffolds [325]. 
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Figure 5.60: Confocal images for HIF-1α expression in hMSCs seeded on SF/CMC/0%nBG, 
SF/CMC/5%nBG, SF/CMC/Cu0.5-5%nBG and SF/CMC/Cu1-5%nBG nanofibrous nano 
composite scaffolds cultured for day 7 (A) and 14 (B). (Scale bar = 25 µm) 
 
From the literature, it is evident that Cu2+ ions play important role not only in expression of 
HIF-1α, but also provides stability towards its expression, which further lead to the activation 
of VEGF expression. The study has revealed that the VEGF expression (Figure 5.61) in 
hMSCs on SF/CMC/Cu1-5%nBG was 1.1 fold higher than SF/CMC/Cu0.5-5%nBG. However, 
The VEGF expression over SF/CMC/Cu1-5%nBG was observed to be 1.1, 1.65 and 1.9 folds 
higher than SF/CMC/Cu0.5-5%nBG, SFCMC/5%nBG and SF/CMC/0%nBG respectively. 
Thus, copper doped bioglass incorporated composite nanofibrous scaffold is superior in terms 
of angiogenic potential as compared  to composite scaffold incorporated with nano-bioglass.  
 136 
 
 
Figure 5.61: Relative VEGF expression in hMSCs seeded over SF/CMC/0%nBG, 
SF/CMC/5%nBG, SF/CMC/Cu0.5-5%nBG and SF/CMC/Cu1-5%nBG nanofibrous scaffolds 
during 7 days culture period. The study confirms that the copper doped bioglass incorporated 
composite nanofibrous scaffold is superior in terms of angiogenic potential as compared to 
composite scaffold incorporated with nano-bioglass.  
 
Table 5.6: Comparison among the most potential scaffolds developed 
Sl 
.No 
Electrospun 
Scaffold 
Average 
fiber 
diameter 
(nm) 
Pore size 
(µm) 
Tensile 
strengt
h (MPa) 
Contact 
angle (˚) 
In-vitro Cell study 
1. 1
1
. 
SF/CMC blend 
scaffold  
227.8 ± 87 4.7 ± 1.9 10.5 ± 
1.3 
57.4 ± 0.3 hMSCs, MTT, ALP, 
Alizarin red S assay, 
RT-PCR, Bone TE 
2. 1
2
. 
SF/CMC/10%nBG 589 ± 161 4.64 7.59 ± 
1.23 
52 hMSCs, MTT, ALP, 
Alizarin red S assay, 
RT-PCR, Bone TE 
3. 1
3
. 
SF/CMC/ Cu1-
5%nBG 
568.40 ± 
172 
4.62 ± 2.3 4.92 ± 
0.14 
56.28 hMSCs, MTT, ALP, 
Alizarin red S assay, 
RT-PCR, VEGF 
analysis, Bone TE 
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CHAPTER 6: Summary and  
Conclusion 
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Bone tissue engineering has emerged as an alternative promising approach for the repairing 
and/or replacing damaged and/or diseased bone tissue. In this technique, the design and 
development of bioactive functional scaffold with nanofibrous architecture from suitable 
biomaterial with desired properties like biocompatible, biodegradable, mechanical, surface 
and bone matrix formation ability is the key challenge to provide a suitable platform for the 
bone tissue regeneration. Silk fibron (SF) derived from Bombyx Mori silk cocoon is a 
potential biomaterial having various superior scaffold properties, however, use of SF alone 
cannot meet all the desirable properties required for bone tissue regeneration due to its poor 
bioactivity, lack of hydrophilicity, flexibility and osteoconductive property.  In this context, 
the blending of SF with CMC seems to be an attractive biomaterial that can overcome many 
of the limitations associated with SF.    
 
Besides material property, fabrication of scaffold with nanofiber architecture is another 
important aspect, which can mimic the body tissue and provide higher surface area. In this 
context, electrospinning has been evolved as the most suitable method for the generation of 
polymer nanofibers so far. 
 
 Therefore, the research in this dissertation work has been focussed on the development of 
novel SF/CMC based electrospun nanofibrous scaffolds for bone tissue engineering 
applications. 
 
The most encouraging results achieved from this research is summarized as follows- 
 
I. In the first phase of dissertation work, attempt has been given to develop SF/CMC blend 
nanofibrous scaffold by free liquid surface electrospinning process. The SF/CMC blend 
nanofibrous scaffolds were prepared by electrospinning with varied compositions of 
SF/CMC (100/0, 99/1, 98/2 and 97/3 (w/w)) blend solutions. The fabricated electrospun 
nanofibrous scaffolds were cross-linked with 3wt% EDC-NHS and calcified with 0.1M 
CaCl2 solution.  Significant improvement in various physico-chemical, mechanical and 
biological properties in comparison to the pure SF nanofibrous scaffold was achieved by 
blending of SF and CMC. Among the various blends, SF/CMC with blend ratio of 
98:2w/w (SF/CMC2) was found to be the most potential, possessing a set of superior  
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scaffold properties in comparison to pure SF scaffold.  The scaffolds were characterized 
for morphological (SEM, AFM), structural (XRD, FT-IR), surface property (% water 
uptake and contact angle measurement), surface roughness (AFM) bioactivity (SBF 
treatment, ARS) and mechanical strength. The average fiber diameter of the blend scaffold 
was measured to be 227.8±87 nm. The scaffold exhibited improved water uptake capacity, 
hydrophilicity, surface roughness and bioactivity as compared to pure Bombyx mori SF.  
The tensile strength of SF (12.7±1.5 MPa) scaffold was slightly reduced by the addition of 
CMC. However, the scaffolds still possess sufficient strength (10.54±1.3 MPa) which can 
support many types of bone tissue regeneration. Whereas, the tensile strain at break of 
blend scaffold (18.37 ± 3.8 %) was significantly higher than SF (8.36 ± 3.3%) scaffold, 
which signifies its ability to facilitate cell penetration within the matrix. In vitro cell 
culture study has confirmed the cell supportive property of the scaffold as evident from 
cell attachment, cell proliferation, cell penetration and cellular metabolic activity of 
hMSCs derived from umbilical cord blood over the scaffold. The developed SF/CMC2 
scaffold further possess good osteogenic property as confirmed by ALP activity, 
biomineralization ability, GAG secretion, osteocalcin, Runx2 and collagen type1 
expression. Thus, the developed SF/CMC2 blend scaffold was selected for the further 
study.  
 
II.  In this phase of work,  nano-bioglass and copper doped nano-bioglass were successfully 
prepared following sol-gel method with the expectation that the incorporation of these 
components will make the developed SF/CMC2 scaffold more potential by improving its  
bioactivity, osteogenic and angiogenic property, which are important aspects for bone 
tissue regeneration. The synthesised nano-bioglass and Cu2+ doped nano bioglass were 
characterized to assess their morphological, structural and physical properties. The 
developed nano-bioglass with and without copper doping were in nano size ≤ 100nm as 
revealed from FESEM and TEM analysis. Moreover, XRD and TEM (SAED) analysis 
further confirm their amorphous nature. The in-vitro bioactivity analysis by soaking in 
SBF, shows apatite forming ability of nano-bioglass with and without copper, which was 
further confirmed by FESEM, TEM (SAED), XRD and FT-IR analysis. The ion release 
from nano-bioglass with and without copper in SBF was measured through inductively 
coupled plasma atomic emission spectrophotometer (ICP-OES). ICP-OES analysis has 
shown the faster dissolution rate of copper doped nano-bioglass that resulted into release 
of calcium ion at higher level, which further augmented the apatite deposition over the 
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bioglass surfaces.  The developed nano-bioglass with and without copper doping were 
used to develop SF/CMC composite scaffold. 
  
III. Efforts have been given in this part of research work to improve the osteogenic potential of 
the developed SF/CMC2 blend scaffold by incorporating nanobioglass (5-20 w/w%) that 
resulted in SF/CMC/nBG composite scaffolds with varying composition. The developed 
composite scaffolds were designated as SF/CMC/5%nBG, SF/CMC/10%nBG and 
SF/CMC/20%nBG. The developed composite scaffolds have shown increased average 
fiber diameter (233 ± 83 nm to 594 ± 157 nm), average pore size (4.5 ± 1.65 to 5.4 ± 1.7 
µm), hydrophilicity (57° to 52° (contact angle)), surface roughness (0.101 to 0.309 µm), 
apatite forming ability and degradation (48.28 to 56.23 %)  with increase in  nano-bioglass 
content from 0 to 20 wt%.  The improvement in pore size, hydrophilicity and surface 
roughness will augment cell supportive property of developed nano-bioglass incorporated 
SF/CMC composite scaffold.  
 
Furthermore, among the SF/CMC/nBG scaffolds, SF/CMC/10%nBG exhibited  superior  
tensile strength of 7.591 ± 1.23 MPa and tensile strain at break of 9.62 ± 0.85% as well as 
other properties such as hydrophilicity (52°), surface roughness (0.291 µm) and 
biodegradation (59.24 %). The in-vitro cell study over SF/CMC/10%nBG has shown 
significantly higher biocompatibility, GAG deposition and cell spreading through 
protrusion of filopodia to attain polygonal osteoblast like morphology than the other 
scaffolds. Moreover, hMSCs cultured over SF/CMC/10%nBG shows significantly higher 
ALP activity, biomineralization and gene expression for osteocalcin and collagen type I. 
Hence, SF/CMC/10nBG composite scaffold is proven to provide better osteogenic 
platform for hMSCs. 
 
Besides osteogenic, angiogenic property of the engineered scaffold is another  important 
factor which makes scaffold suitable for bone tissue regeneration. Therefore, in this phase 
of research work, effort has been given to improve the angiogenic property of 
SF/CMC/nBG composite scaffolds by incorporating Cu2+   ion in the form of  Cu 2+ doped 
nano bioglass prepared in the Chapter 5B. Various batches of copper doped nano-bioglass 
incorporated SF/CMC composite nanofibrous scaffolds (SF/CMC/Cu0.5-5%nBG, 
SF/CMC/Cu0.5-10%nBG, SF/CMC/Cu1-5%nBG and SF/CMC/Cu1-10%nBG) were 
prepared. Among the scaffolds with varied compositions, SF/CMC/Cu1-5%nBG exhibited 
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superior osteogenic and angiogenic property. Though a slightly higher OCN expression 
was observed over SF/CMC/Cu0.5-5%nBG composite scaffold than SF/CMC/Cu1-5%nBG, 
the difference in the expression was not statistically significant. This signifies that 
osteogenic potential of both the composite scaffold is comparable. 
Moreover, the angiogenic potential of the developed scaffold was analysed in terms of 
HIF-1α and VEGF expression. The developed SF/CMC/Cu1-5%nBG shows higher 
angiogenic potential than SF/CMC/0.5Cu-5%nBG as evident from HIF-1α and VEGF 
expression. The VEGF expression by hMSCs over SF/CMC/Cu1-5%nBG was observed to 
be 1.1, 1.65 and 1.9 folds higher than SF/CMC/Cu0.5-5%nBG, SFCMC/5%nBG and 
SF/CMC/0%nBG respectively. Thus the developed composite scaffold incorporated with 
5% Cu1-nBG proved to be suitable candidate for bone tissue engineering and needs to be 
further assessed through in-vivo studies 
 
Overall, in this dissertation work, a novel electrospun silk fibroin/carboxymethyl 
cellulose (SF/CMC) blend nanofibrous scaffold was developed which is proven to be a 
good substrate for bone tissue engineering application. The surface, bioactivity and 
osteogenic property of the scaffold was further augmented by the incorporation of nano-
bioglass into the scaffold matrix which resulted in SF/CMC/nBG nano composite  scaffold 
which prompted the recruitment and  differentiation of mesenchymal stem cells derived 
from Umbilical Cord blood to osteogenic lineage. The angiogenic property of the 
developed scaffold was further improved by adding Cu2+   doped nano bioglass thereby 
novel SF/CMC/Cu1-5%nBG was developed. In conclusion, the results demonstrated that 
the developed SF/CMC blend scaffold can be a potential base polymeric scaffold for tissue 
engineering application including bone tissue regeneration. Furthermore, electronspun 
nanofibrous SF/CMC/Cu1-5%nBG nanocomposite scaffold developed in this study may 
provide an excellent platform for future bone tissue regeneration. 
 
IV. Suggested Future Work  
   The following research work are suggested for future study with the developed 
composite scaffolds- 
i. Detail in-vivo animal study can be undertaken for assessing its suitability for possible 
future clinical application. 
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ii. Three dimensional scaffolds with appropriate design and structure may be fabricated 
by adopting advanced scaffold fabrication technique like rapid prototyping 
technique. 
 
iii. Research may be undertaken to develop aqueous based composite scaffolds rather 
than organic solvent to avoid risk of toxicity.   
 
 
Electrospun nanofibrous scaffold possess suitable nano-architecture which mimics natural 
extracellular matrix of collagen fiber (50 – 500 nm). However, it is difficult to fabricate and 
achieve a 3D design of the scaffold with appropriate geometry and controlled pore size using 
electrospinning technique. In this context, RP technique is attractive and therefore, effort may 
be given to fabricate scaffold using rapid prototyping (RP) technique. 
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